Function and regulation of AMP-activated protein kinase in in vitro development and lipid metabolism of preimplantation bovine embryos by Prastowo, Sigit
  
Institut für Tierwissenschaften, Abt. Tierzucht und Tierhaltung 
 
Title: 
Function and regulation of  AMP-activated protein kinase in in vitro development  
and lipid metabolism of preimplantation bovine embryos 
 
 
 
Inaugural-Dissertation 
zur  
Erlangung des Grades 
 
 
Doktor der Agrarwissenschaft 
(Dr. agr.) 
 
 
der 
Landwirtschaftlichen Fakultät 
der 
Rheinischen Friedrich-Wilhelms-Universität Bonn 
 
 
 
 
von 
Sigit Prastowo 
 
aus 
Boyolali, Indonesien 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referent:    Prof. Dr. Karl Schellander 
Koreferent:    Prof. Dr. Dr. agr. Helga Sauerwein 
Tag der mündlichen Prüfung: 06. Juli 2015 
Erscheinungsjahr:   2015 
 
 
  
 
 
 
 
 
 
Dedicated to 
My beloved family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
V 
 
Abstract 
Function and regulation of  AMP-activated protein kinase in in vitro development  
and lipid metabolism of preimplantation bovine embryos 
 
One of the major problems associated with the in vitro production of bovine embryos is lipid 
accumulation due to the presence of serum in culture media. AMP-activated protein kinase 
(AMPK) is well documented as a master regulator of energy metabolism, particularly lipid 
metabolism, in mammalian cells. The present study aimed to explore the potential role of the 
AMPK pathway in bovine embryos related to lipid accumulation. For this, the whole study 
was divided into 3 experiments. In experiment 1, the AMPK activity of in vitro produced 
blastocysts in the presence or absence of serum was analyzed and associated with lipid 
metabolism phenotypes. In experiment 2, 5-aminoimidazole-4-carboxamide riboside 
(AICAR) was applied to enhance AMPK activity during in vitro culture, to investigate its 
effect on embryo development rate, blastocyst cell number, AMPK activity, mitochondrial 
activity and the expression of lipid metabolism genes. Furthermore in experiment 3, the post 
transcriptional regulatory mechanism of AMPKA1 gene was investigated in bovine granulosa 
cells. The results showed that the presence of serum suppressed the expression of genes in the 
AMPK pathway (AMPKA1, STK11) and mitochondrial activity (CPT1, PGC1A), while the 
expression of lipid synthesis gene (ACC) was significantly increased. In addition to the 
reduced activity of AMPK, the presence of serum increased the level of ROS accumulation 
followed by low mitochondrial activity in resulting blastocysts. The application of AICAR 
during embryo culture showed no impact on embryo development rate but significantly 
reduced blastocyst cell number. The presence of AICAR increased the expression AMPKA1, 
STK11, CPT2, PGC1A, NQO1 genes, while ACC was suppressed. In experiment 3, in silico 
study predicted 11 miRNAs as potential regulators of AMPKA1. The miRNA profiling in 
granulosa cells showed that miR-33b is the most abundant miRNA accompanied by low 
expression of AMPKA1 and high lipid droplet accumulation. Luciferase assay validated the 
binding of miR-33b and the 3’UTR of AMPKA1. Inhibition of miR-33b resulted in up 
regulation of AMPKA1 and significantly increases PGC1A gene expression. Moreover, miR-
33b was highly expressed in blastocysts derived from culture with serum, while AMPKA1 
showed a reverse pattern compared to without serum. Altogether, the present study 
demonstrates that expression of AMPK and lipid metabolism pathway in blastocysts were 
affected by the presence of serum in culture media leading to accumulation of lipid.  
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Abstract (German) 
Funktion und Regulation der AMP aktivierte Proteinkinase in der in vitro Produktion 
und dem Lipidmetabolismus von präimplantierten Embryonen 
 
Ein Hauptproblem bei der in vitro Produktion von bovinen Embryonen ist die 
Lipidanreicherung, die durch das im Kulturmedium enthaltene Serum entsteht. AMP 
aktivierte Proteinkinase (AMPK) ist ein Hauptregulator für den Energiemetabolismus vor 
allem des Lipidmetabolismus in Säugetierzellen. Das Ziel der vorliegenden Studie war die 
Rolle des AMPK Signalwegs in bovinen Embryonen in Verbindung zur Lipid Anreicherung 
zu untersuchen. Dafür unterteilte sich die vorliegende Studie in 3 experimentelle Ansätze. Im 
ersten Experiment wurde die AMPK Aktivität in in vitro produzierten Blastozysten in der An- 
und Abwesenheit von Serum analysiert und in Verbindung zum Lipidmetabolismus gesetzt. 
Im zweiten Experiment kam AICAR für die Verbesserung der AMPK Aktivität während der 
in vitro Kultur zum Einsatz. Dabei sollte der Effekt von AICAR auf die embryonale 
Entwicklungsrate, Blastozystenzellzahl, AMPK Aktivität, Mitochondrienaktivität und die 
Expression von Genen des Lipidmetabolismus untersucht werden. Zusätzlich wurden im 
dritten Experiment post transkriptionelle regulatorische Mechanismen des AMPKA1 Genes in 
bovinen Granulosazellen untersucht. Die Ergebnisse zeigten, dass das Serum die Expression 
der Gene des AMPK Signalwegs (AMPKA1, STK11) und der Mitochondrienaktivität (CPT1, 
PGC1A) unterdrückt, wohingegen die Genexpression der Lipidsynthese (ACC) signifikant 
erhöht war. Zusätzlich zu der reduzierten AMPK Aktivität erhöht das Serum das ROS Level 
gefolgt von einer geringen Mitochondrienaktivität in den Blastozysten. Die AICAR Zugabe 
während der Embryokultur zeigte keinen Einfluss auf die embryonale Entwicklungsrate, aber 
eine signifikant reduzierte Blastozystenzellzahl. AICAR erhöhte die Genexpression von 
AMPKA1, STK11, CPT2, PGC1A sowie NQO1 und unterdrückte die Genexpression von 
ACC. Die in Experiment drei durchgeführte in silico Untersuchung erbrachte 11 miRNAs als 
potentielle AMPKA1 Regulatoren. Die miRNA Profilanalyse in Granulosazellen zeigte, dass 
die miR-33b am höchsten detektiert war woraus eine geringe AMPKA1 Expression sowie 
eine hohe Lipidtröpfchenanreicherung resultierte. Durch den Luciferase Assay konnte die 
Bindung zwischen der miR-33b und der 3’UTR des AMPKA1 überprüft werden. Eine miR-
33b Hemmung resultierte in einer Hochregulierung des AMPKA1 und einen signifikanten 
Anstieg der PGC1A Genexpression. Außerdem war die miR-33b von in Serum kultivierten 
Blastozysten hoch exprimiert, wohingegen AMPKA1 ein gegenläufiges Muster im Vergleich 
zu serumfreien Blastozysten zeigte. Zusammenfassend veranschaulicht die vorliegende 
Studie, dass die AMPK Expression und der Signalweg des Lipidmetabolismus in Blastozysten 
durch das Serum im Kulturmedium beeinflusst werden sowie zur Lipidanreicherung führt.
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1 Introduction 
 
Despite the success of embryo transfer from IVP technology in the presence of serum, many 
problems attributed to low quality of embryos still remain unsolved (Crosier et al. 2001, 
Lazzari et al. 2002, Smith et al. 2009, Viuff et al. 2001). One of the major problems of IVP 
embryos is low freezing tolerance which is associated with enhanced cytoplasmic lipid 
accumulation compared to those derived from in vivo or those cultured without serum (Abe et 
al. 2002, Gomez et al. 2008). Excess lipid formation is suggested to come from culture 
environment which modified internal embryo properties and lead to lipid accumulation (Abe 
et al. 2002, Abe and Hoshi 2003, Ferguson and Leese 1999, Gomez et al. 2008). Addition of 
serum to embryo culture media provides beneficial components for embryo development such 
as nutrients, growth factors and antioxidants which subsequently increased blastocyst 
formation (Oliveira et al. 2006, Rizos et al. 2003, Sudano et al. 2011, Wrenzycki et al. 2001). 
On the other hand, serum has been shown to cause harmful effects on embryo metabolism by 
increasing the production of oxidative stress leading to reactive oxygen species (ROS) 
accumulation which alter mitochondrial structure and function (Abe et al. 2002, Cagnone and 
Sirard 2014, Crosier et al. 2001, Thompson et al. 2007). Reports have noted that oxidative 
stress has a negative effect on early embryonic development by altering gene expression as 
well as embryo metabolism (Balasubramanian et al. 2007, Harvey et al. 2002, Rinaudo et al. 
2006), lowering embryo quality, increasing apoptotic rate and fragmentation (Khurana and 
Niemann 2000b, Liu and Keefe 2000) and also increasing intracellular lipid accumulation 
(Abe et al. 2002, Barcelo-Fimbres and Seidel 2007a, Sudano et al. 2011).  
 
Intracellular lipid accumulation is a hallmark of cellular stress. It is mediated by oxidative 
stress which hampers mitochondrial integrity and activity in excessive ROS production 
(Alfaradhi et al. 2014, Lee et al. 2013, Tanaka et al. 2008). Oxidative stress has been reported 
as the causative factor for mitochondrial dysfunction (Bonnard et al. 2008, Lockman et al. 
2012) or vice versa (Kumari et al. 2014, Murphy 2013). Excessive generation of ROS has 
been reported to modulate mitochondrial function through β-oxidation process (Van Hoeck et 
al. 2013b). Moreover, the homeostasis of lipid metabolism is controlled by mitochondrial 
activity where low activity is demonstrated to be associated with increased lipid accumulation 
(Somfai et al. 2011). To the best of our knowledge, the mechanism of intracellular lipid 
accumulation in embryos derived from in vitro culture is still unclear. However, several lines 
of evidences documented that embryos are able to take up fatty acid as the basic of lipid 
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molecules, which are available in culture environment (Barcelo-Fimbres and Seidel 2007a, 
Ferguson and Leese 1999, Sata et al. 1999). Fatty acids are metabolized by mitochondrial β-
oxidation and when their supply is plentiful there is an overload of mitochondria activity 
(Koves et al. 2008) that results in elevated ROS production (Burton et al. 2003). In bovine 
embryos, high ROS level increases lipid accumulation and lipid stress pathway (Cagnone and 
Sirard 2014, Gomez et al. 2008) by reducing mitochondrial activity (Amin et al. 2014). 
Moreover, it is known that mtDNA is sensitive to ROS and any disruption resulted in 
mitochondrial dysfunction (Yakes and Van Houten 1997).  
  
Recent study in our group showed that blastocysts derived from alternate culture of 
preimplantation embryo in vitro and in vivo, resulted in differential expression of protein 
kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1) or namely AMPKA1 (Gad et al. 
2012), which is part of the AMPK heterotrimetric complex (Carling 2004). AMPK is reported 
as the master regulator of metabolic energy balance in several mammalian cells and acts as a 
master metabolic regulator of lipid, glucose and protein metabolism. It is a direct regulator of 
ACC gene activity which is responsible for de novo lipid synthesis (Hopkins et al. 2003). 
AMPK is regulated by the ratio of AMP:ATP rather than the intracellular depletion of ATP or 
accumulation of AMP (Corton et al. 1994). AMPK is activated by energetic stress and it 
promotes catabolic metabolism and inhibits anabolic reactions (Agathocleous and Harris 
2013). The active form of AMPK has been prove to suppress lipogenic genes and to control 
lipid production in mice and human  skeletal muscle (Li et al. 2011, Thomson and Winder 
2009), regulate glucose metabolism in diabetes (Viollet et al. 2009) and decrease obesity (Xu 
et al. 2012) in humans. However, the inactive form increases lipid synthesis (Hopkins et al. 
2003) and lipid accumulation by suppressing mitochondrial activity (Picard et al. 2012). In 
addition, AMPK is required for mitochondrial biogenesis and activities (Zong et al. 2002) and 
also reported to be antioxidant activator in response to oxidative stress (Austin and St-Pierre 
2012, Finkel 2006).  
 
Lipid homeostasis in embryos can be modulated by the presence of chemicals in culture 
media and these chemicals will act on lipid metabolism pathway (Barcelo-Fimbres and Seidel 
2007b, Barcelo-Fimbres and Seidel 2007a). AICAR is one of permeable chemicals which are 
capable of stimulating AMPK activity and have diverse effect on glucose metabolism, lipid 
metabolism and protein synthesis (Hardie et al. 2003, Smith et al. 2005). It has been 
extensively used to enhance AMPK activity in many types of cells with various physiological 
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processes to control lipid and glucose metabolism (Hawley et al. 2003, Imai et al. 2006, Li et 
al. 2011, Merrill et al. 1997, Thomson et al. 2007). 
 
Previous studies have demonstrated that in vitro culture media affect the pattern of bovine 
embryo gene expression (Niemann and Wrenzycki 2000, Saadeldin et al. 2011, Sagirkaya et 
al. 2006) and subsequent differences in metabolic status (Khurana and Niemann 2000a). For 
instance, addition of serum to bovine culture media significantly increases the expression 
level of genes related to apoptosis (Bax) and oxidative stress (MnSOD, SOX), meanwhile the 
expression of genes related to gap junctions (Cx43) and maternal recognition of pregnancy 
(IFN-tau) was decreased (Rizos et al. 2003). As reviewed by Cortessis et al. (2012) gene 
expression is influenced by environment through epigenetic process. At least 3 processes are 
involved in epigenetic regulatory mechanisms that are DNA methylation, histone 
modification and miRNA (Fabbri et al. 2007, Feil and Fraga 2011, Hu et al. 2014, 
Lennartsson and Ekwall 2009). In the field of miRNA studies, miRNA control gene 
expression through sequences complementary to mRNA (Krol et al. 2010). MicroRNAs 
control many cellular processes by modulating the precise amount of proteins either by 
promoting mRNA degradation or repressing mRNA target translation (Siomi and Siomi 
2010). In addition to that, Kropp et al. (2014) revealed that miRNAs are secreted from pre-
implantation embryos into culture media and the miRNA expression may correlate with the 
developmental competence of the embryo which is reflected in gene expression. In this regard 
miRNA display a fundamental role in early bovine embryonic development which is 
important to regulate folliculogenesis, fertilization, early embryonic survival and blastocyst 
development (Tripurani et al. 2011, Tripurani et al. 2013). 
 
Considering the fact that AMPK is the master regulator of lipid metabolism, mitochondrial 
biogenesis and mitochondrial activity, in this study it is hypothesized that the activity of 
AMPK during embryo development mediates lipid accumulation in embryos cultured in vitro. 
Consequently, the present study aimed to explore the role of the AMPK during in vitro bovine 
embryo production. In order to test that hypothesis, 3 experiments were performed. In the first 
experiment, the expression of AMPK and its lipid metabolism related genes were investigated 
in different types of culture media. In the second experiment, the activity of AMPK was 
modulated using AICAR as exogenous activator to explore its effect on embryo metabolism 
in terms of lipid accumulation. Moreover, in order to investigate the regulatory mechanism of 
the AMPKA1 gene, in the third experiment potential candidate of miRNAs were identified 
and validated for their interaction with the target gene.  
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2 Literature review 
 
2.1 In vitro production of bovine embryos 
 
The increasing demand of milk and meat products all over the world makes dairy and meat 
industries have a huge economic value. The continuous supply of these products relies on 
animal reproduction system which functions to increase population and accelerate genetic 
gain between generations. One of technologies that can be used to improve both aims is IVP 
of bovine embryos. Since the first calf was born from an IVP embryo (Brackett et al. 1982), 
many progress and improvements have been made so far. One of those improvements is the 
use of in vitro matured oocytes fertilized by frozen sperm, that allows mass production of 
embryos by in vitro protocol (Ball et al. 1983, Parrish et al. 1986). Combined with bull 
genetic selection, semen sexing, estrus synchronization and embryo cryopreservation, IVP 
embryos becomes a valuable genetic material to enhance cattle population and genetic merit 
simultaneously compared to other assisted reproduction technologies.  
 
The IVP of bovine embryo is well known to be established from IVM, IVF and IVC steps. In 
the IVM step, immature oocytes are aspirated from small follicles (3-5 mm) and matured in 
maturation medium which is supplemented with 10% fetal FCS and gonadotropin hormones 
(FSH, LH) under 5% CO2 at 37-38°C. This process will take place 20-24 h of incubation and 
will complete its maturation process signaled by extrusion of a first polar body. Thus matured 
oocytes are ready to be fertilized. As widely practiced today, the semen that is used for 
fertilization is frozen semen. The best quality of motile sperm is separated by a Percoll 
gradient, as common system. In general, two types of media are used for IVF i.e. tyrode's 
albumin lactate pyruvate (TALP) based medium or a SOF based medium with or without 
glucose. Moreover, heparin is also added to the IVF medium aiming to increase sperm 
motility and induce capacitation which increase the successful of fertilization (Fukui et al. 
1990). Fertilization is performed by co-incubating oocytes with sperm for 18-20 h. 
Afterwards, presumptive zygotes were transferred to IVC media for embryo development 
until they are ready for embryo transfer or storage (Galli et al. 2003). During culture in vitro 
all necessary nutrients, waste metabolism removal and toxic protection effect are provided by 
culture media. However, culture media and protein source in post fertilization influence 
embryonic gene expression subsequent to development potential of in vitro produced embryos 
(Gad et al. 2012, Rizos et al. 2003, Sagirkaya et al. 2006, Van Hoeck et al. 2013a, Warzych et 
al. 2007, Wrenzycki et al. 2001). 
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2.1.1 In vitro culture of embryos 
 
Instead of in vivo, production of embryo by in vitro systems has been capable to produce 
embryos for transfer or research purposes. It is offering a flexibility of protocol and capable to 
do mass production of bovine embryos. All of the in vitro system relies on culture media 
which provide all important nutrition for embryo development. Embryo culture media are 
containing nutrients and buffer systems to support cell growth and in the same time prevents 
the cell metabolite toxicity during culture. Even though embryo production has been 
developed 40 years ago, further studies are required to develop culture media which meet the 
precise requirements of embryo metabolism. In this regard, with respect to resulting 
blastocyst quality, in vitro culture media are reported to be major factors while oocytes 
quality is important for blastocyst yield (Rizos et al. 2002). Over the last decade, there are two 
types of embryo culture media, basal media, that have been widely used are tissue TCM-199 
and SOF. TCM-199 is a complex and undefined medium, while SOF is a simple and 
relatively well defined medium. TCM-199 was designed particularly for somatic cells 
cultured in vitro rather than for mammalian embryo culture. Therefore, embryo generated 
from SOF medium shows greater similarity to in vivo on the basis of gene expression patterns 
than those generated by the TCM system (Wrenzycki et al. 2001). In addition to the basal 
medium, IVC systems with and without serum are the two major types widely applied in IVP 
protocols (Gstraunthaler 2003). 
 
Despite the ability of culture media to support embryo development during IVP, there is 
ample evidence showing differences between embryos derived from in vitro and in vivo with 
respect to morphology and molecular aspects. During the last few decades, many types of 
IVC media have been developed by varying embryo nutrient combination (Leese 2012). 
Several lines of evidence reviewed by Gardner et al. (2000b) show the plasticity of embryo 
metabolism to its surrounding environment, which enables mammalian embryos to develop in 
a wide variety of culture conditions. However, further adaptation of this process leave a 
signature in embryonic gene expression and subsequently influence on embryo metabolism, 
developmental competence and even affect the resulting offspring. Previous studies have 
documented that culture environment influence embryonic gene expression (Block et al. 
2009, Gad et al. 2012, Rizos et al. 2003, Sagirkaya et al. 2006, Wrenzycki et al. 2001), 
cryotolerance (Abe et al. 2002, Gad et al. 2012, Gomez et al. 2008) and pregnancy rates 
following transfer (Block et al. 2009, Lim et al. 2007). In addition to that, differences in 
metabolism (Khurana and Niemann 2000b), especially high lipid content (Abe et al. 2002, 
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Gomez et al. 2008), organelle structure (Crosier et al. 2001) and chromosomal abnormalities 
were observed in resulting embryos (Lonergan et al. 2004). The IVC systems were also 
reported to influence fetal and placental development, indicate large of spring syndrome 
(LOS), particularly by increase birth weight and placenta abnormalities (Farin et al. 2001, 
Lazzari et al. 2002).  
 
2.1.2 Serum addition in embryo culture media 
 
Although it is undefined and its composition varies from batch to batch, the use of serum is 
widely applied as a supplement in various culture media. Serum was obtained from sterile 
liquid fraction of clotted blood and widely used for in vitro culture considered being rich of 
components which are support cells survival and living of mammalian cells in vitro. In the 
market, there are 5 types, based on sources, of serum available namely fetal bovine serum, 
newborn calf serum, calf serum, donor bovine serum and adult bovine serum (categorized by 
EMEA 1793 & Ph.Eur. 2262 & 9CFR Australia and United States origin).  
 
Serum in embryo culture media has been shown to be beneficial as it is a premium source of 
nutrients for embryo development such as amino acids, pH buffer, molecule carries and 
maintenance the surface tension of the culture media (Gardner 2008). Addition of serum to 
embryo culture media is beneficiary for embryo development such as nutrients, growth 
factors and antioxidants. Moreover, it is well documented that the addition of serum during 
embryo culture resulted in increased blastocyst formation rate and development kinetics when 
compared to culture without serum system (Gutierrez-Adan et al. 2001, Oliveira et al. 2006, 
Rizos et al. 2003, Sudano et al. 2011, Wrenzycki et al. 2001). However, different 
development kinetics have been reported to affect the abundance of specific transcripts in 
later periods which is suggested due to different energy substrate during embryo culture and 
might affect the implantation rate of the resulting embryo (Khurana and Niemann 2000a). The 
difference in developmental speed is also associated with the alteration of gene expression, 
which is important for physiological embryonic process (Dode et al. 2006, Oliveira et al. 
2006, Ripamonte et al. 2012).   
 
On the other hand, serum addition also has been shown to cause harmful effects on embryo 
metabolism (Abe et al. 2002). Serum addition is reported to increase ROS (Rizos et al. 2003). 
The accumulate of ROS then alter mitochondrial structure and function (Abe et al. 2002, 
Cagnone and Sirard 2014, Crosier et al. 2001, Rizos et al. 2003, Thompson et al. 2007), alter 
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gene expression as well as embryo metabolism (Balasubramanian et al. 2007, Harvey et al. 
2002, Rinaudo et al. 2006), reduce embryo quality by elevating blastocyst apoptotic rate and 
fragmentation (Khurana and Niemann 2000b, Liu and Keefe 2000) and increase intracellular 
lipid accumulation (Abe et al. 2002, Barcelo-Fimbres and Seidel 2007a, Sudano et al. 2011). 
This has been evidenced by dark colour of in vitro produced blastocysts compared to their in 
vitro counterpart (Abe et al. 2002, Gad et al. 2012, Gomez et al. 2008). In vitro produced 
embryos have a modified lipid metabolism, which may account for different in membrane 
structure thus increasing their sensitivity to oxidative stress and their high sensitivity to 
cryopreservation (Abe et al. 2002, Gomez et al. 2008). 
 
Previous studies suggested that lipid accumulation in in vitro embryo is due to the incapability 
of mitochondria to metabolize the abundant lipid in form of fatty acids in culture media (Abe 
et al. 2002, Barcelo-Fimbres and Seidel 2007b, Ferguson and Leese 1999, McEvoy et al. 
2000). From that point of view, one factor which influenced lipid accumulation is the 
presence of abundant energy source in culture media that came from the addition of serum. As 
reviewed by Gstraunthaler (2003) serum contains protein, glucose and cholesterol that can be 
used as energy. In addition to that, Sata et al. (1999) showed that fatty acids, particularly 
linoleic acid (LA; C18:2), is the most abundance component in serum. Moreover, McKeegan 
and Sturmey (2011) stated that different types of fatty acids play different role in developing 
mammalian oocytes and early embryos by affecting metabolism, oxidative stress, membrane 
composition, cell signaling and gene expression. The effect of individual fatty acids has been 
reported in previous studies. For example, 100 µM LA in the maturation medium affected 
bovine oocytes maturation rates, increased prostaglandin E2 (PGE2) secretion from COC, had 
significantly lower cleavage and blastocyst rate compared to control medium without serum 
(Marei et al. 2010). The presence of LA is also reported to reduce mRNA expression of 
glutathione peroxidase 1 (GPX1) and superoxide dismutase 1 (SOD) (Khalil et al. 2013) and 
to increase triacylglycerol accumulation (Carro et al. 2013) in bovine oocytes. Moreover, 
supplementation of LA can induce molecular change of oocytes associated with oocyte 
maturation leading to decreased developmental potential. Addition of palmitic acid (C16:0) or 
stearic acid (C18:0) during oocyte maturation had negative effects on maturation, fertilization 
and cleavage rate, blastocyst yield and embryo cryotolerance (Leroy et al. 2005, Shehab-El-
Deen et al. 2009). More apoptotic cumulus cells were also observed in cumulus-oocyte 
complexes matured in the presence of these two fatty acids (Leroy et al. 2005). 
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Serum supplementation, the common method for in vitro embryos production, is effective but 
having high variability composition from batch to batch production. In addition to that, using 
serum incites specific issues concerning on scientific and animal welfare, particularly the fetal 
bovine serum (FBS) regarding its harvest and production methods, recommends to avoid 
using serum in culture media (Brunner et al. 2010). Effort to omit serum from culture media 
has been developed, for example, by Keskintepe and Brackett (1996) and Wydooghe et al. 
(2014). Many component of serum may be eliminated by using bovine serum albumin (BSA) 
as protein source and the macromolecular requirement for embryo culture is often satisfied by 
BSA. Culturing embryo with BSA is possible without affecting blastocyst yield and quality. 
Furthermore it could improve embryo survival after freezing (Gomez et al. 2008, Mucci et al. 
2006). However, several lines of evidences show a lower development rate (Holm et al. 1999, 
Rizos et al. 2003) of blastocyst derived in vitro without serum compared to with serum. In 
addition, early develop of blastocysts reported to induce higher pregnancy rates compared to 
the later one (Barrenetxea et al. 2005, Hasler 2000, Jacob et al. 2012, Muthukumar et al. 
2013).  
 
2.2  Embryo energy metabolism 
 
During preimplantation development, embryos undergo significant changes in their 
physiology. Along with that, embryo needs to uptake nutrients and then convert them into 
energy to support the physiological change (Gardner 1998). In general, nutrients for embryo 
development come from internal storage or external source in culture media. Several studies 
have been reported that glucose, pyruvate, lipid and amino acids are used as energy substrate 
in embryos at preimplantation stages (Ferguson and Leese 2006, Gardner et al. 2001, Rieger 
et al. 1992). A previous study (Khurana and Niemann 2000a) reported that the presence of 
glucose during IVC is beneficial for embryo development. In addition to that, consumption of 
glucose, pyruvate and oxygen were relatively low at zygote until 16-cells stages, while its 
uptake will be significantly increased during compaction and cavity formation started at 
morula until blastocyst (Khurana and Niemann 2000b). Lipid and its derivate, triglycerides 
and fatty acids, are reported to be the key energy source during bovine oocyte maturation and 
preimplantation embryo development (Dunning et al. 2010, Ferguson and Leese 2006). 
Addition of amino acids in the culture media positively affects bovine blastocyst development 
(Lee and Fukui 1996, Pinyopummintr and Bavister 1996). Recent study (Van Hoeck et al. 
2011) also reported that amino acids are important nutrient which has influence on the 
regulation of embryo metabolism. The amino acid turnover in the culture medium could be 
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used as non-invasive marker indicating the embryo viability (Hemmings et al. 2012, Sturmey 
et al. 2010).  
 
The nutrient breakdown and metabolism status of embryos can be used as indicator of embryo 
quality. According to the metabolism status, embryos cultured in vitro having higher 
oxidative phosphorylation (oxphos) rates and more lactate compared to the in vivo condition 
(Khurana and Niemann 2000b). The embryo cultured in vitro also reported having high 
glycolysis rate, when fresh embryo in vivo was transferred into in vitro culture media (Lane 
and Gardner 1998). Low embryo glycolytic rate reported close to in vivo develop blastocyst 
and had higher viability that those with abnormal elevated levels of glycolysis (Lane and 
Gardner 1996). These studies indicated the influence of IVC media in control embryo 
metabolism status. It’s also widely accepted that culture media is the stress factor for embryo 
during IVC. For instance, in vitro embryo produced with elevated or different types of fatty 
acids shows higher amino acid turn over, which means more noise in metabolism, compared 
to the normal ones (Van Hoeck et al. 2011). In here, noisier embryo indicated the more 
deviation of metabolism from normal, thus embryo demanding more energy for its 
metabolism. It also can be stated that high energy demand of in vitro embryo is indicator of 
stress response from culture media. At this point of view, based on metabolic indicator, shows 
that preimplantation embryo survival is best served by a relatively low level of metabolism, 
which support quite embryo metabolism hypothesis (Baumann et al. 2007, Leese 2002). 
 
2.2.1 ATP as energy source for embryo development 
 
ATP is the major energy currency in preimplantation stages of embryos; it’s produced in 
mitochondria and relies on oxphos process (Leese 2012, Sturmey and Leese 2003, Thompson 
et al. 1996). Similar to other mammalian cells, the consumption of available glucose, 
pyruvate, lipid and amino acids were used to generate ATP. Previous study showed that ATP 
production is essential for bovine embryo development (Thompson et al. 2000). Disturbance 
of ATP production through mitochondrial inhibition reported impaired blastocyst 
development (Dunning et al. 2010, Wakefield et al. 2011), meanwhile improved 
mitochondrial activity positively affect embryo developmental competence (Dunning et al. 
2010, Dunning et al. 2011).  
 
In mammalian cells, ATP generation occurs via oxphos or glycolysis pathway. Oxidative 
phosphorylation occurs in mitochondria and requires oxygen, meanwhile glycolysis occurs 
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without oxygen in cytoplasm. Oxidative phosphorylation generates more ATP than glycolysis 
in each round of reaction (30 ATP vs 4 ATP; respectively). The process of ATP production 
depends on the availability of Acetyl Co-A as the starting material. In general, pyruvate and 
fatty acids are converted into Acetyl Co-A in mitochondria. Thereafter, Acetyl Co-A goes to 
TCA cycle in oxidative phosphorylation process, as machinery which relies on ETC (e-) and 
proton pumps (H+), to generate ATP (Alberts et al. 2002). Electron transport chain made by 5 
groups of protein complexes that coded by mtDNA. First of 4 proteins complex (I - IV) are 
responsible for carrying out the protein function, while the 5th complex (V) is responsible for 
ATP production at final step. Brief flow of ATP generation in mitochondria is illustrated in 
figure 1. 
 
 
 
Figure 1: A summary of energy generating metabolism in mitochondria as illustrated by 
Alberts et al. (2002). 
 
The TCA cycle initiated by oxidation of Acetyl Co-A and resulting electron transferred to 
nicotinamide adenine dinucleotide (NAD+) and flavin adenine dinucleotide (FAD) to produce 
NADH and FADH2. These electrons are donated to the ETC at complexes I and II 
respectively.  Electrons are shuttled from complex I and II to complex III via ubiquinone and 
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from complex III to complex IV via cytochrome c.  The two electrons are finally donated to 
the molecular oxygen (1/2 O2) to generate H2O. Incomplete, one-electron reduction of oxygen 
(O2) can occurs at complexes I, II, and III subsequently produce superoxide (O2-). At this 
point, superoxide (source of ROS) production is increased with the concentration of oxygen 
and electron donor. By electron transport, different current leads to proton pumping across 
inner mitochondrial membrane create a gradient, which is used to produce ATP. In addition to 
that, mitochondria also produce ROS as by product during ATP production. The rise level of 
NADH/NAD+ is a major factor leading to increased mitochondrial ROS production. When the 
breakdown of metabolites in the TCA cycles exceeds the capacity of ETC to fully acquire the 
resulting electron, thereafter ROS production is increased.  In this regards, it can be stated that 
electron leaking occur due to over capacity of ETC in energy conversion process (Murphy 
2009, Turrens 2003). In addition, the presence of excessive ROS might cause developmental 
arrest and apoptosis in the blastocyst due to at preimplantation stage mammalian embryos is 
very sensitive to oxidative stress (Dumollard et al. 2009). 
 
2.2.2 ATP and cells energy balance 
 
In almost all mammalian cell, the cellular functions are depends on the presence of ATP. ATP 
content is known to reflect the balance between energy production and consumption. ATP as 
energy currency, generated from diverse source of nutrient in the cells. It is need to be kept in 
mind that ATP is an energy coupling, not a fuel or energy storage for further use. The use of 
ATP in cell is initiated by hydrolysis of ATP into ADP or AMP. The following reaction 
shows how the ATP breakdown. 
 
ATP → ADP + Pi 
 
2ADP ↔ ATP + AMP 
 
In normal energy demand, ATP converted into ADP and Pi (phosphate). At the times when 
more energy is required, ATP releases 2 phosphates producing AMP and a chain of two 
phosphates namely pyrophosphate. In the condition when ATP hydrolyzed into ADP, ATP 
spending one phosphate. Immediately ADP is recycled and charged into ATP, by hooking one 
phosphate in mitochondria. This cycle of spending and charging phosphate for ATP is 
continuously cycled, to ensure that cell has enough energy to maintain the homeostasis 
condition. Meanwhile in the condition of ATP hydrolyzed into AMP, AMP is produced in 
two steps. First, hydrolysis of ATP produces ADP, and then the reaction catalyzed by 
Literature review 
 
12
adenylate kinase to produce AMP. In addition to that, ATP transfers one phosphate molecules 
to AMP producing 2ADP, then ADP goes into TCA cycle then converted into ATP (Alberts 
et al. 2002). In this regards, the presence of [AMP] is a much more sensitive indicator of a 
cell’s energetic state than [ATP].  Normally cells have a far higher [ATP] (5 to 10 mM) than 
[AMP] (<0.1 mM) (Nelson and Cox 2005). As the [ATP] is typically 30 to 100 times higher 
than that of [AMP], a small decrease in [ATP] will be manifested as a much larger percentage 
increase in [AMP] (Gardner et al. 2000b). For instance Nelson and Cox (2005) calculate the 
chemical equation balance if [ATP] drops by 10% and producing [ADP] and [AMP]  in the 
same amount, the relative change in [AMP] is much greater (Table 1). 
 
Table 1: Relative changes in [ATP] and [AMP] when ATP is consumed. 
 
Adenine nucleotide 
Concentration before 
ATP depletion (mM) 
Concentration after 
ATP depletion (mM) 
Relative change 
ATP 5.0 4.5 10% 
ADP 1.0 1.0 0 
AMP 0.1 0.6 600% 
 
One important mediator of the process regulate by AMP is AMPK, which responds to an 
increase in AMP concentration by phosphorylating key proteins, thereby regulating their 
activities. The rise in AMP concentration may be caused by a reduced nutrient supply on an 
increased exercise. The action of AMPK increases glucose transport and activates glycolysis 
and fatty acid oxidation, while suppressing energy requiring process such as the synthesis of 
fatty acids, cholesterol and protein (Nelson and Cox 2005). AMP which is accumulated as the 
result of ATP breakdown binds to and activates phosphorylase in purpose of activating 
AMPK. In the contrary at times when ATP levels are adequate, ATP blocks the allosteric site 
that AMP binds, then inactivates phosphorylase to deactivate the AMPK (Hardie and Hawley 
2001, Hawley et al. 1996). In this regards, ATP is important as an on-off switch signal that 
control chemical reaction in the cell. 
 
2.3 Mitochondria of preimplantation bovine embryos  
 
In every mammalian cell, mitochondria are the powerhouse, which serves ATP as energy. 
Mitochondria are highly dynamic organelles whose length, shape, size and number are 
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controlled by fusion and fission process to ensure mitochondrial functional state (Detmer and 
Chan 2007). It is essential for the cellular adaptation in response to cellular metabolic status, 
stress and other intracellular or environmental signals (Palikaras and Tavernarakis 2014). In 
this regard, mitochondria proper function is crucial to the maintenance of cellular 
homeostasis. Mitochondria are structured by outer membrane, inner membrane and matrix. 
The outer membrane functions as a cover, freely permeable to facilitate molecules and ion 
transport in and out the mitochondria. The inner membrane or called cristae, structurally 
layered and folds where many chemical reactions occur to generate ATP. Fatty acid β-
oxidation, amino acid oxidation and TCA cycles are the chemical reaction, which occurs in 
this surface. Therefore, more surfaces in this part mean more energy that can be generated. 
The matrix contains fluid where many enzymes, soluble metabolic intermediates, ions, ATP, 
ADP, Pi, ribosome and mtDNA lies (Alberts et al. 2002, Nelson and Cox 2005).  
 
2.3.1 Mitochondrial development in oocytes and embryos 
 
Mitochondria have an important role as central determinants of developmental competence of 
oocytes and preimplantation embryo (Van Blerkom 2009). It is unique due to it has its own 
genetic material (mtDNA), which maternally transmitted and amplified during oogenesis 
(Cummins 1998). Since embryonic mitochondrial replication does not occur until after the 
hatched blastocyst stage, mature oocytes, fertilized oocytes and early cleavage stage embryos 
are dependent on the function of the mitochondrial pool, which is present at ovulation time 
(Cummins 2000, Spikings et al. 2006). Consequently, any adverse influence on mitochondria 
will negatively impact embryo development, particularly by excessive ROS level.  
 
During embryo preimplantation stages there are no replication of mtDNA (Cummins 1998, 
Cummins 2001). For that, the presence of mitochondrial biogenesis protein, PGC1A, is 
important to ensure mitochondria to be normally function (Austin and St-Pierre 2012). 
PGC1A influences in organelle remodeling by maintenance mitochondrial internal properties, 
thus maintaining ATP production. In addition, PGC1A also increase mitochondrial 
capabilities in scavenging ROS, which is harmful in excessive level (Austin and St-Pierre 
2012, Finkel 2006). Different mitochondrial structure during embryo preimplantation was 
demonstrated in embryo cultured under serum system (Abe et al. 2002, Crosier et al. 2001) as 
the result of excessive of ROS production (Gomez et al. 2008). Moreover, increased level of 
ROS in bovine embryos is followed by low mitochondrial activity and low PGC1A 
expression level (Prastowo et al. 2014), means reduced ATP production.  
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2.3.2 Mitochondrial ROS production during embryo metabolism 
 
Several line of evidence reviewed by Murphy (2009) and Samoylenko et al. (2013) show that 
mitochondria are the important source of ROS. ROS is byproduct of mitochondrial 
metabolism and normally produced during ATP generation. In excessive level, ROS causing 
oxidative stress due to imbalance between the ROS generation and scavenging, antioxidant, 
mechanism. The abundant generation of ROS during early embryo development is 
detrimental (Harvey et al. 2002, Rizos et al. 2003). The ROS hamper mitochondrial DNA 
structure and subsequently cause their dysfunction (Abe et al. 2002, Crosier et al. 2001). That 
in turn leads to decrease mitochondrial oxidation capacity and TCA cycle and subsequently 
induces excessive lipid droplet formation (Lee et al. 2013, Schrauwen and Hesselink 2004, 
Wang et al. 2009). This is accompanied by inactivation of enzymes that are essential for 
energy production and detoxification of ROS resulting in modulated mitochondrial functions 
(Kumari et al. 2014). The over generation of ROS is known to affect the capability of 
embryos to metabolize lipids (Abe et al. 2002, Abe and Hoshi 2003, Barcelo-Fimbres and 
Seidel 2007a, Barcelo-Fimbres and Seidel 2007b, Cagnone and Sirard 2014).  
 
ROS produced during IVC post fertilization was reported to alter the mtDNA. It is 
demonstrated that mtDNA copy number during embryo development is sensitive to 
environmental factors (McConnell and Petrie 2004). The mtDNA encodes essential enzymes 
for oxphos reaction (Chandrasekaran et al. 1997, Marusich et al. 1997, Shoubridge 2001). For 
that, any defect on mtDNA can induce metabolic dysfunction and disturbs embryo 
development (Wilding et al. 2009). Oxidative stress induced mitochondrial 
dysfunction/damage by attacking mtDNA due to it is susceptible to mutation and lack of 
histones (Cui et al. 2012, Lenaz et al. 2002, Stuart and Brown 2006). Mitochondrial 
morphology changes after oocyte maturation might be caused by the of lack of mtDNA 
replication (Bavister and Squirrell 2000).  
 
An increase of ROS has been measured in mouse embryo in vitro compared to in vivo (Goto 
et al. 1993), in vitro embryo derived from 5% O2 compared to 20% in mouse (Kwon et al. 
1999), porcine (Karja et al. 2006, Kitagawa et al. 2004) and bovine (Amin et al. 2014).  The 
presence of high glucose concentration also increases ROS production in mouse (Trocino et 
al. 1995) and porcine (Karja et al. 2006) embryo. Another study also found an increasing 
oxidative stress and down regulation of antioxidant response gene during embryo 
development in vitro in the presence of serum compared to without serum, high glucose 
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concentration and in vitro compared to in vivo (Cagnone et al. 2012, Gad et al. 2012, Rizos et 
al. 2003). Those results underlined the factors that are affecting ROS production in the 
embryo produced in vitro.  In addition, the role of mitochondria in lipid homeostasis also has 
been emphasized strongly in the recent study. It is reported that mitochondrial dysfunction 
can lead to disorder of lipid metabolism and triglyceride accumulation (Vankoningsloo et al. 
2005). Mitochondrial dysfunctions are mostly caused by defects in the enzymes which are 
involved in mitochondrial respiration and oxidative phosphorylation (Wallace 1999). It is 
reported that mitochondrial dysfunction is indicated by more truncated mtDNA, and the 
consequences are the decrease in mitochondrial membrane potential, rate of ATP synthesis, 
and cellular ATP/ADP (Porteous et al. 1998). Defective mitochondrial function is also found 
to be the signal of mammalian aging.  This aging was reported to increase fat accumulation by 
reducing ±40% of mitochondrial oxphos, which results in less ATP concentration in cell 
(Canto and Auwerx 2011). 
 
2.4 AMPK as energy metabolism regulator 
 
AMPK is known as a master regulator of metabolic energy balance in a wide range of tissue 
and cells (Carling 2004, Carling et al. 2011). Moreover it is a central component of a cellular 
signaling system that regulates multiple metabolic enzymes and pathways in response to 
reduced intracellular energy level (Hong et al. 2003). AMPK is controlling the ratio of 
AMP:ATP (Corton et al. 1994) and its activity is regulated by high ratio of AMP:ATP. 
AMPK also documented by Hopkins et al. (2003) as the master regulator of lipid, glucose and 
protein metabolism. In addition, it has been reported that AMPK is important for 
mitochondrial biogenesis and activities (Zong et al. 2002) in response to oxidative stress 
(Austin and St-Pierre 2012). The role of AMPK as central regulator of glucose, protein and 
lipid metabolism is illustrated in figure 2.  
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Figure 2:  The effect of AMPK on cellular metabolism (Hardie et al. 2012). 
 
The regulation of AMPK to mitochondrial activity has been reported in human (O'Neill et al. 
2013, Wu et al. 2014) and also in mice (Dugan et al. 2013). Regarding to this, down 
regulation of AMPK is followed by low mitochondrial activity, low mitochondrial biogenesis 
and low antioxidant system (Austin and St-Pierre 2012, Hopkins et al. 2003, Li et al. 2011, 
Zong et al. 2002). Growing evidences showed that AMPK become one of promising target in 
combating diseases related to mitochondrial dysfunction such as diabetes, obesity and cancer 
in human research area (Bokko et al. 2007, Faubert et al. 2013, Hardie 2013, Hawley et al. 
2003, Kim et al. 2014, Zhang et al. 2009).  
 
2.4.1 AMPK structure and its activity 
 
Based on its structure, AMPK is heterotrimetric complex, which consists of 3 subunits 
namely α, β, and γ. The α subunit (two isoforms AMPKA1, AMPKA2) is catalytic, whether β 
(two isoforms AMPKB1, AMPKB2) and γ (three isoforms AMPKG1, AMPKAG2, 
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AMPKAG3) are the regulatory subunits (Carling 2004). The α subunit contains the kinase 
domain at the N terminus and C-terminal regulatory domain containing an auto inhibitory 
region that inhibits protein kinase in the absence of AMP. The β subunit act as scaffold which 
function as α and γ subunit binding site and γ subunit acts as the binding site of AMP. In 
activated AMPK, AMP bind to the γ subunit and stabilized the connection between α-γ and 
then α subunit will be phosphorylated the target protein (Hardie and Hawley 2001).  
 
AMPK is regulated by the ratio of AMP:ATP rather than the intracellular depletion of ATP or 
accumulation of AMP (Corton et al. 1994). AMPK is activated upon an increase in the AMP 
to ATP ratio, which reflects the energy status of the cell (Canto and Auwerx 2011). AMPK is 
regulated allosterically by AMP and reversible phosphorylation. Threonine-172 (Thr172) 
within the catalytic subunit α was identified as the major site for phosphorylation in AMP-
activated protein kinase (Hawley et al. 1996). AMPK became active if Thr172 in the α 
subunit is phosphorylated and leads to increase its activity for several hundred folds.  
Mutation of Thr172 site is reported to decrease more than 90% of AMPK activity following 
treatment with protein phosphatases (Stein et al. 2000), this study shown that Thr172 involved 
in the sensitivity of AMPK complex to AMP. Control of Thr172 phosphorylation is the major 
mechanism for AMPK regulation because the binding of AMP to AMPK and activation of its 
Ser/Thr protein-kinase domain have been well characterized.  The agent responsible for the 
phosphorylation process, in mammals, is the kinase LKB1 or CaMKKβ and it is promoted by 
AMP that binding in AMPK γ subunit. Binding of AMP to the regulatory γ subunit triggers 
phosphorylation of the catalytic α subunit by the upstream kinase LKB1 and the activated 
kinase switches on ATP generating catabolic pathways while in the same time switching off 
ATP requiring processes (Hardie 2005). In inactive AMPK, the dephosphorylation is 
promoted by a high level of ATP and the releasing phosphate is to be mediated by protein 
phosphatases such as PP2a and PP2c (Oakhill et al. 2011, Xiao et al. 2011).  
 
Liver kinase B1 (LKB1) or also known as serine/threonine kinase 11 (STK11) is a master of 
kinase in most mammalian tissues (Hawley et al. 2003, Shackelford and Shaw 2009).  This 
gene, which encodes a member of the serine/threonine kinase family, regulates cell polarity 
and functions as a tumor suppressor. LKB1 encodes a serine-threonine kinase that directly 
phosphorylates and activates AMPK (Thomson et al. 2007). Over nutrition and 
hyperglycemia suppress LKB1-AMPK signaling pathway that leads to obesity or diabetic 
condition (Shackelford and Shaw 2009). In addition to that, it’s also reported that LKB1 
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activity is 50% down regulated subsequent to decrease AMPK activity by the present of 
palmitate and linoleate. In addition to that, LKB1 is also reported to be the regulator of fatty 
acid in mice muscle (Thomson et al., 2007) and adipocytes (Gormand et al. 2011) by 
inhibiting acetyl-CoA carboxylase (ACC) and regulating, malonyl-CoA level. LKB1 is also 
reported to regulate glucose and lipid metabolism (Imai et al. 2006). These studies 
demonstrated that AMPK activity decreased by the high concentration of FA (Watt et al. 
2006). Similarly, Zhou et al. (2007) also reported in human ovarian that inhibition of fatty 
acid synthesis causes AMPK activation. These report indicated that the presence of FA would 
decrease the AMPK activity. Active AMPK suppresses the expression of lipogenesis 
associated genes such as fatty acid synthase, pyruvate kinase and ACC. In contrast, active 
AMPK increase of FA oxidation and suppress lipogenic enzyme (Dzamko et al. 2008, Lee et 
al. 2006, Zhou et al. 2001). Once AMPK got activated, AMPK regulates a number of 
transcriptional factors and signals the transduction protein, such as acetyl CoA carboxylase, 
hepatic nuclear factor and MAPK. Activated AMPK leads to control enzyme expression of 
gluconeogenesis, glucose 6-phosphatase and phosphoenolpyruvate carboxylase through 
LKB1 activities (Imai et al. 2006). Moreover, AMPK can be activated through other kinases, 
such as CaMKK and transforming growth factor-β-activated kinase. However, activation 
through this kinase is only restricted in specific cells and different tissue (Carling et al. 2008, 
Witczak et al. 2008).    
 
2.4.2 AMPK and its role in lipid metabolism 
 
Active forms of AMPK have been demonstrated to suppress lipogenic genes and control lipid 
production in mice (Li et al. 2011), fat metabolism in human skeletal muscle (Thomson and 
Winder 2009), regulate of glucose metabolism in diabetes (Viollet et al. 2009) and to decrease 
obesity (Xu et al. 2012). However, inactive form of AMPK increases lipid synthesis (Hopkins 
et al. 2003) and lipid accumulation due to down regulation of mitochondrial activity (Picard et 
al. 2012). AMPK is activated by energetic stress then promotes catabolic and simultaneously 
inhibits anabolic reactions (Agathocleous and Harris 2013). Active AMPK promotes fatty 
acid oxidation and inhibits fatty acid synthesis (Dzamko et al. 2008, Lee et al. 2006, Osler and 
Zierath 2008, Viollet et al. 2009, Zhou et al. 2001). These previous reports, displayed that 
AMPK is important signal for switch on or off cell metabolism, catabolism and anabolism, to 
generate or to store energy in cell. It’s governed how the cells behave in response to the 
energy demand.  
 
Literature review 
 
19
The rate-controlling enzymes for cholesterol and fatty acid biosynthesis are phosphorylated 
and inactivated by the AMP-activated protein kinase. When this protein kinase is activated, 
either through phosphorylation or in response to the binding of its allosteric activator 5′-AMP, 
the two major pathways responsible for the synthesis of lipids from acetyl-CoA both are 
inhibited. AMPK activation is resulting in the inhibition of energy-consuming biosynthetic 
pathways (such as fatty acid synthesis in liver and adipocytes, cholesterol synthesis in liver, 
protein synthesis in liver and muscle and insulin secretion from β-cell) and the activation of 
ATP-producing catabolic pathways (such as fatty acid uptake and oxidation in multiple tissue, 
glycolysis in heart and mitochondrial biogenesis in muscle). AMPK can also modulate 
transcription of specific genes involved in energy metabolism, thereby exerting long-term 
metabolic control (Viollet et al. 2009). 
 
The rates of cholesterol and triglyceride biogenesis are predominantly controlled by SREBP 
(Horton et al. 2002). Sterol Regulatory Binding Protein (SREBP) mediated the expression of 
lipogenic genes.  SREBP is transcription factor that regulate the gene expression of FA and 
cholesterol metabolism.  SREBP family is divided into three types they are SREBP-1a, 
SREBP-1c and SREBP-2.  The SREBP 1-a function is to activate all SREBP responsive 
genes. To the date it is known that SREBP is the direct transcription of more than 30 genes 
for uptake and synthesis cholesterol, FA, TG, and Phospholipids (Horton et al. 2002). Two 
forms of SREBP are SREBP-2 and SREBP-1c, which preferentially regulate the lipogenic 
genes involved in sterol biosynthesis and fatty acid synthesis. SREBP-1c is responsible in the 
gene related to FA, phospholipids and TG synthesis, meanwhile SREBP-2 acts in cholesterol 
biosynthesis and LDL receptor. Whereas SREBP-1c stimulates transcription of genes required 
for fatty acid synthesis, such as acetyl-CoA carboxylase and fatty acid synthase.    
 
Activation of SREBP-1c affected lipid accumulation in heart cells (Marfella et al. 2009), in 
mouse liver (Shimomura et al. 1999) and in mouse kidney cell (Wang et al. 2005). High 
activity of SREBP-1c is accompanied by an insulin resistance (Wang et al. 2005). In the other 
side, increasing activity of SREBP-2 resulted in an increase of cholesterol efflux induces by 
the expression of low-density lipoprotein receptor (LDLR) and HMG-CoA reductase 
(HMGCoR), which increases low-density lipoprotein (LDL) cholesterol uptake and nascent 
cholesterol biosynthesis (Van Rooyen and Farrell 2011). Mechanisms of SREBP work depend 
on the SCAP and Insulin Signal (Insig).  SCAP deficient in mice showed an 80% reduction in 
basal rates of cholesterol and FA synthesis, decreasing mRNAs encoding biosynthetic 
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enzymes (Matsuda et al. 2001). Insig-1 effectively blocks the transcription of SREBP-1c, 
preventing the activation of the genes for lipid biosynthesis (Chen et al. 2011). 
 
The connection between AMPK-SREBP1 pathway in lipid accumulation has been 
demonstrated in previous research (Jung et al. 2011), where SREBP1 and ACC activity were 
suppressed by the abundance of AMPK. Recent study in cell culture and animal model 
demonstrated that AMPK suppress the SREBP activity in hepatic cells, resulted in lowering 
lipid synthesis and decreased insulin resistance (Li et al. 2011). AMPK interact directly with 
SREBP-1c and 2. AMPK inhibits the cleavage and transcriptional activity of SREBP by direct 
phosphorylation and resulted effect is lowering FA/TG and cholesterol biosynthesis.  Previous 
study (Yap et al. 2011) reported that activation of AMPK suppress hepatic SREBP-1c 
transcription by inhibiting endogenous liver X receptor (LXR) ligand production and 
processing.  Moreover, stimulation effect of AMPK reported lowering lipid and inhibiting 
LDLR activity (Lian et al. 2011, Zang et al. 2006).   
 
2.4.3 Artificial modulation of AMPK activity 
 
AMPK can be activated artificially by using diabetic treatment drug such as AICAR ,5-
aminoimidazole-4-carboxamide riboside (Hawley et al. 2003, Imai et al. 2006, Li et al. 2011, 
Merrill et al. 1997, Thomson et al. 2007) and metformin (Stephenne et al. 2011, Zang et al. 
2004). AICAR is pharmacological cell permeable molecule which has been extensively used 
to increase AMPK activity in a wide variety of cells under the various physiological 
processes. In principle, AICAR is imidaZole monophosphate (ZMP) which its structure 
similar to AMP inside the cell. By increasing the AMP concentration, artificially, AMPK can 
be activated.  
 
In the field of animal reproduction, the use of AICAR to increase AMPK activity has been 
well documented in hen preovulatory follicle (Tosca et al. 2006), mouse embryo (Eng et al. 
2007), mouse oocytes (Chen et al. 2006, Downs et al. 2010) and bovine oocytes (Bilodeau-
Goeseels et al. 2007). Activation of AMPK in mouse oocytes to regulate its maturation (Chen 
and Downs 2008, Downs et al. 2002, Downs et al. 2010, LaRosa and Downs 2006), while in 
bovine oocytes, AICAR inhibits nuclear maturation (Bilodeau-Goeseels et al. 2007).  AICAR 
also has been reported to have various effect on the cellular function, such as either induce (Li 
et al. 2008, Zang et al. 2008) or inhibit (Giri et al. 2006) cell differentiation, up regulate 
embryonic stem cells pluripotency (Adamo et al. 2009, Shi et al. 2013), reduce lipid 
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accumulation and in parallel inhibits cell proliferation (Giri et al. 2006, Jose et al. 2011). 
Another effect of AICAR is the enhancement of mitochondrial activity for ATP production 
through AMPK activity. Therefore, AICAR is more effective in cells with low steady-state 
ATP content and a high proliferation rate (Jose et al. 2011) such as cancer or tumor cells. In 
addition, enhanced mitochondrial activity through β-oxidation reduced cytoplasmic lipid 
droplet (Somfai et al. 2011). Lipid droplet in term of lipid metabolism in oocytes is closely 
associated with mitochondria in regards with ATP production in the process called β-
oxidation (Dunning et al. 2010, Dunning and Robker 2012, Sturmey et al. 2006). 
 
2.5 miRNAs in animal reproduction and energy metabolism 
 
miRNAs are non-coding RNAs with post-transcriptional regulator gene expression functions 
(Krol et al. 2010). It is a class of small (19–24 nt) regulatory RNA and controls many 
developments and cellular process by modulating the precise amount of proteins in a cell 
either by promoting degradation or repressing of mRNA target translation (Siomi and Siomi 
2010). There are more than 28.000 miRNAs have been listed in miRBase 
(http://www.mirbase.org/ released at February 2015). Its regulates a wide range of biological 
processes through the recognition of complementary sequences between miRNAs and their 
target genes, and have essential role during animal development (Liu et al. 2010).  
 
As explained by Carletti and Christenson (2009), the miRNA biogenesis begins in the nucleus 
and initiated with the transcription of miRNA gene in the help of RNA polymerase II 
providing long precursor transcripts know as pri-miRNA. Mediated by Drosha and DGCR8A, 
pri-miRNA proceeds to processing into hairpin structure called pre-miRNA which has a 
shorter sequence. The pre-miRNA then transported to cytoplasm that facilitated by a transport 
enzyme called exporting 5, and then followed by editing process by DICER resulted in a 
matured miRNA. The mature miRNA will be approximately 22 nt and ready to target specific 
mRNA. In its action, mature miRNA and Ago protein form RISC, a ribonucleoprotein 
complex, mediating post-transcriptional gene activity by bind to the 3-UTR of mRNA. 
miRNA control down regulation of gene expression thorough mRNA translation inhibition 
and degradation (Beilharz et al. 2009, Huang et al. 2007, Li et al. 2013).  Several reports also 
indicated that miRNA can be functioning as post transcriptionally stimulates gene expression 
(Ma et al. 2010, Place et al. 2008, Vasudevan et al. 2007).  In this regards, it can be 
underlined that presence of miRNA in cell regulation is to fine tune or orchestrated the 
protein level.  
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2.5.1 miRNA regulate animal reproduction process 
 
Regulation of gene expression plays a central role in defining cell fates and controlling organ 
formation which is transcriptionally controlled by coordinating the expression of selected 
genes at specific times and places (Suh and Blelloch 2011). Moreover, the identification and 
characterization of differentially regulated genes especially in bovine oocytes and 
preimplantation embryos are required to explore which is important in maturation, 
fertilization, early cleavage and even long-term development process (Cui and Kim 2007).  So 
far, the bioinformatics prediction indicated that mammalian miRNAs able to regulates 30% of 
all protein-coding genes (Filipowicz et al. 2008). In bovine research area, miRNA expression 
have been observed, for example, in sperm (Amanai et al. 2006), maturated oocytes (Tesfaye 
et al. 2009), ovaries (Hossain et al. 2009), zygotes (Svoboda and Flemr 2010) and 
preimplantation embryos (Kues et al. 2008). The correct regulation of mRNA expression by 
miRNAs is believed to be important for early development. Detailed analyses of gene 
expression profiles during embryogenesis will become valuable tools to a better 
understanding of basic cellular and molecular mechanisms that control early development, 
thus allowing the better strategies for improving the efficiency or use in other technologies 
such as transgenic and cloning. 
 
 Table 2:  The role of miRNA in animal reproduction process. 
 
miRNA 
name 
Gene Animal 
Related reproduction 
process 
Status Reference 
      
miR-106a, 
Let-7  
MYC 
WEE1A 
Bovine Oocytes Predicted (Miles et al. 2012) 
 
 
miR-205  Bovine Preimplantation embryo Predicted (Abd El Naby et al. 
2013) 
 
miR-212 FIGLA Bovine Preimplantation embryo Validated (Tripurani et al. 2013) 
 
miR-196a NOBOX Bovine Preimplantation embryo Validated (Tripurani et al. 2011) 
 
miR-27b, 
miR-372, 
miR-382 
ACVR1, 
ID2 
Equine Pre-ovulatory granulosa 
cells 
Predicted (da Silveira et al. 
2014) 
 
 
miR-376a PCNA Mouse Oocyte apoptosis Validated (Zhang et al. 2014) 
 
miR-34c BCL-2 Mouse First cell division in zygote Validated (Liu et al. 2012) 
 
miR-29a NASP Mouse Epididymal cell proliferation Validated (Ma et al. 2012) 
 
miR-145 ACVR1B Mouse Granulosa cell proliferation Validated (Yan et al. 2012) 
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Table 2:  Cont. 
 
miRNA 
name 
Gene Animal 
Related reproduction 
process 
Status Reference 
 
miR-320 E2F1, SF-1 Mouse Granulosa cell proliferation 
and steroidonegesis 
 
Validated (Yin et al. 2014) 
miR-224 SMAD4 Mouse Granulosa cell proliferation 
and steroidonegesis 
Validated (Yao et al. 2010) 
 
 
miR-224 Ptx3 Mouse Granulosa cell expansion Validated (Yao et al. 2010) 
 
miR-200a PTEN Mouse Uterus Validated (Shen et al. 2013) 
 
miR-34a INHBB Porcine Granulosa cell apoptosis Validated (Tu et al. 2014) 
 
miR-136-3p LHR Rat Granulosa cells Validated (Kitahara et al. 2013) 
      
Let-7, miR-22 ESR1, 
CYP19A1, 
SOX9 
Sheep Estrogen-signalling pathway 
during fetal testicular 
development 
Predicted (Torley et al. 2011) 
      
 
In animals, most of miRNA control gene expression by binding on the 3-UTR sequence of 
mRNA target at nucleotides number 2-8 known as seeding region (Ambros 2004, Bartel 2009, 
Zhou et al. 2013).  Several studies, (listed in Table 2), shows the function of miRNA in 
animal reproduction, however, information about its function is limited compared to miRNA 
that studied in human area especially for cancer model. However it shows a promising area 
for future research in evaluating miRNA functional effect on gene translation subsequent to 
biological pathways in livestock. Another importance of miRNAs is as their role as molecular 
biomarker or potential target for diseases therapy needs to be developed in further. In animal 
production area, growing evidence shows that miRNA involvement in regulating gene 
expression subsequent to animal production traits, need to be underlined and given more 
attention in the further. For instance, Govindaraju et al. (2012) found different miRNAs 
expression between bulls with high and low fertility. Other studies also reported that miRNA 
is involved in milk production (Jabed et al. 2012) and control postpartum period (Fatima et al. 
2014) of the cow. Therefore, more research needs to be completed for understanding the 
miRNA role and its application in animal agriculture (McDaneld 2009).   
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2.5.2 miRNA regulate energy metabolism 
 
Growing evidences have been demonstrated that miRNA is involved in control of metabolism 
by sensing variation of nutrients, hormones and cytokines. These variations of stimuli effect 
on the miRNA biogenesis and its expression, leads to the cause of changes in gene expression 
which lies in metabolism pathway (Dumortier et al. 2013). Regulations of different miRNAs 
in different type of cell and organism have been reported in the previous studies. For example, 
miR-278 (Teleman et al. 2006) in Drosophila, miR-26a in rectal cancer cells (Chen et al. 
2014), miR-223 in human cardiac cells (Lu et al. 2010) and miR-33a/b in human hepatic cells 
(Ramirez et al. 2013) were involved in glucose metabolism. Another studies, documented that 
miR-33a/b (Davalos et al. 2011, Goedeke et al. 2013), miR-27b (Vickers et al. 2013), and 
miR-224 (Peng et al. 2013) were involved in lipid and fatty acid metabolism. These studies, 
display to us the role of miRNA in controlling cell metabolism. However, to the best of our 
knowledge little studies have been made in the regulation of miRNAs in animal reproduction 
especially the one that dealing with energy metabolism in embryo research area.
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3 Material and methods 
 
In order to explore the function and role of AMPK in in vitro bovine embryos and its 
association with embryo development and lipid accumulation, three experiments were 
performed as follows: 
 
Experiment 1: Expression of AMPK and lipid metabolism genes in bovine embryos 
under different culture environments 
  
To determine the AMPK gene expression and its association with lipid accumulation in 
embryos, the first experiment was divided into 3 parts as indicated in figure 3. As indicated, 
the expression of genes in AMPK pathway (AMPKA1, AMPKA2), lipid metabolism (ACC) 
and mitochondrial activities (CPT1, PGC1A) were quantified using qRT-PCR method. 
Moreover, lipid droplets and its quantity from blastocysts derived in vitro vs. in vivo were 
evaluated in the first part of experiment 1. Due to the difference of in vitro vs. in vivo is the 
presence of serum, in the second part of experiment bovine embryos were produced with and 
without serum. Embryos from 2-, 8- and 16-cell were collected at 31, 72, and 168-192 h post 
insemination aiming to know the temporary expression of AMPK and its related lipid 
metabolism genes. In this part, expression of genes in AMPK pathway (AMPKA1, AMPKA2, 
STK11), lipid metabolism (SREBP2, SREBP1, ACC), antioxidant (NQO1) and mitochondrial 
activity (CPT1, PGC1A) were quantified in each stage of embryos development. In addition, 
mitochondrial activities of embryo cultured with and without serum were detected at 
blastocyst stage. In order to know whether different culture media affecting AMPKA1 
activity, embryos were cultured under different macromolecule supplementation in the third 
part of experiment. The expression level of genes in AMPK pathway (AMPKA1, AMPKA2), 
lipid metabolism (ACC) and mitochondrial activities (CPT1, CPT2, PGC1A) were quantified. 
Moreover, the embryo development competent, ROS production level, mitochondrial activity, 
protein expression of AMPK and AMPK phosphorylation at Thr-172 and lipid content were 
evaluated at blastocyst stage.  
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Figure 3:  Brief workflow of experiment 1. 
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Experiment 2: Modulation of AMPK activity by using AICAR as exogenous activator 
 
In the effort to modulate AMPK activity, AICAR was applied in the embryos culture media. 
Initially, 4 dosages of AICAR (0, 1, 10, 100 mM) were applied and followed by AMPKA1 
gene expression analysis at blastocyst stage. The initial study then allowed to select one 
AICAR dosage that gives higher AMPKA1 expression. As indicated in figure 4, expression 
level of genes in AMPK pathway (AMPKA1, AMPKA2), lipid metabolism (ACC), 
antioxidant (NQO1) and mitochondrial activities (CPT1, CPT2, PGC1A) were quantified. 
Moreover, the embryo development competent, blastocyst cell number, protein expression of 
AMPKA, mitochondrial activity and lipid content were evaluated at blastocyst stage. 
 
 
 
 
 
 
 
 
Figure 4:  Brief workflow of experiment 2. 
 
Experiment 3: The potential post transcriptional regulation of AMPKA1 by miRNA in 
bovine granulosa cells as the model 
 
This experiment aimed to know the regulatory mechanism of AMPKA1 using miRNA. Due 
to miRNA target validation can’t perform directly in the embryo, bovine granulosa cells were 
selected as the model. As indicated in figure 5, this study was initiated with in silico study 
using bioinformatics approach to select potential candidate of miRNA targeted to AMPKA1.  
For further target validation, potential candidate of miRNAs were profiled from granulosa 
cells sample which cultured with and without serum system. miRNA target validation was 
performed through plasmid construction, miRNA co-transfection and luciferase assay. 
 
Once the miRNA candidate is validated, the miRNA mimic and inhibitor were transfected 
into granulosa cells to know its effect on gene and protein expression level of AMPKA1, 
followed by gene expression analysis of  lipid metabolism (ACC) and mitochondrial activities 
(CPT1, PGC1A). Moreover, cultured granulosa cells in the presence of AICAR followed by 
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Granulosa cells culture 
miRNA transfection 
Control Mimic Inhibitor 
AICAR + AICAR - 
Gene expression 
Protein analysis 
Blastoysts cultured 
with serum 
Blastoysts cultured 
without serum 
 
• AMPKA1 gene expression 
• Validated miRNA profile 
Granulosa cells culture 
Serum - Serum + 
Lipid content 
Gene expression 
In silico study 
miRNA profiling 
Plasmid construction 
Luciferasse assay 
Validated miRNA 
miRNA candidate 
AMPKA1 quantification were performed for comparison purposes. Moreover, validated 
miRNA targeted to AMPKA1 also profiled in blastocysts sample derived from culture in the 
presence or absence of serum, aiming to know its expression for further functional study at 
embryo stage.  
 
 
 
   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5:  Brief workflow of experiment 3. 
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3.1  Materials 
 
3.1.1 List of chemicals and kits 
 
During the whole experiment, various types of chemical and kit were used and supplied from 
different companies. The use of those chemicals and kits were based on the protocol supplied 
or with minor modification if necessary until it’s stated.   
 
Chemical and kit Manufacture / supplier 
  
10x PCR Buffer S complete Genaxxon bioscience GmbH, Germany 
Acturus® PicoPure® RNA isolation Life Technologies, USA 
Agarose Carl Roth GmbH, Karlsruhe, Germany 
AICAR Sigma-Aldrich Chemie GmbH 
Alexa Flour 568 secondary antibody Life Technologies, USA 
Ampicillin Sigma-Aldrich Chemie GmbH, Munich, Germany 
AMPKA1/2 antibody (H-300) Santa Cruz Biotechnology 
Bromophenol blue Sigma-Aldrich Chemie GmbH, Munich, Germany 
BSA Sigma-Aldrich Chemie GmbH, Munich, Germany 
BSAFAF Sigma-Aldrich Chemie GmbH, Munich, Germany 
Calcium L-lactate hydrate Sigma-Aldrich Chemie GmbH, Munich, Germany 
Chloroform Sigma-Aldrich Chemie GmbH, Munich, Germany 
Cloprostenol Essex, Munich, Germany 
Competent cell, E. coli bacterial strain Promega, Germany 
Deoxynucleotide Set, 100 mM Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
DL-Dithiothreitol  Sigma-Aldrich Chemie GmbH, Munich, Germany 
DMSO Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany 
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DNA digesting enzyme, SacI New England Biolabs, USA 
DNA digesting enzyme, Xbal New England Biolabs, USA 
DNA Ladder Fermentas Gene Ruler™  
1 kb Plus  
Thermo Scientific, USA 
Dual-Luciferase® Reporter Assay 
System 
Promega, USA 
Dulbecco’s Modified Eagle’s 
Medium/Nutrient Mixture F-12 Ham 
Sigma-Aldrich Chemie GmbH, Munich, Germany 
EDTA Sigma-Aldrich Chemie GmbH, Munich, Germany 
Estrumate Essex Pharma GmbH, Munich, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Sigma-Aldrich Chemie GmbH, Munich, Germany 
Ethylene glycol Sigma-Aldrich Chemie GmbH, Munich, Germany 
ExiLENT SYBR® Green Master mix Exiqon, USA 
Fetal Calf Serum Gibco, Karlsruhe, Germany 
First Strand cDNA Synthesis Kit Thermo Scientific, USA 
Formaldehyde solution Sigma-Aldrich Chemie GmbH, Munich, Germany 
FSH, Folltropin Stimufol, Liege, Belgium 
Fungizone® Antimycotic Life Technologies, USA 
GenElute™ Plasmid Miniprep Kit Sigma-Aldrich Chemie GmbH, Munich, Germany 
Gentamycin sulphate Sigma-Aldrich Chemie GmbH, Munich, Germany 
Glacial Acetic Acid Sigma-Aldrich Chemie GmbH, Munich, Germany 
Glucose Sigma-Aldrich Chemie GmbH, Munich, Germany 
Glycerol Sigma-Aldrich Chemie GmbH, Munich, Germany 
Glycin Carl Roth GmbH, Karlsruhe, Germany 
Green Fluorescence Plasmid (GFP), 
pmaxGFP® 0.5 µg/µL 
Amaxa biosystems, USA 
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Hefeextrakt Carl Roth GmbH, Karlsruhe, Germany 
Heparin sodium salt Sigma-Aldrich Chemie GmbH, Munich, Germany 
Hepes Sigma-Aldrich Chemie GmbH, Munich, Germany 
Hypotaurine Sigma-Aldrich Chemie GmbH, Munich, Germany 
Intergonan 6000® (eCG) Intervet, Boxmeer, The Netherlands 
IPTG Sigma-Aldrich Chemie GmbH, Munich, Germany 
Isopropyl alcohol Sigma-Aldrich Chemie GmbH, Munich, Germany 
iTaqTM Universal SYBR® Green 
Supermix 
Bio-Rad Laboratories, USA 
iTaq™ Universal SYBR® Green 
Supermix 
Bio-Rad, Germany 
KCl Carl Roth GmbH, Karlsruhe, Germany 
KH2PO4 Carl Roth GmbH, Karlsruhe, Germany 
L-Glutamine Sigma-Aldrich Chemie GmbH, Munich, Germany 
LigaFast™ Rapid DNA Ligation 
System 
Promega, USA 
Lipofectamine® 2000 Transfection 
Reagent 
Life Technologies, USA 
 
Mg2+ Sigma-Aldrich Chemie GmbH, Munich, Germany 
Mineral oil Sigma-Aldrich Chemie GmbH, Munich, Germany 
miRCURY LNA™ microRNA PCR, 
Polyadenylation and cDNA synthesis 
kit II 
Exiqon, USA 
 
miRCURY LNA™ Universal RT 
microRNA PCR, SYBR Green master 
mix 
Exiqon, USA 
 
miRNeasy Mini Kit  Qiagen, Germany 
Mitotracker® Red CMXRos Life Technologies, USA 
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Mounting Medium with DAPI 
VECTASHIELD® 
VECTOR Laboratories, United Kingdom  
Na2HPO4 Carl Roth GmbH, Karlsruhe, Germany 
NaCl Fisher Scientific GmbH, Germany 
NaHCO3 Sigma-Aldrich Chemie GmbH, Munich, Germany 
NaOH Carl Roth GmbH, Karlsruhe, Germany 
Oil Red O Sigma-Aldrich Chemie GmbH, Munich, Germany 
Opti-MEM® Reduced Serum Medium, 
GlutaMAX™ Supplement 
Life Technologies, USA 
Ovogest 5000® (hCG) Intervet, Boxmeer, The Netherlands 
PCR Primer set Eurofins 
Penicillamine Sigma-Aldrich Chemie GmbH, Munich, Germany 
Penicillin-Streptomycin Life Technologies, USA 
Percoll Sigma-Aldrich Chemie GmbH, Munich, Germany 
pGEM®-T Easy Vector Systems Promega, Germany 
pmirGLO Dual-Luciferase miRNA 
Target Expression Vector 
Promega, Germany 
PVA, Poly(vinylalcohol)  Sigma-Aldrich Chemie GmbH, Munich, Germany 
QIAquick PCR Purification Kit Qiagen, Germany 
Rnase-Free Dnase Set Qiagen, Germany 
SacI DNA restriction enzyme New England Biolab, USA  
Secondary Antibody, Alexa Flour® 
568 Goat Anti-Rabbit IgG (H+L)  
Life Technologies, USA 
Sodium pyruvate Sigma-Aldrich Chemie GmbH, Munich, Germany 
Sucrose Sigma-Aldrich Chemie GmbH, Munich, Germany 
Taq Polymerase S Genaxxon bioscience GmbH, Germany 
TCM-199 medium Sigma-Aldrich Chemie GmbH, Munich, Germany 
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Tris(hydroxymethyl)-aminomethane Carl Roth GmbH, Karlsruhe, Germany 
Triton X-100 Carl Roth GmbH, Karlsruhe, Germany 
Trypton/Pepton Carl Roth GmbH, Karlsruhe, Germany 
Universal cDNA Synthesis Kit II Exiqon, USA 
Urea Sigma-Aldrich Chemie GmbH, Munich, Germany 
Vectashield, mounting medium Vector Laboratories, UK 
WST-1 Cell Proliferation Assay Kit Cayman Chemical, USA 
XbaI DNA restriction enzyme New England Biolab, USA 
Xgal, Blue-White Select™ Screening 
Reagent  
Sigma-Aldrich Chemie GmbH, Munich, Germany 
Xylene Cyanol Sigma-Aldrich Chemie GmbH, Munich, Germany 
 
3.1.2 Reagents and media preparation 
The following reagent and media were prepared with ddH2O and when it is necessary pH was 
adjusted with NaOH or HCl. In addition, solutions or buffers that dealing with cell culture 
systems needs to be autoclaved at 120°C for 20 minutes or filtered through 0.2 µm filter. 
 
Media or solution Chemical ingredients Amount / volume 
   
10x TBE buffer (HOCH2)3CNH2 (Tris base) 108 g 
 H3BO3 (Boric acid) 55 g 
 EDTA (0.5 M) 40 ml 
 ddH2O up to 1000 ml 
10x PBS NaCl 8.77 g 
 Na2HPO4 1.50 g 
 NaH2PO4 2.04 g 
 ddH2O up to 1000 ml 
10x TAE buffer Tris 48.5 g 
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 acetic acid 11.4 ml 
 EDTA 0.5 M (pH 8.0) 20 ml 
 ddH2O up to 1000 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O 25 ml 
Cell culture medium Dulbecco's Modified Eagle's 
Medium/Nutrient F-12 Ham  
44 ml 
 FCS 5 ml 
 Penicillin-Streptomycin 0.5 ml 
CR1-aa culture medium Calcium lactate 273.0 mg 
 Streptomycin sulphate 3.9 mg 
 Penicillin G 1.9 mg 
 NaCl 315.6 mg 
 Potassium chloride 11.2 mg 
 Sodium hydrogen carbonate 105 mg 
 Sodium pyruvate 2.2 mg 
 L-Glutamine 7.3 mg 
 Phenol red solution 100 µl 
 Sodium hydrogen carbonate 80 mg 
dNTP solution dATP (100 mM) 10 µl 
 dGTP (100 mM) 10 µl 
 dTTP (100 mM) 10 µl 
 ddH2O 400 µl 
 Fungizole 0.5 ml 
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EDTA 0.5 M (pH 8.0) EDTA 186.1 g 
 ddH2O 1000 ml 
 NaOH (pH adjusting) - 
Glucose 2 M Glucose 36 g 
 ddH2O 100 ml 
Glycine 0.3 mmol/l (stock 
solution) 
Gylcine 0.02252 g 
PBS (CMF) 10 ml 
Glycine working solution Gylcine stock 100 µl 
 PBS-PVA 9.9 ml 
Guanidin-ethanol solution  
(50 ml) 
Guanidin 1,43 g 
95% Ethanol  up to 50 ml 
In vitro culture medium CR1aa 50 ml 
 Hemi-calcium lactate 273 mg 
 Streptomycin sulphate 3.9 mg 
 Penicillin G 1.9 mg 
 Sodium chloride 315.6 mg 
 Potassium chloride 11.2 mg 
 Sodium hydrogen carbonate 105 mg 
 Sodium pyruvate 2.2 mg 
 L-Glutamine 7.3 mg 
 Phenol red solution 100 µl 
 Sodium hydrogen carbonate 80 mg 
In vitro fertilization medium 
(Fert-TALP medium) 
CaCl2.2H2O 29.4 mg 
KCl 23.9 mg 
MgCl2.6H2O 10.1  mg 
 NaH2PO4.H2O 5.5 mg 
 Lactic Acid (Sodium salt; 60% w/w 186 µl 
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syrup) 
 NaCl 666 mg 
 NaHCO3 210 mg 
 Na Pyruvate 1.0 ml 
 Penicillamine 2 mM 
 Hypotaurine 1 mM 
 Epinephrine 250 µM 
 BSA 600 mg 
 Gentamycin 50 µg/ml 100 µl 
 ddH2O up to 100 ml 
In vitro maturation medium 
(modified parker medium) 
TCM-199  99 ml 
Hepes 149 mg 
NaCHO3 25 mg 
OCS (heat inactivated) 12% 
L-glutamine 0.5 mM 
Pyruvate 0.2 mM 
Gentamycin sulphate 50 µl/ml 
FSH 10µl/ml 
KCl 1 M KCl 74.55 g 
 ddH2O 100 ml 
LB Agar NaCl 4.0 g 
 Peptone 4.0 g 
 Yeast extract (Hefeextrakt) 2.0 g 
 Agar 8.0 g 
 ddH2O 400.0 ml 
 NaOH 1 M (pH: 7) 280 µl 
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Lysis buffer Tris pH 7.6 50 mmol/L 
 NaCl 150 mmol/L 
 SDS 0.1% 
 NP-40 1% 
 Protease and phosphatase inhibitor 
cocktails 
1 mg 
Mg2+ 2 M Mg2+ 4.861 g 
 ddH2O 100 ml 
Modified tissue culture 
medium (oocyte collection 
medium) 
TCM-199 medium ready solution 
Hepes 4.4 mM 
NaCHO3 33.9 mM 
Pyruvate 2 mM 
Calcium lactate 2.9 mM 
Gentamycin sulphate 55 mg/ml 
NaCl 0.9% (saline) NaCl 9.0 g 
 ddH2O 1000 ml 
NaCl 1 M NaCl 58.44 g 
 ddH2O 100 ml 
PBS Ca and Mg free (CMF) 
10x 
NaCl 8.0 g 
KCl 0.2 g 
Na2HPO4 1.15 g 
KH2PO4 0.2 g 
ddH2O 1000.0 ml 
95% Etanol up to 50 ml 
PBS-PVA PBS 50 ml 
 PVA 150 mg 
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SOC Media Trypton 8.0 g 
 Yeast extract (Hefeextrakt) 2.0 g 
 NaCl 1 M 4.0 ml 
 KCl 1 M 3.4 ml 
 ddH2O 400.0 ml 
 Mg2+ 2 M 4.0 ml 
 Glucose 2 M 4.0 ml 
Urea/DTT (10M urea, 50 mM 
DTT) 
Urea 3 g 
DTT 250 µl 
ddH2O 3 ml 
 
3.1.3 List of equipment 
The equipment used in the present study is listed below. 
 
Equipment name Manufacture / supplier 
  
Analytical Balance Mettler Toledo XS603S Mettler Toledo GmbH, Switzerland 
Autoclave Systec 3870 ELV Tuttnauer Europe b.v. The Netherlands 
Chemidoc XRS (Bio-Rad) instrument BioRad, Munich, Germany 
Clean bench Heraeus Herasafe HSP 12 Heraeus Instruments, Germany 
Clean bench KOJAIR Kojair Tech Oy, Vippulla, Finland 
CO2 incubator (MCO-17AI) Sanyo, Japan 
Confocal Microscope CLSM-710 Carl Zeiss, Germany 
Cover glass 24x24 mm Marienfeld, Germany 
Cover glass 24x60 mm Marienfeld, Germany 
CryotubeNunc Roskilde, Germany 
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CytoOne 96-Well Plate Starlab, Switzerland 
Diagnostic Microscope Slides Thermo Scientific, Germany 
Digital pH-Meter Type 643 Knick, Germany 
Electrophoresis unit BioRad, Munich, Germany 
Falcon tube 15ml Cellstar® Greiner Bio-One  GmbH, 
Frickenhausen, Germany 
Falcon tube 50ml Cellstar® Greiner Bio-One  GmbH, 
Frickenhausen, Germany 
Four well dishes for embryo culture Nunc, Roskilde, Denmark 
GenomeLab GeXP Genetic Analysis System Beckman Coulter, Germany 
Grant Bio PMR-30 Platform Rocker (rotational 
schaker) 
Keison International Ltd, UK 
Haemocytometer Set, Neubauer Marienfeld, Germany 
Ice Flaker Scotsman AF80  Scotsman® Ice Systems, England 
Incubated and Refrigerated ShakerMaxQ 6000 
Stackable 
Thermo Scientific, USA 
Incubator Memmert BE 600 Memmert GmbH, Germany 
Injection Needle Sterican® 18G x 1½”  Braun Melsungen AG, Germany 
Injekt luer Solo B. Braun Medical Inc., Pennsylvania, 
USA 
Inverted microscope, ECLIPSE TS100 Nikon, Japan 
Labnet Hermle Z200 M/H benchtop micro 
centrifuge 
Labnet International, Inc., USA 
Labnet Hermle Z233 MK Refrigerated Centrifuge Labnet International, Inc., USA 
Lab-Tek II Chamber Slide w/Cover 154941 CC2 Thermo Fisher Scientific, USA 
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Glass Slide Sterile 
Liquid nitrogen container Taylor-Wharton, USA 
Luminometer plate MICROTESTTM Flat Bottom 
Tissue Culture, Treated by Vacuum Gas Plasma 
Becton Dickinson Labware Europa, Le 
Pont De Claix, France 
Magnetic Stirer IKA Big Squid White 115V IKA 
3050009 
IKA Werke GmbH & CO. KG, Staufen, 
Germany 
Micropipette PIPETMAN Classic™ 0.2-2 µL Gilson Inc, France 
Micropipette PIPETMAN Classic™ 100-1000 µL Gilson Inc, France 
Micropipette PIPETMAN Classic™ 10-100 µL Gilson Inc, France 
Micropipette PIPETMAN Classic™ 20-200 µL Gilson Inc, France 
Micropipette PIPETMAN Classic™ 2-20 µL Gilson Inc, France 
Microscope slide 25x75x1.0 mm Thermo Scientific, Germany 
Millipore Milli-Q A10) Ultra-Pure Water Purifier 
(FMQS6V0TY) 
EMD Milipore Corporation, USA 
Mini-Centrifuge Sprout®  Heathrow Scientific, USA 
MyCyler Thermal cycler  Bio-Rad Laboratories, USA 
Mµlti®-SafeSeal®Tubes, natural Carl Roth GmbH+Co. KG, Karlshure, 
Germany 
NanoDrop 8000 Thermo Scientific, USA 
Orbital shaker KL2 Edmund Bühler, Tubingen, Germany 
PCR Strip Tubes, PCR-0208-C Axygen, USA 
Precision Hot Plates PRÄZITERM I.M.P Vienna, Austria 
RT-PCR ABI PRISM 7000 DS Applied Biosystems, USA 
RT-PCR plate MicroAmp® Fast Optical 96 well Applied Biosystems, USA 
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Spectrophotometer Ultraspec2100 pro GE Healthcare Europe GmbH, Freiburg, 
Germany 
Sub-Cell GT Cell and PowerPac Basic 300V 
Power Supply Gel electrophoresis 
Bio-Rad Laboratories, Inc., USA 
The Universal Microplate Luminometer Centro 
LB 960 
Berthold Technologies, Germany 
Thermal Cycler MyCycler™  Bio-Rad Laboratories, Inc., USA 
Thermo Max Elisa plate reader MWG-Biotech Germany 
Ultra low freezer (-80°C ) Labotech GmbH, Göttingen, Germany 
Ultratip Blue (100-1000 µl) Greiner Bio-One GmbH, Germany 
Ultratip White (1-10 µl) Greiner Bio-One GmbH, Germany 
Ultratip Yellow (10-200 µl) Greiner Bio-One GmbH, Germany 
Universal Hood II Bio-Rad Laboratories, Inc., USA 
UV Transluminator (Uvi-tech) Uni Equip, Martinsried, Germany 
Vortex Certomat MV B. Braun Biotech International GmbH, 
Melsungen, Germany 
X-Clear Advanced Polyolefin StarSeal Starlab International GmbH, Hamburg, 
Germany 
 
3.1.4 List of software 
During the experiments, the following software was used:  
 
Software name Link / source 
ENSEMBL genome browser http://www.ensembl.org/ 
GraphPad Prism 5 GraphPad Software, San Diego California 
USA 
NCBI Blast http://www.ncbi.nlm.nih.gov/blast 
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Pimer3 http://bioinfo.ut.ee/primer3-0.4.0/ 
Quantity One® 1-D analysis software Bio-Rad 
QuickCalcs molarity calculator http://www.graphpad.com/quickcalcs/Molarit
yform.cfm 
Weight to molar quantity (for nucleic acids) http://molbiol.ru/eng/scripts/01_07.html 
Zen 2011 http://microscopy.zeiss.com/ 
miRanda http://www.microrna.org/microrna/home.do 
miRBase http://www.mirbase.org/ 
miRecords http://mirecords.biolead.org/ 
MikroWin 2000 http://www.mikrotek.de/content/view/19/56/ 
TargetScan http://www.targetscan.org/ 
PICTAR http://www.pictar.org/ 
DNA reverse and complementary sequence http://www.bugaco.com/calculators/dna_reve
rse_complement.php 
FINDTAR3 http://bio.sz.tsinghua.edu.cn/ 
ImageJ v.1.48 http://bio.sz.tsinghua.edu.cn/ 
Softmax Pro v4.0 http://www.moleculardevices.com/Products/S
oftware/SoftMax-Pro.html 
Serial Cloner v.2.6.1 http://serialbasics.free.fr/Serial_Cloner.html 
GenomeLab System v.10.0.30 https://www.beckmancoulter.com/wsrportal/
wsr/research-and-discovery/products-and-
services/genetic-analysis-systems/index.htm 
 
3.2 Methods 
 
3.2.1 Sample production 
 
There are two types of sample that is produced during this study. First is bovine embryos 
derived from in vivo and in vitro, and the second one is bovine granulosa cells cultured in 
vitro.   
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3.2.1.1 In vivo production of bovine embryos 
The part of experiment that deals with animals was performed and handled according to the 
animal protection laws of Germany. In vivo blastocysts were produced as described 
previously (Tesfaye et al. 2004). Simmental heifers were super ovulated with 2000 IU of eCG 
by intra muscular injection at Day 9 of estrus cycle. The superovulation followed by double 
injection of PGF2α in 8-10 h interval at Day 13 in a purpose to induce a luteolysis. On Day 
15, 3000 IU of hCG were administrated intravenously to the cows, followed by two times of 
artificial insemination using frozen-thawed semen. In this study, semen for artificial 
insemination and IVF come from a commercial bull. At Day 7 after insemination, in vivo 
blastocysts were flushed out by a non-surgical uterine flushing method. Consequently 
blastocysts were pooled in groups of 10, snap frozen with lysis buffer in liquid nitrogen and 
stored at -80°C until further use for gene expression analysis.  
 
3.2.1.2 In vitro production of bovine embryos 
The processes of in vitro production consist of 4 main parts namely oocytes collection, in 
vitro maturation, in vitro fertilization and in vitro culture, respectively. The entire steps were 
performed in Animal Biotechnology Laboratory, Frankenforst Research Station, University of 
Bonn. Bovine ovaries were collected from local abattoir (Bernhard Frenken GmbH Vieh und 
Fleischhandel Schlachthof Düren) and transported to the laboratory while keeping it warm 
(37°C) in saline solution (0.9% NaCl) within 1-2 h after the collection. Immediately after 
arrived, ovaries were then washed 3 times with 37°C saline and 1 time with 70% ethanol for 
30 seconds respectively. The COCs were aspirated by using 18G needle attached on 10 ml 
syringe containing 2 ml aspiration medium, then pooled in 50 ml tubes and kept warm at 
37°C. The COCs that are surrounded by more than three compact layers of cumulus cells 
were selected and separated under stereomicroscope using a glass pipette. Briefly, selected 
COCs were transferred to TCM-199 medium that was supplemented with 12% ECS (heat 
inactivated). 
 
The maturation process of selected COCs was initiated by 3 times washing in pre warmed 
maturation medium then COCs were grouped in each 50. Briefly, COCs were transferred into 
four well dishes containing 400 µl pre-incubated maturation medium and covered by mineral 
oil. Oocytes were then incubated for 22-24 h at 37°C 5% CO2. Prior fertilization, two times 
washing in fertilization medium was performed. Afterward, oocytes were fertilized by co-
incubated with 2x106 spermatozoa/ml in 400 µl of fertilization medium. The best qualities of 
motile sperm were selected from top layer of percoll gradient. Sperm were collected by 
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centrifugation method at 10.000 rpm for 10 minutes, followed by 2 times washing and finally 
re-suspended in a fertilization medium. Fertilization process will take place for 18 h at 37°C 
5% CO2. 
 
Presumptive zygotes were collected in 15 ml falcon tube containing 1 ml culture medium then 
denuded from cumulus cells. After a series of washing, in order to remove dead sperm and 
cumulus cells, 50 zygotes were then grouped and transferred into 4 well dishes each 
containing 400 µl IVC medium (SOF) covered by mineral oil. The first cleavage of embryos 
was expected within 48 h post fertilization, following with incubation for consecutive days to 
produce different stages of preimplantation embryos according to the experimental design and 
analysis purposes.  
 
In the second part of experiment 1, presumptive zygotes were randomly transferred into 2 
types of culture media. First group is zygotes that cultured in the presence of 10% OCS (with 
serum) and the second one was cultured in media with the addition of PVA 0.1% (without 
serum).  Resulting embryos at 2-, 8-, 16-cell and blastocyst stage were harvested. All embryos 
sample were snap frozen with lysis buffer in liquid nitrogen and stored at -80°C for RNA 
isolation subsequently to gene expression analysis. Moreover, in the experiment 1 part 3, 
zygotes were subsequently divided into 3 groups then transferred to culture medium 
supplemented with different macromolecules source namely 10% serum, 0.3% BSA and 0.3% 
BSAFAF. For all embryo culture media, essential amino acids and non-essential amino acids 
were supplemented for each 10 µl/ml. Zygotes were cultured until Day 9 of blastocyst stages 
for development rate calculation. Blastocysts which develop at Day 7 were snap and frozen at 
-80°C for RNA isolation. Part of the resulted blastocyst also used for phenotype analysis such 
as lipid content, mitochondrial activity, ROS detection and protein detection by 
immunohistology method.   
 
3.2.1.3 AICAR application in bovine embryo culture media 
In this study, AICAR was used in attempt to increase AMPK activity in embryos artificially. 
Briefly, 25 mg AICAR was diluted in 2.5 ml sterile ddH2O resulted 10 mg/ml AICAR as 
stock solution. Considering of AICAR molecular weight (MR: 258.23), a calculation with the 
help of molarity calculator was performed to prepare 1 mM AICAR as working solution by 
diluted AICAR stock in the culture medium followed by filtration. Desired AICAR working 
solution concentration (0, 1, 10 and 100 µM) then can be prepared by the same dilution 
method and applied to bovine in vitro culture media in the presence of serum.  We treated 
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embryos by AICAR from zygote until blastocyst stage. Result from this preliminary 
treatment, allowed us to select one AICAR concentration which shows the highest AMPKA1 
gene expression compared to the other groups. The selected concentration is then applied in 
IVP of embryo and resulted blastocyst were pooled and snap frozen with lysis buffer and 
stored at -80°C for RNA extraction and for specific phenotype analysis. 
 
3.2.1.4 Bovine granulosa cells culture 
Granulosa cells were collected from 2-8 mm growing follicle by aspirate the follicular fluid 
then pooled in 15 ml falcon tube containing 5 ml PBS without Ca2+ and Mg2+. Thereafter, cell 
debris was let settled down for 15 minutes. To collect granulosa cells, 500 x g of 
centrifugation followed by discard flow through were performed for 5 minutes. Pooled 
granulosa cells were then centrifuged and the resulted pellet was washed two times and re-
suspended in cell culture media. Number of granulosa cells were counted using 
haemocytometer and its viability were assessed by trypan blue staining. Final granulosa cells 
suspension was delivered into 24 wells tissue culture plate and viable cells were seeded in 
concentration 2x105 cells/ml. Granulosa cells were cultured in F12 culture medium 
supplemented with 10% FCS or 0.3% BSAFAF, 200U/mL penicillin streptomycin and 100mg 
/mL fungizone. Culture media were changed in every 24 h. In this granulosa cells culture 
work, Day 0 set as 24 h, Day 1 as 48 h and Day 2 as 72 h post seeding. Cells confluency was 
visually observed by counting the proportion of attached cells to the bottom of culture dish. In 
addition, in each observed day, granulosa cells were harvested using 400 µl of EDTA after the 
removal of culture media and two times washing with PBS using pipetting method. Cells 
were then incubated at 37°C for 10 minutes followed by gently rocking backward and 
forward. Detached cells were then transferred into 15 ml falcon tube, pooled from 3 to 6 wells 
and centrifuged at 1000 x g for 5 minutes followed by discarding the supernatant. Afterward, 
cells pellet were washed two times using PBS and centrifuged with the same previous speed. 
Thereafter, granulosa cells were stored in -80°C for further RNA isolation work.   
 
3.2.2 RNA isolation  
 
During the experiment, two types of RNA isolation kit were used. Total RNA from embryos 
sample were isolated using Acturus® PicoPure® RNA isolation kit, while total RNA from 
granulosa cells were isolated using miRNeasy Mini Kit.  
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3.2.2.1 Total RNA isolation from preimplantation stage of embryos 
Ten embryos from each preimplantation stage were pooled in one tube as one replication and 
3 replicates were needed for each group. Total RNA from embryos was isolated using 
PicoPure RNA isolation kit and performed according to the manufacture protocol. Briefly, 75 
µl of extraction buffer was added to the tube, which is containing embryo sample followed by 
well mixing by repeated pipetting. Thereafter, samples were incubated in 42°C for 30 minutes 
and before the end of incubation time purification columns were prepared by pipetting 250 µl 
of conditioning buffer. The purification columns then incubated for 5 minutes at room 
temperature followed by columns centrifugation at 13250 rpm for 1 minute. At the end of 
incubation time, 75 µl of ethanol 70% was added to the samples then mixed well by repeat 
pipetting. Afterward, the cells extract, which is a mix between samples and ethanol was 
transferred to preconditioned purification column then centrifuge at 1000 rpm for 2 minutes to 
bind RNA. And then the column is immediately centrifuged at 13250 rpm for 30 seconds. 
Columns were then continued to the washing step by pipetting 100 µl wash buffer 1 and 
centrifuge at 9500 rpm for 1 minuet. An additional of DNA digestion step was performed 
afterward, by mixing 5 µl of DNase I with 35 µl of RDD buffer then adding the mixture to the 
purification column followed by 15 minutes incubation at room temperature. By the end of 
incubation time, 40 µl of wash buffer 1 was pipetted into column and centrifuge at 9500 rpm 
for 15 seconds. This process then followed by two times washing step with 100 µl washing 
buffer 2. The first washing step was followed by centrifugation at 9500 rpm for 1 minute, and 
then the second step followed by centrifugation at 13250 rpm for 2 minutes. After that, any 
residual buffer was observed in the column. At this point if there was any fluid remaining, 1 
minute re-centrifugation at 13250 rpm will be performed. Columns were then transferred to 
the new 0.5 ml micro collection tubes and 12 µl of elution buffer was pipetted directly onto 
the middle of column membrane followed by 1 minute incubation at room temperature.  To 
collect the total RNA, columns were centrifuged at 3250 rpm followed by 13250 rpm and 
each centrifugation is for 1 minute. Total RNA concentration was determined by NanoDrop 
and stored in -80°C for further use.      
 
3.2.2.2 Total RNA isolation from granulosa cells 
Total RNA was isolated from three pools of granulosa cells as a replicate by using miRNeasy 
mini kit. Briefly, 200 µl of QIAZOL was added into each granulosa cells samples followed by 
gently vortex until all the cells were diluted. Thereafter, 5 minutes incubation at room 
temperature was performed. By the end of incubation time, 200 µl was added followed by 
short vortex, 2 minutes incubation and 15 minutes centrifugation at 4°C. Keeping in mind, all 
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centrifugation steps in this protocol were performed at 12.000 x g. Five hundred µl of upper 
aqueous phase was transferred to a new collection tube and immediately 750 µl of ethanol 
100% was added followed by gently mixing by repeat pipetting. Resulted mixtures then 
transferred to RNeasy Mini Spin Column, followed by 30 seconds centrifugation at room 
temperature. The step was repeated until the rest of remaining sample. Afterward, 1 time 
washing by 700 µl RWT buffer and 2 times with RPE were performed and in each step 
followed by centrifugation at room temperature for 1 minutes and discard flow through. 
Columns were then transferred into fresh collection tube and centrifuged at maximal speed to 
dry the columns for 2 minutes. Later on columns were leaved open for 1 minute and 
transferred to a non-stick RNase free microfuge tube. Carefully, 30 µl of RNAse free water 
was added into center of column membrane, followed by incubation for 1 minute at room 
temperature and 1 minute centrifugation to collect RNA. RNA concentration then determined 
by Nanodrop and stored at -80°C for further work. 
 
3.2.2.3 Small RNA isolation from bovine embryos 
For miRNA profiling in bovine blastocysts sample, small RNA was isolated using 
miRNAeasy kit. The protocol was as identical as total RNA isolation in granulosa cells.  
Briefly 20 embryos were pooled into one replicates per groups and each group contain 3 
replicates. Before RNA extraction protocol started, the tube containing blastocysts were 
thawed and centrifuged at room temperature for 1 minute. Afterward, normal steps RNA 
isolation as mentioned in granulosa cells was performed. 
 
3.2.3 First strand cDNA synthesis 
 
Adjusted total RNA concentration was converted into first strand cDNA synthesis in 20 µl 
volume reaction. The entire chemicals used in this procedure were ordered from 
Thermofischer Company namely First Strand cDNA Synthesis Kit. Briefly, chemicals were 
thawed, mixed and stored on ice before use. Total RNA concentration from its original stock 
was adjusted at 1 ng per reaction for RNA from cells and 200 ng for RNA from embryos, by 
adding nuclease free water (supplied by company). After that, 0.5 µl of Oligo-dT and 0.5 µl 
Random Primer were added, mixed well by pipetting, followed by short centrifugation and 
incubation at 65°C for 5 minutes. In the meantime, a master mix containing 4 µl of 5x 
reaction buffer, 1 µl of RiboLock RNase inhibitor, 2 µl of 10 mM dNTP mix and 2 µl of M-
MulV reverse transcripts were mixed by gently pipetting. At the end of incubation time, 9 µl 
of master mix was added to each reaction followed by incubation at 37°C for 60 minutes, then 
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70°C for 5 minutes to terminate the reaction. At this point, cDNA product can be directly 
preceded to gene quantification or stored at -20°C for further use.   
 
3.2.4 Transcription level quantification 
 
The mRNA expression levels were quantified by qRT-PCR by using relative standard curve 
method. For that, serial dilution for each gene was prepared accordingly by a series of gene 
cloning and DNA sequencing work. 
 
3.2.4.1 Gene specific cloning for serial dilution 
Primer 3.0 software was used to design specific gene primers, and then primers were ordered 
from Exiqon Company. The primers sequence was listed in table 3. Primers were diluted with 
ddH2O treated with UV to 1 mmol/µl as stock solution, and working solution was prepared at 
0.1 mmol/µl. Specific gene sequences was amplified in PCR thermocycler and bovine gDNA 
was used as the template. The PCR product then proceeds to DNA sequencing process, once 
it is confirmed a series of ligation work were performed.   
 
Table 3:  Details of primers used for gene expression analysis. 
 
Gene 
name 
Accession number  
(NCBI) 
Primer sequence 5’-3’ 
Annealing 
temperature 
(°C) 
Product 
size (bp) 
      
AMPKA1 NM_001109802.2 F AGCCCTTCCTTCTCTTGCTC 55 246 
  R AGGATGCCTGAAAAGCTTGA   
AMPKA2 NM_001205605.1 F AGCAGAGGTCTGGTTCCTCA 55 155 
  R TGAGACAGAGGACGACATGC   
STK11 XM_003586293.2 F TTTACAGAGGGCGAGCTGAT 53 207 
  R GATTTTGACGGCTCTTCTGC   
ACC NM_174224.2 F CTCTTCCGACAGGTTCAAGC 55 248 
  R ACCATCCTGGCAAGTTTCAC   
CPT1 NM_001034349.2 F CTGGGACTCAACACAGAGCA 53 285 
  R CTTCTTGATGAGGCCTTTGC   
CPT2 NM_001045889.1 F CACAACATCCTGTCCACCAG 54 209 
  R CCTTCCAAGGCATCAAACAT   
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Table 3:  Cont. 
 
Gene 
name 
Accession number  
(NCBI) 
Primer sequence 5’-3’ 
Annealing 
temperature 
(°C) 
Product 
size (bp) 
 
NQO1 NM_001034535.1 F AACCAACAGACCAGCCAATC 54 154 
  R CACAGTGACCTCCCATCCTT   
PGC1A NM_177945.3 F GGCAATTGTCAGGTTGGAGT 55 296 
  R AAAAGTCACGTCGGCCATAC   
GAPDH NM_001034034.2 F CCAGGGCTGCTTTTAATTCT 55 166 
  R ATGGCCTTTCCATTGATGAC   
M13 - F TTGTAAACGCGGCCAGT 59  
  R CAGGAAACAGCTATGACC   
      
 
Briefly, ligation was set up by mixing 4 µl PCR product, 3 µl 2x Rapid Ligation buffer, 0.5 µl 
pGEM®T Easy Vector plasmid and 0.5 µl T4 DNA ligase. The ligation components were then 
gently mixed by pipetting followed with overnight incubation at 4°C to get the maximum 
number of ligation product. On the following days, ligated PCR products were transformed to 
Escherichia coli (E.coli) as competent cell. Slowly, frozen competent cell was thawed on ice, 
while 8 µl of ligation product was prepared in 15 ml falcon tube. Sixty µl of competent cell 
was carefully transferred into the falcon tube by very gently pipetting then placed on ice for 
20 minutes. Afterward, competent cell was shock heated in water bath at 42°C for 90 seconds 
and returned immediately to an ice bucket for 2 minutes. Moreover, 750 µl of SOC media, 
without ampicillin, was added to the tubes containing cell, and followed by shaking 
incubation (100 rpm) at 37°C for 90 minutes. In the meantime, sterile bended glasses were 
prepared to spread previous incubated cells over LB agar plates. Afterward, LB agar plates 
were prepared by spreading IPTG and X-gal, each 20 µl, onto its surface by using of bended 
glass, then allowed absorbing for 10-20 minutes under laminar flow.   
 
At the end of incubation time, 400 µl of transformed cell was spread over prepared LB agar 
plate. The agar plate then stored under the hood for 15 minutes followed by incubation at 
37°C for 13-15 h. Expected insert colonies were screened by observe white and blue colonies. 
Visible white colonies, minimum 5, were picked up and diluted in SOC media containing 4 
µl/ml of ampicillin for further multiplication in shaking incubator (100 rpm) at 37°C. In 
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parallel, part of diluted colonies and also blue colonies for non-inserted control, were 
amplified using M13 primers in normal PCR reaction. Part of resulted PCR product then 
analyzed in agarose gel.  
 
Selected colonies, based on product size estimation in agarose gel, were briefly transferred to 
15 ml falcon tube containing 8 ml SOC media with ampicillin and incubated in the shaking 
incubator (100 rpm) at 37°C for overnight. On the following day, plasmids were harvested 
using GenElute Plasmid Miniprep Kit according to the supplied protocol. In the plasmid 
isolation work all centrifugation process was performed at 13.000 x g. Briefly, falcon tube 
containing plasmid and SOC media were centrifuged for 5 minutes and the supernatant was 
discarded. Afterward, 200 µl re-suspension solutions was added and gently mixed by 
pipetting followed by transfer to 2 ml new collection tube. The steps were followed by adding 
200 µl lysis solutions, and mixed by 5 times tube inversion then allowed it to clear for 5 
minutes. The next step is adding 350 µl of neutralization solution and mixed it also by 
inversion, followed by centrifugation for 10 minutes. Meanwhile, binding columns were 
prepared by adding 500 µl preparation solution and centrifuged for 1 minuet then discard flow 
through. The clear part was briefly transferred into the binding column then centrifuged for 1 
minute. Subsequent steps by adding 500 µl optional wash solution and 750 µl washing 
solution were respectively performed and each step was followed by centrifugation and 
discards the flow through. Columns were then dried by additional centrifugation at maximum 
speed for 1 minute and then transferred to fresh collection tube. Thereafter, plasmids were 
collected by adding 50 µl of elution buffer into columns, followed by 1 minute centrifugation. 
Plasmid concentration was determined using NanoDrop and serial dilution was prepared in 
109-101 concentration. Prepared serial dilution for each gene then stored at -20°C for further 
gene expression quantification. 
 
3.2.4.2 Quantitative real time PCR 
The mRNA expression level was quantified using qRT-PCR analysis. Specific primers (Table 
3) and its combination was performed in 20 µl reaction which is composed by 2µl sample, 8µl 
master mix (primer + water) and 10µl SYBR green fluorescent detection dye under an ABI 
PRISM®7000 instrument (Applied Biosystems, USA). The thermal cycler program was set at 
95°C for 3 minutes for initial denaturation step, followed by 40 cycles of 15 seconds at 95°C 
and 45 seconds at 60°C then followed by melting curve. The amount of transcripts in each 
gene was normalized to GAPDH as internal control.  
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3.2.5 DNA sequencing 
 
To confirm the amplified sequence of PCR product, samples were sequenced using CEQ™ 
8000 Series Genetic Analysis System (Beckman Coulter). Briefly, 5 µl of DNA sample was 
cleaned by adding 1 µl of Exosap-IT and incubated at 37°C for 30 minutes. ExoSap-IT was 
then deactivated at 80°C for 15 minutes. Samples were then amplified in PCR machine using 
forward or reverse primer in 16 µl reaction consist of 5 µl ddH2O, 5 µl DNA template, 2 µl 
forward or reverse primer (specific for each DNA sample) and 4 µl DTCS (Dye Terminator 
Cycle Sequencing) mix.  For this purpose, PCR programs were run at 96°C for 2 minutes, 
50°C for 2 minutes and 60°C for 4 minutes respectively for 30 cycles. Afterward, PCR 
product then transferred to a sterile 1.5 ml micro centrifuge and mixed gently by pipetting up 
and down.  In the meantime, fresh stop solution consist of 2 µl 3M NaOAc (pH : 5.2), 2 µl 
100 mM EDTA (pH : 8.0) and 1 µl glycogen were freshly prepared.  
 
In brief, 5 µl of stop solution was added to PCR product and mixed with 60 µl of ethanol 98% 
in a sterile tube by vortex. Afterward, 15 minutes centrifugation at 4°C was performed and 
supernatant was removed using micropipette. This step then followed by two times washing 
with 200 µl ethanol 70%, and each washing step was accompanied by 5 minutes 
centrifugation at 4°C. The PCR products were then dried in vacuum dry machine for 10 
minutes and continued for 5 minutes at 35°C. The resulted pellet then re-suspended in 40 µl 
SLS (Sample Loading Solution). After 2 minutes incubation, samples were transferred to a 
CEQ sample plate and covered with mineral oil.  In the other side, fresh CEQ separation 
buffers also need to be prepared and filled into the well. The DNA reading program was 
initiated according to the manufacturer instruction and resulted sequence was analyzed using 
NCBI Blast.   
 
3.2.6 Immunofluorescence staining of AMPKA protein 
 
Immunohistochemistry was performed to detect AMPK protein in blastocysts sample. Briefly 
blastocysts were fixed in 4% paraformaldehyde for overnight at 4°C and on the following day 
two times washing with glycine in PBS (GPBS) was performed. Afterward, samples were 
treated by 0.5% (v/v) Triton-X100 in PBS for 3 h at room temperature. Blastocysts were then 
incubated in 3% donkey serum in PBS at room temperature for 1 h, followed by incubation at 
4°C for overnight in primary antibodies against AMPKA1/2 (H-300 Santa Cruz, dilution 
1:100) to detect AMPK protein expression. In the next day, samples were washed two times 
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in PBS and secondary antibody Alexa Flour 568 (Invitrogen, dilution 1:300) goat anti-rabbit 
IgG (H+L) was applied by incubating the sample for 1 h incubation at 37°C. After two 
additional wash in PBS, samples were fixed and mounted on a slide glass using Vectashield 
(H-1200) containing DAPI. Images were captured under laser confocal scanning microscope 
LSM 710 (Carl Zeiss, Germany) and Zen 2010 software was used to process the images.  
 
3.2.7 Immunofluorescence staining of AMPKA phosphorylation site  
 
In order to detect AMPK protein activity which known active by phosphorylation process, 
AMPK phosphorylation site at Thr172 was stained by immunohistochemistry method in 
blastocyst sample. Briefly blastocysts were fixed in 4% paraformaldehyde for overnight at 
4°C followed by two times washing in GPBS. The following process is as same as in AMPK 
protein staining protocol, however the difference is the use of primary antibody against 
phospho-AMPKA (p-AMPKA Thr172, 40H9, rabbit monoclonal antibody, Cell Signaling 
Technology, dilution 1:100).  
 
3.2.8 Assessment of embryo mitochondrial activity  
 
Activity of mitochondria was assessed using dyes that are accumulated in mitochondrial 
membrane, represent electron gradient at ATP production in oxidative phosphorylation 
process (Chazotte 2009). Mitochondrial activity was visualized by MitoTracker Red 
CMXRos (M7512 Invitrogen) as described by the previous study (Amin et al. 2014). Briefly, 
blastocysts were incubated with 200nM MitoTracker Red (Mt-Red) for 45 minutes, followed 
by two times washing with PBS-PVA 0.1%. Blastocysts were then fixed in 4% formaldehyde 
at 4°C for overnight. Thereafter, samples were washed two times with PBS-PVA 0,1% and 
mounted on slide glass with Vectashield (H-1200) containing DAPI. Samples were visualized 
under laser scanning confocal microscope, LSM 710 (Carl Zeiss, Germany), and appropriate 
wavelength for the Mt-Red (579-599 nm) was used to acquire and photograph the images at 
x40 lens magnification. Images were then processed using Zen 2011 software. 
 
3.2.9 Blastocyst ROS detection 
 
ROS level in blastocysts sample were determined using cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Life Technologies, USA).  Briefly, 10 
blastocysts were incubated in 400 µl of 5 µM H2DCFDA for 20 minutes at 37°C in dark 
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conditions followed by two times washing with PBS-PVA 0.01%. Thereafter, the blastocyst 
ROS level was evaluated under inverted fluorescence microscope (Leica DM IRB, Wetzlar, 
Germany), and images were captured using green fluorescence filter which emitting 517-527 
nm wave length.  
 
3.2.10 Embryo lipid droplet staining and quantification 
 
Oil red was applied to blastocyst sample in purpose to stain lipid droplet in the cytoplasm. 
Briefly, embryos were removed from culture media followed by 2 times in PBS-PVA 0.1%. 
Afterward, blastocysts were fixed for overnight with formaldehyde 10% at 4°C. In the 
following day, embryos were washed 2 times in PBS-PVA 0.1% and then incubated for 10 
minutes in isopropanol 60%. Oil red was applied to embryos for 1 h followed by 4 times 
washing with PBS-PVA 0.1%. For quantitative measurement of lipid contents, oil red in 
blastocyst was eluted with isopropanol 100%. Briefly, stained blastocysts were incubated in 
rotational shaking machine at 100 rpm for 1 h leading to diffusion of lipid bound oil red out of 
the embryos into the surrounding isopropanol, and eluted oil red was quantified under 
spectrophotometer (Ultraspec 2100pro, GE Healthcare Europe, Germany) at 490 nm 
wavelength. Finally, absolute values for optical densities were calculated to relative values. 
 
3.2.11 Assessment of blastocyst cell number 
 
Cell number was scored by counting an individual blastocyst on each group of treatment.  
Briefly 20 blastocysts were removed from culture medium and washed 2 times in drop of 
PBS-PVA by transferring embryo from drop to drop. Then, blastocysts were fixed in 
paraformaldehyde 4% for 10 minutes, followed by three times washing in drop of PBS. 
Blastocysts were then mounted on clean microscope slide glass, stained with DAPI 
(0.01µg/µL in PBS) for 10 minutes and gently pressed with 16x16 mm cover glass. The 
blastocyst nucleus which emitting blue signal was counted under fluorescent microscope. 
 
3.2.12 miRNA target prediction (in silico study) 
 
miRNA target prediction was performed in bioinformatics database that are miRBase, 
PICTAR, miRanda and TargetScan. Common miRNAs, which were found in at least 3 
databases, were selected as candidate then profiled in the granulose cell samples. Then the 
selected miRNA, which is the most abundance, was uploaded into FINDTAR3 web based 
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software along with 3’UTR of AMPKA1 in purpose to predict its binding site (Ye et al. 
2008). Thereafter, selected binding site then proceeded to 3’UTR primer design for plasmid 
construction.  
 
3.2.13 miRNA expression profiling 
 
The expression level of miRNAs targeted to AMPKA1 was profiled in qRT-PCR using 
Universal RT microRNA PCR SYBR Green master mix. To do that, small RNA was 
converted into small cDNA using miRCURY LNA™ Universal RT MicroRNA PCR system. 
All these processes were performed according to the protocol supplied. 
 
3.2.13.1  Small cDNA synthesis 
Total RNA concentration that carries small RNA was adjusted to 100 ng. In brief, 5x reaction 
buffer was gently thawed and placed on ice. The RNA spike-in was re-suspended by adding 
40 µl nuclease free water and mixed by vortex prior usage then were left on ice for 15-20 
minutes. Immediately before use, enzyme mix was thawed by gently flicking the tube and 
placed it on ice. Master mix was set up for each reaction in 20 µl total volume containing 4 µl 
5x reaction buffer, 9 µl nuclease free water, 2 µl enzyme mix, 1 µl synthetic spike-in control 
and 4 µl template total RNA. The master mix then gently dispersed into nuclease free tubes, 
followed by RNA template in each tube. This step is followed by mixing the reaction in a 
very gentle way by pipetting and continued with a short spin down. Samples were incubated 
at 42°C for 60 minutes followed with heat inactivation at 95°C for 5 minutes and immediately 
cooled down to 4°C. By the end of the incubation time, cDNA were placed on ice and diluted 
to 20 folds by adding nuclease free water and stored in -20°C.  
 
3.2.13.2  miRNA expression analysis 
In brief, diluted small cDNA and SYBR green were thawed for 15-20 minutes and placed on 
ice. At this point, SYBR green master mix vials must be protected from light by covering it 
with aluminum foil. The PCR reactions were set up in 10 µl volume by pipetting 5 µl SYBR 
green master mix, 1 µl PCR primer mix and 4 µl cDNA templates into each well of PCR 
plate. After that, 2 minutes centrifugation at 1000 rpm was performed to ensure that all 
ingredients are mixed well. The RT-PCR was performed by setting up the program in a real 
time PCR machine with an initial denaturation process at 95°C for 10 minutes, 40 cycles 
amplification process at 95°C for 10 seconds then 60°C for 1 minute, and a default program 
for the melting curve analysis. Three reference miRNAs (U6, Snord48 and 5S) were used for 
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normalization and plotted as reference by geometric mean. Relative quantification of each 
miRNA expression was calculated with the 2−∆∆Ct method and data were presented in a graph.  
 
3.2.14 miRNA target validation 
 
To validate miRNA which targeted to AMPKA1, luciferase assay method was performed. 
The luciferase assay work was initiated by plasmid construction followed by luciferase 
activity measurement.  
 
3.2.14.1  Plasmid construction 
In this study, pmirGLO was selected as carrying vector considered it has luciferase promoter 
sequence and its activity will be measured in luciferase assay. The DNA insert will be cloned 
in multiple cloning region of pmirGLO as illustrated in figure 6. Initially, plasmid was 
constructed virtually in Serial Cloner software. Briefly, AMPKA1 3’UTR contain miRNA 
binding sites were uploaded to the software then primers were designed by adding restriction 
enzyme sequence. In the other side, a mismatch of oligonucleotide was designed in the same 
way. The mismatch oligonucleotides were designed according to the method in the previous 
study (Eades et al. 2011). Virtual PCR, DNA digestion and ligation were performed 
respectively aimed to ensure the primers and mismatch oligonucleotide perfectly cloned in 
pmirGLO multiple cloning regions. In the present study, selected region of AMPKA1 3’UTR 
was amplified using bovine gDNA in normal PCR reaction. Moreover, mismatch 
oligonucleotide was annealed using annealing buffer which supplied by Promega. Thereafter, 
amplified DNA and annealed sequence were digested using restriction enzyme and purified 
using QiaQuick PCR Purification Kit. Then, the concentration of purified plasmid was 
measured in NanoDrop. At this step, purified DNA can be proceed to ligation step 
immediately or stored at -20°C.  
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Figure 6:  pmirGLO plasmid and its features. 
 
In the present work, ligation was performed in 10 µl reaction using T4 DNA ligase according 
to the supplied protocol. By the end of the ligation step, 2 types of plasmid namely pmirGLO-
AMPKA1-3’UTR-Wild Type (WT) and pmirGLO-AMPK1-Mismatch (MT) will be 
constructed. The wild type plasmid is carrying miRNA binding site, while the mismatch 
carries the mutated one. Purified DNA in the previous step was ligated using linearized 
pmirGLO with concentration 3:1. In order to achieve maximum ligation product, 4°C 
incubation for overnight was performed. On the next day, ligated DNA was transformed into 
competent cell and platted in agar medium for 12-14 h. The transformation protocol, bacterial 
spreading, colony picking followed by bacterial growing were identical as mentioned in gene 
cloning for serial dilution methods. In regards to screen inserted plasmid contain intended 
DNA sequence, 10 bacterial colonies were picked up on the following days, and insertion 
result were confirmed by PCR using pmirGLO primer which amplify multiple cloning site. 
Product size comparison displayed between colonies in agarose gel was the information for 
colonies selection. Inserted plasmids will have a greater product size compared to the non-
inserted one. Thereafter, inserted colonies were inoculated in SOC media followed by 
incubation in a shaking chamber, 100 rpm at 37°C, for further plasmid isolation. Moreover, 5 
µl of PCR product also prepared for DNA sequencing. Once clone sequences were verified, 
plasmids were harvested by using GenElute™ Plasmid Miniprep Kit and concentration was 
measured in NanoDrop. At this point, plasmids can be proceeds directly into co-transfection 
work or stored at -20°C for further use.  
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3.2.14.2  Luciferase assay 
Luciferase activity was measured using Dual-Luciferase® Reporter Assay System according 
to the manufacture protocol. Initially, effective dosage of transfection reagent was selected by 
transfect granulosa cells with different dosage of Lipofectamine that combined with 
fluorescence green plasmid (pmaxGFP® 0.5 µg/µl). Thereafter the most effective dosage was 
used for further granulosa cells transfection. In the transfection part, briefly, granulosa cells 
were seeded at 2 x 105/µl in 24 wells plate. After cells confluency reach 80-90%, cells were 
co-transfected between constructed plasmid either wild type or mutant with miRNA mimic 
using Lipofectamine followed by incubation for 24 h at 37°C. On the following days, cell 
culture media was removed and cells were rinsed using PBS. Afterward, 100 µl of 1x passive 
lysis buffer was added into each well of cell culture plate then gently shake for 15 minutes at 
room temperature to harvest cell lysate. Lysate were then transferred to a clean tube, and at 
this point cell lysate can be stored at -80°C of immediately proceed to luciferase activity 
assay.  
 
Luciferase assay was initiated with reagent II (LAR II) and Stop & Glo reagent preparation. 
Luciferase assay reagent was prepared by adding 10 ml of luciferase assay buffer II to 
lyophilized luciferase assay substrate. Afterward, LAR II can be stored at -80°C or 
immediately used. Meanwhile, Stop & Glo reagent were prepared by adding 2.1 ml of 50x 
Stop & Glo substrate to 105 ml of Stop & Glo buffer followed by vortex for 10 seconds. Once 
it is prepared, Stop & Glo reagent can be stored at -20°C for 15 days. In this study 
luminometer Berthold Centro LB 960 was used to measure luciferase reporter activity. 
Injector 1 and 2 in luminometer machine were set to disperse 100 µl of LAR II and Stop & 
Glo respectively. Briefly, 20 µl of cell lysate were dispersed in each well of luminometer 
plate then loaded in luminometer machine. For luciferase signal measurement, luminometer 
was set at 2 seconds delay and 10 seconds read time. The resulted luciferase activity data were 
then analyzed using MikroWin 2000 software, where renilla luciferase activity was 
normalized to the firefly luciferase activity. Normalized luciferase activity was compared to 
the un-transfected cells to ensure the transfection protocol is in proper way. In this assay we 
were measuring luciferase activity of un-transfected cell, transfected with WT plasmid and 
transfected with MT plasmid. 
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3.2.15 miRNA mimic or inhibitor transfection 
 
In the aim to study the regulatory mechanism of AMPKA1 post transcriptionally, granulosa 
cells were transfected with validated miRNA inhibitor. In this study, 50 nM (in total) of 
miRNA inhibitor in 550 µL culture medium was used in each well of 24 wells plate. To 
achieve that concentration, cells were cultured in 500 µL culture media, and 50 µl as the 
complex, 25 µl containing Lipofectamine and 25 µl containing miRNA, were gently added 
into each well. In addition cells were seeded in 24 wells plates for 2 days prior transfection at 
confluency around 80-90%.  Fifty nM of miRNA was transfected in each 24 well plate using 
MEM reduced serum system and granulosa cells were continued for incubation in F12 
medium plus 10% FCS for the next 24 h. On the following day, cells were harvested and store 
at -80°C until RNA isolation and protein extraction. 
 
3.2.16 Protein isolation from granulosa cells and Western blot analysis 
 
Granulosa cell proteins were isolated from organic phenol portion during RNA isolation using 
miRNeasy kit as protocol supplied by the company.  Briefly, 300 µl of 100% ethanol was 
added, mixed and incubated for 2-3 minutes at room temperature. Following centrifugation at 
2000 x g at 4°C, supernatant which containing protein fraction was transferred into a new cap 
lock tube then 1.5 ml isopropanol was added, and followed by 10 minutes incubation at room 
temperature. Samples were then centrifuged at 12.000 x g for 10 minutes at 4°C and 
supernatant was removed. At the following step, all centrifugation and incubation was 
performed at room temperature until it stated. Immediately, 2 ml of guanidine ethanol was 
added followed by 20 minutes incubation. By the end of the incubation time, samples were 
centrifuged at 7500 x g and discarded the flow through. Afterward, 2 ml of 100% ethanol was 
added, vortexes, incubated for 20 minutes and centrifuged at 7500 x g for 5 minutes followed 
by discarding the supernatant. Final centrifugation was performed at 13.000 x g for 5 minutes, 
followed pellets air dried for 10 minutes. Fifty µl of urea-DTT solution was added and pellet 
was broken up using long needle. Another 450 µl of urea-DTT was also added to the previous 
solution, followed by incubation for 1 h. After incubation time, protein solutions were 
transferred into a new collection tube and centrifuged at 10.000 x g for 10 minutes. Then 
supernatant that containing protein was transferred to a new collection tube. Afterward, 500 
µl of urea-DTT solution was added and incubated at 95°C for 3 minutes followed by a 
transfer into a new collection tube and centrifuged at 10.000 x g for 10 minutes. Thereafter, 
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supernatant was transferred into a new collection tube and NanoDrop was used to determine 
its protein quantity. 
 
For Western blot analysis, protein from each sample were loaded and resolved in 12% SDS-
PAGE polyacrylamide gels (Bio-Rad, Corp., Hercules, CA, USA) then transferred to 
nitrocellulose membranes (Biotrace NT, Pall life Sciences, Pensacola, FL, USA). Membranes 
were blocked using 5% non-fat dried milk in TBST for 1 h at room temperature and incubated 
with polyclonal antibodies raised in rabbit against AMPKA1/2 dilution 1:500 at 4°C for 
overnight. On the following days, after subsequent washing in PBST (5 times each 5 
minutes), membranes were incubated with secondary antibodies anti-rabbit for 1 h at room 
temperature with continuous agitation. In here, primary and secondary antibodies were diluted 
in 0.1 X Roti-Block buffer. Afterward, membranes were washed in PBST for 5 times each for 
5 minutes, then incubated for 5 minutes in chemiluminescent substrate (Thermo Scientific, 
Waltham, USA) and immunoreactive proteins were visualized under Chemidoc XRS (Bio-
Rad) instrument. 
 
3.3 Statistical analysis 
 
In all experiments, samples were produced minimum 3 times and each represents biological 
replicate. Data were statistically analyzed using Statistical Analysis System (SAS) version 9.1 
(SAS Institute Inc., Cary, NC, USA), while graphs were generated using GraphPad Prism 5.0 
for Windows, GraphPad Software, San Diego California USA. Mean differences between 
groups were statistically analyzed using t-test. In experiment which has more than 2 groups, 
their mean differences were compared using one-way ANOVA followed by post hoc multiple 
pairwise comparisons using Student Newman Keuls’s (SNK) method.  Finally, data were 
presented as means ± standard deviation (SD) in all experiments and p<0.05 was considered 
to be significant.  
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4 Results 
 
4.1 AMPK activity and lipid metabolism in bovine embryos under different culture 
environments 
 
4.1.1 Expression pattern of AMPK gene and lipid accumulation in blastocysts derived 
in vitro vs. in vivo 
 
Based on transcriptome analysis of blastocysts derived from in vitro vs. in vivo culture,  the 
AMPKA1 was found to be down regulated in blastocysts which is spend longer time in in 
vitro culture environment compared to in vivo (Gad et al. 2012). On the pathway analysis (by 
IPA software) it was shown that lipid metabolism was the top affected pathway (FC≥2; 
p<0.05). Therefore, genes in AMPK pathway (AMPKA1, AMPKA2), lipid metabolism 
(ACC) and mitochondrial activity genes (CPT1, PGC1A) were selected to investigate their 
expression in in vitro vs. in vivo blastocysts. As the result, AMPK catalytic subunit α, 
AMPKA1 and AMPKA2, were significantly lower in blastocysts derived from in vitro 
compared to those derived from in vivo. In contrast, expression of ACC showed significantly 
higher when embryos were cultured in vitro. Meanwhile the expression of mitochondrial 
activity genes, CPT1 and PGC1A, were significantly higher in blastocysts derived in vivo 
(Figure 7).  
 
 
 
Figure 7: AMPK and its related lipid metabolism genes in blastocysts derived in vitro vs. in 
vivo. Asterisk (*) represent statistically significant differences (p<0.05). 
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Lipid staining analysis showed a higher lipid droplets stained in blastocysts derived from in 
vitro than those derived from in vivo (Figure 8A and B). Quantification of these accumulated 
lipid showed a twofold higher lipid level in IVP embryos than in vivo ones (Figure 8C).   
 
 
 
Figure 8: Lipid droplet accumulation as stained by oil red in in vitro (A), in vivo (B) 
blastocysts and quantified lipid concentration (C). Lipid droplet showed by arrow 
and  asterisk (*) represent statistically significant differences (p<0.05). 
 
4.1.2 Expression pattern of AMPK and its lipid metabolism related genes in embryos 
cultured in vitro in the presence or absence of serum 
 
Taking into account that the widely used protocol for embryo production is IVC and in order 
to reduce lipid effect which is abundant in serum, we used PVA fatty acid free as the source 
of macromolecule and as a model of in vitro culture without serum. For that, the gene 
expression of embryos cultured in the presence or absence of serum at 2-, 8-, 16-cell and 
blastocyst stages were compared. In this part, genes in AMPK pathway (AMPKA1, 
AMPKA2, STK11), lipid metabolism (SREBP2, SREBP1, ACC), antioxidant (NQO1) and 
mitochondrial activity (CPT1, PGC1A) were selected. 
 
The result revealed that expression of AMPKA1 transcript at 2- and 8-cell stage (Figure 9) in 
embryos cultured in the presence of serum was significantly lower compared to those cultured 
without serum. Meanwhile, expression of AMPKA1 at 16-cell and blastocysts were 
significantly higher in embryos cultured without serum, while there was no significant 
difference in AMPKA2 expression between groups at 2- to 16-cells stage. In addition to that, 
higher values of AMPKA2 were obtained at blastocysts stage when embryos cultured without 
serum. The expression of STK11, responsible for upstream kinase protein, showed 
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significantly higher expression from 2-cell to blastocyst stage in embryo cultured without 
serum.  
 
In SREBP1 and ACC were express significantly higher when embryos were cultured in 
presence of serum. SREBP2 showed a reciprocal pattern in 2-cell stages, with no differences 
in 8- and 16-cell stage on those cultured in the presence or absence of serum. The NQO1, 
CPT1 and PGC1A showed higher expression in the absence of serum compared to those with 
serum (Figure 9).  
 
 
 
Figure 9: Temporal expression of AMPK and lipid metabolism in various development 
stages of preimplantation bovine embryos produced in vitro in the presence (black 
bar) and absence of serum (white bar). Asterisk (*) represent statistically 
significant differences (p<0.05). 
 
Considering solely the blastocyst stages, the gene expression of AMPK was confirmed with 
protein analysis expression. As the result, blastocyst cultured in the presence of serum 
With serum 
Without serum 
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expresses lower AMPK protein compared to without serum. As evidence, lower red 
fluorescence signals were observed in blastocysts derived from with serum compared to its 
counterpart (Figure 10). 
 
 
 
Figure 10:  Protein expression of AMPK in bovine blastocysts produced in the presence or 
absence of serum.  Red signal shows AMPK protein (Label A, B) while blue 
signal is nuclear cells stained by DAPI. Scale bars, 50 µm. 
 
4.1.3 Mitochondrial activity of embryo cultured in vitro in the presence or absence of 
serum 
 
Here the mitochondrial activity of bovine blastocysts cultured in the presence or absence of 
serum were compared. Blastocysts cultured in the presence of serum exhibit lower 
mitochondrial activity as compared to the absence of serum. This was evidenced by, higher 
red fluorescence signal observed in blastocysts derived from culture without serum compared 
to those derived from the culture on the presence of serum (Figure 11).  
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Figure 11: Mitochondrial activity detection of blastocysts cultured in the presence or absence 
of serum. Red signal in label A and B represent MitoTracker, blue signal A1 and 
B1 represent DAPI. Scale bars, 50 µm. 
 
4.1.4 Developmental competence of embryos cultured in vitro with different 
macromolecules supplementation 
 
Taking into account that serum contains abundant fatty acids (Brunner et al. 2010, 
Gstraunthaler 2003, Sata et al. 1999), different macromolecules which contain different 
amount of fatty acids were used, to investigate their effect on the expression of AMPK and 
lipid metabolism genes. For this, embryos were cultured in media with abundant fatty acid 
(serum), intermediate fatty acid (BSA) and free fatty acid (BSAFAF). 
 
Embryos cultured in the different of macromolecules supplementation were compared in 
terms of cleavage, blastocyst rate and development speed (Tabel 4). There were no significant 
differences in cleavage rate between these three groups.  On the other hand, embryos cultured 
in the presence of serum reached to blastocyst stage at Day 7 significantly faster compared to 
BSA and BSAFAF media. This difference then disappears in Day 8 and Day 9. Moreover, 
embryos cultured in the presence of serum developed faster compared to the other two 
groups.  
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Table 4: Developmental rates of bovine blastocysts produced with different 
macromolecules supplementation.  
 
Developmental rate 
Serum BSA BSAFFA 
n % n % n % 
Matured oocytes 872 - 809 - 827 - 
Cleavage 683 78.33 654 80.84 665 80,41 
Blastocyst Day 7   246 28.2a 137 16.93b 164 19.83b 
Blastocyst Day 8   306 35.09 228 28.18 245 29.63 
Blastocyst Day 9   340 38.99 271 33.50 282 34.10 
Kinetic development (Day 7/Day 9) - 72.35a - 50.55b - 58.16b 
a,b Value with different superscripts indicate within rows differ significantly. 
 
4.1.5 AMPK and lipid metabolism related gene expression in embryos cultured in vitro 
with different macromolecules supplementation 
 
The AMPKA1 expression of blastocysts cultured with different macromolecules 
supplementation was significantly lower in embryos derived from IVC in presence of serum 
compared those cultured in BSA or BSAFAF, while AMPKA2 didn’t show any differences 
between groups (Figure 12).  Adversely, ACC showed a significant higher expression in 
embryos cultured in the presence of serum compared to those cultured in the other two 
groups. The expression of CPT1, CPT2 and PGC1A were significantly lower in embryos 
cultured in the presence of serum compared to those cultured in BSA or BSAFAF groups.  
 
 
 
 
 
 
 
 
 
Figure 12:  Expression of AMPK pathway in blastocysts produced in vitro with serum (black 
bar), BSA (grey bar) and BSAFAF (white bar). a,bDifferent superscripts indicate 
significant difference among groups (p<0.05). 
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Immunofluorescence staining of AMPK protein supported the gene expression data. The 
lowest signal intensity of AMPK was detected in blastocyst cultured in the presence of serum 
compared to the other two groups (Figure 13). Due to AMPK protein activity depend on 
phosphorylation process, therefore we detect the phosphorylation site of AMPKA at 
Threonin-172 (p-AMPKA Thr172) at blastocyst stage. As result, the lowest fluorescent signal 
intensity of p-AMPKA Thr172, indicate low AMPK activity or low phosphorylation, was 
detected in blastocysts cultured in the presence of serum.  Meanwhile the highest AMPK 
activity was detected in blastocysts cultured with BSAFAF (Figure 14). 
 
 
 
Figure 13:  Protein expression of AMPK in bovine blastocysts produced with serum, BSA 
and BSAFAF.  Red signal showed AMPK protein (Label A, B, C) while blue 
signal is nuclear cells stained by DAPI. Scale bars, 50 µm. 
 
Results 
 
67
 
 
Figure 14:  Protein expression of phosphorylated AMPKA at Thr172 (p-AMPK Thr172) in 
bovine blastocysts produced with serum, BSA and BSAFAF.   Red signal showed 
p-AMPK protein (Label A, B, C) while blue signal is nuclear cells stained by 
DAPI. Scale bars, 50 µm. 
 
4.1.6 ROS level, mitochondrial activity and lipid accumulation in blastocysts derived 
from in vitro culture with different macromolecules supplementation 
 
The ROS level between groups was compared by visual evaluation of fluorescence signal 
exhibited by resulting blastocyst. The result demonstrated a brighter green fluorescence signal 
intensity which represents more ROS in blastocysts derived from culture in the presence of 
serum compared to the other two groups (Figure 15).  
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Figure 15:  ROS level of blastocysts produced with serum (A), BSA (B) and BSAFAF (C). 
Brighter green signal indicated more ROS production. Scale bars, 70 µm. 
 
 
 
Figure 16: Mitochondrial activity of bovine blastocysts produced with serum, BSA and 
BSAFAF.  Mitochondria were stained with MitoTracker Red (Label A, B, C) and 
nucleus was stained with DAPI. Scale bars, 50 µm. 
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Moreover, the increased level of ROS was accompanied by the reduction of mitochondrial 
activity. In this regards, blastocysts cultured in the presence of serum exhibit lowest 
mitochondrial activity, while blastocysts cultured with BSAFAF showed the highest one.  
Low intensity of red florescence detected in blastocysts derived from culture in the presence 
of serum and higher intensity was observed in BSAFAF group (Figure 16). Investigation of 
lipid accumulation showed that blastocysts cultured in vitro in the presence of serum to show 
the highest lipid level compared to those cultured in BSA or BSAFAF (Figure 17).  
 
 
 
Figure 17: Lipid content of blastocysts produced in vitro with serum, BSA and BSAFAF.       
a,b Different superscripts indicate significant difference among groups (p<0.05). 
 
4.2 Modulation of AMPK using AICAR as exogenous activator 
 
In an effort to reduce lipid accumulation through AMPK activity modulation, AICAR as 
AMPK exogenous activator was applied in bovine embryos culture media. Compared to the 
lower concentration levels, 100 µM AICAR has been found to increase significantly 
AMPKA1 gene expression as presented in figure 18.  
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Figure 18: AMPKA1 gene expression of blastocysts cultured with different AICAR dosage. 
a,bDifferent superscripts indicate significant difference among groups (p<0.05). 
 
4.2.1 Effect of AICAR on embryos development competence and blastocyst cell 
number 
As shown in table 5, there is no significant difference of blastocysts development rate. 
However, the development speed of blastocyst cultured with AICAR was 3.83% lower 
compared to the control. On the other hand, blastocyst derived from culture with AICAR had 
significantly lower cell number compared to those without AICAR (116 ± 11.98 vs. 132 ± 
14.83; respectively). 
 
Table 5: Bovine embryo development rate of in vitro culture with and without AICAR. 
 
Culture 
medium 
Matured 
oocytes 
Cleavage 
Blastocyst rate Development 
speed Day 7 Day 8 Day 9 
n n % n % n % n % % 
Serum 464 374 80.60 141 30.39 183 39.44 200 43.10 70.50 
Serum + 
AICAR 
478 383 80.13 140 29.29 186 38.91 210 43.93 66.67 
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4.2.2 Effect of AICAR on AMPK expression and its related lipid metabolism genes 
 
As shown in figure 19, the expression of AMPKA1, STK11, PPP2CA were significantly 
higher in blastocysts derived from culture with AICAR compared to without AICAR. 
Meanwhile the ACC expression is significantly lower in blastocysts with AICAR. On the 
expression of NQO1, CPT2, PGC1A are express significantly higher in AICAR treatment. 
Moreover, the presence of AICAR in culture media didn’t show any effect on the CPT1 
expression level. 
 
 
 
Figure 19: AMPK and its related lipid metabolism genes expression in blastocysts produced 
with and without AICAR. Asterisk (*) represent statistically significant 
differences (p<0.05). 
 
4.2.3 Effect of AICAR on AMPK protein expression and mitochondrial activity 
 
Alteration on AMPKA1 gene expression due to AICAR treatment at protein level was 
validated using immunofluorescence. AICAR increases AMPK protein abundant as evidence 
by higher fluorescent signal intensity was detected in blastocysts cultured with AICAR than 
that without AICAR (Figure 20). Moreover, AICAR also show to increase mitochondrial 
activity of blastocyst stage embryos. Visually, blastocysts derived from culture with AICAR 
exhibit stronger fluorescent signal compared to the absence of AICAR (Figure 20). In 
addition to that, fluorescent signal quantification of AMPK protein and MitoTracker 
(mitochondrial activity) confirmed the difference significantly (Figure 21). 
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Figure 20: AMPK protein expression and mitochondrial activity assessment in blastocysts 
cultured with and without AICAR. Red signal showed AMPK protein (Label A, 
B); MitoTracker (Label C, D) while blue signal is nuclear cells stained by DAPI. 
Scale bars, 50 µm. 
 
 
 
Figure 21: Fluorescent signal intensity quantification of AMPK and MitoTracker from 
blastocysts cultured with and without AICAR. Asterisk (*) represent statistically 
significant differences (p<0.05). 
 
4.2.4 Effect of AICAR on lipid accumulation of embryo cultured in vitro 
 
Here, the effect of AICAR treatment on blastocysts lipid content was investigated.  The result 
showed that blastocysts derived from in vitro with AICAR treatment has 8.9% lower lipid 
content compared to without AICAR (Figure 22). However, this result difference was not 
statistically significant (p>0.05). 
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Figure 22: Lipid droplet accumulation as stained by oil red of bovine blastocysts cultured 
without (A), with (B) AICAR and quantified lipid content (C). 
 
4.3 Potential post transcriptional regulation of AMPKA1 by miRNA  
 
4.3.1 AMPKA1 expression and lipid accumulation of granulosa cell cultured in the 
presence and absence of serum 
 
In order to investigate the post-transcriptional regulatory mechanism of AMPKA1 in embryo 
by miRNA, granulosa cell culture model was used to validate the  miRNA – mRNA 
interaction. There are two reasons why granulosa cells were used as cell model. First, it is the 
closest cells to oocytes and second its luteinization process which marked by lipid 
accumulation post ovulation. Moreover, the luteinization process can be easily mimicked by 
IVC under the presence of serum (Kayani et al. 2009). In addition, miRNA target validation 
to specific genes cannot perform directly in embryos, therefore cell model is needed to bridge 
the gap.   
 
This study was initiated by cultured granulosa cells in the medium with serum or without 
serum (BSAFAF). Granulosa cells cultured with serum shows rapid development (more 
confluence) from Day 0 to Day 2 when compared to without serum (Figure 23). This means 
the serum gives better support for cells growth which is similar to our result in the 
development rates of embryos cultured under serum system.  
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Figure 23: The confluency of bovine granulosa cells cultured in the presence and absence of 
serum. Original magnification 20x. 
 
The AMPKA1 was found significantly down regulated in Day 2 compared to Day 0 and Day 
1 of culture (Figure 24A). More lipid droplets were accumulated in granulosa cell cultured 
with serum compared to without serum. This result was confirmed by oil red quantification, 
where culture in the presence of serum significantly increases lipid content at Day 2 (Figure 
24B and 24C).  
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Figure 24: AMPKA1 gene expression (A), lipid content (B) and stained lipid droplet by oil 
red (C) in bovine granulosa cells cultured in the presence or absence of serum. 
Lipid droplet shown by arrow (original magnification 40x). a,bDifferent 
superscripts indicate significant difference among groups (p<0.05). 
 
The initial result indicated that the presence of serum in culture media, down regulate 
AMPKA1 gene expression and increases lipid accumulation across culture time of bovine 
granulosa cell. Next, we performed in silico analysis aiming to predict miRNA which is 
potentially targeted to AMPKA1. 
 
4.3.2 In silico analysis and miRNA profiling  
 
A series of in silico analysis using bioinformatics tools including mirBase, PICTAR, 
mirWalk, miRanda and Targetscan were performed to identify and select miRNAs which 
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potentially targeted to AMPKA1. As a result in table 6, 11 miRNAs were chosen based on 
similarity sequence comparison between human (hsa) and bovine (bta). The reason behind 
this is due to the most available miRNA primer in the market is designed for human miRNA.  
 
Table 6: Bovine miRNA primer and its similarity to human miRNA sequence.  
 
miRNA Sequence Accession number 
Similiarity 
(%) 
    
bta-mir-101 UACAGUACUGUGAUAACUGAA MIMAT0003520  
hsa-miR-101-3p UACAGUACUGUGAUAACUGAA MIMAT0000099 100 
    
bta-mir-130 CAGUGCAAUGUUAAAAGGGCAU MIMAT0009223  
hsa-miR-130a-3p CAGUGCAAUGUUAAAAGGGCAU MIMAT0000425 100 
    
bta-mir-148b UCAGUGCAUCACAGAACUUUGU MIMAT0003814  
hsa-miR-148b-3p UCAGUGCACUACAGAACUUUGU MIMAT0000759 100 
    
bta-mir-152 UCAGUGCAUGACAGAACUUGGG MIMAT0009238  
hsa-miR-152 UCAGUGCAUGACAGAACUUGG MIMAT0000438 95.45 
    
bta-mir-301a CAGUGCAAUAGUAUUGUCAAAGCAU MIMAT0009276  
hsa-miR-301a-3p CAGUGCAAUAGUAUUGUCAAAGC MIMAT0000688 92 
    
bta-mir-301b CAGUGCAAUGAUAUUGUCAAAGCAU MIMAT0009277  
hsa-miR-301b CAGUGCAAUGAUAUUGUCAAAGC MIMAT0004958 92 
    
bta-mir-33a GUGCAUUGUAGUUGCAUUGCA MIMAT0009294  
hsa-miR-33a-5p GUGCAUUGUAGUUGCAUUGCA MIMAT0000091 100 
    
bta-mir-33b GUGCAUUGCUGUUGCAUUGC MIMAT0009295  
hsa-miR-33b-5p GUGCAUUGCUGUUGCAUUGC MIMAT0003301 100 
    
bta-mir-144 UACAGUAUAGAUGAUGUACUAG MIMAT0009234  
hsa-miR-144-3p UACAGUAUAGAUGAUGUACU MIMAT0000436 90.90 
    
bta-miR-19a UGUGCAAAUCUAUGCAAAACUGA MIMAT0004336  
hsa-miR-19a-3p UGUGCAAAUCUAUGCAAAACUGA MIMAT0000073 100 
    
bta-miR-19b UGUGCAAAUCCAUGCAAAACUGA MIMAT0004337  
hsa-miR-19b-3p UGUGCAAAUCCAUGCAAAACUGA MIMAT0000074 100 
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To select the most abundance of miRNA among candidates, expression profiling analysis in 
granulosa cells samples that cultured in the presence of serum from Day 0 to Day 2 was 
performed. To do that, 3 miRNA reference genes (U6, Snord48 and 5S) and geometrical 
mean from those genes was used for miRNA expression normalization (Figure 25A). As 
indicated in figure 25B, all miRNAs showed a certain expression pattern over the day of 
culture. However, in Day 2 of culture we found miR-33b to be is the most abundant one 
compared to the other miRNA. In addition, when compared to AMPKA1 gene expression, 
miR-33b express in the opposite direction (Figure 24A) but similar pattern with lipid 
accumulation (Figure 24C). Based on this result, therefore, miR-33b was selected and 
followed with target validation and functional study.  
 
 
 
Figure 25: The stability of miRNA reference genes across culture time (A) and miRNA 
candidate expression profiling in granulosa cells cultured in the presence of serum 
(B). a,bDifferent superscripts indicate significant difference among groups 
(p<0.05). 
 
The miR-33b target validation to AMPKA1 was initiated by analyzing the miR-33b binding 
site in 3’UTR of AMPKA1. The AMPKA1 3’UTR and miR-33b sequence were uploaded into 
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online prediction software FINDTAR 3.0 (http://bio.sz.tsinghua.edu.cn/) which give score, 
∆G and alignment or binding site position (Ye et al. 2008). Thereafter, 3 binding sites of miR-
33b in AMPKA1 3’UTR were found as illustrated in figure 26. This work then followed by 
binding site position mapping and finally two position 2426-2449 and 2553-2571 were 
selected as DNA template (150 bp). To amplify the DNA template and to construct plasmids, 
in silico analysis using Serial Cloner v.2.61 software was performed, aiming to design 
specific primer and choose the appropriate restriction enzyme for cloning purposes. To ensure 
the designed primers are working, virtual PCR and ligation were also performed. As the 
result, specific primer carrying restriction enzyme sequence are generated as presented in 
table 7.  
 
 
 
Figure 26: miR-33b binding site (red shadow) on AMPKA1 3’UTR predicted by FindTar 3.0 
software. 
 
Table 7: Details of primers used for plasmid construction. 
 
Primer name sequence (5’-3’) 
  
AMPKA1 3’UTR forward (Sacl) GCGAGCTCAAGATGTAAGGGAGTCAATGC 
AMPKA1 3’UTR reverse (Xbal) GCTCTAGAACAGTACATTTCTGGCAAATG 
Mismatch sense (Sacl) GCGAGCTCAAAGATGTATAAGGCATTTGCCAG
AACGTTACTGTTTCTAGA 
Mismatch antisense (Xbal) TCTAGAAACAGTAACGTTCTGGCAAATGCCTT
ATACATCTTTGAGCTCGC 
 
 
Bold and underlined shows the restriction enzyme sequence 
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4.3.3 AMPKA1 3’UTR - miR-33b plasmid construction 
 
In order to test whether miR-33b could regulate the predicted binding sites of AMPKA1-
3’UTR, luciferase assay was performed by construct plasmid which carries AMPKA1-3’UTR 
binding site. Insert DNA carrying miR-33b binding site were in silico cloned to construct 
AMPKA1-3’UTR WT (Wild Type). A DNA fragment which carry mismatch miR-33b 
binding site was also constructed by mutating 3 nucleotide bases and cloned to construct 
AMPKA1-3’UTR MT (Mismatch). Both constructed DNA were cloned in the multiple 
cloning region using two restriction enzymes namely Xbal and Sacl (Figure 27). 
 
To construct plasmid in the “wet” lab, DNA fragment of mir-33b AMPKA1-3’UTR was 
amplified in normal PCR reaction using primer containing specific restriction enzyme (Table 
7). All DNA fragment were sequenced to confirm the sequence and the confirmed one then 
proceed to ligation process in pmirGLO to construct intended plasmid.  
 
 
 
Figure 27: A DNA insert containing miR-33b binding site in multiple cloning region of 
pmirGLO plasmid. 
 
4.3.4 miR-33b - AMPKA1 target validation by luciferase assay 
 
To perform luciferase assay, the work was initiated by selecting the lipofectamine dosage, by 
transfecting granulosa cell using pmaxGFP and observed the result under fluorescent 
microscope. Figure 28 shows that 5 µl of lipofectamin in 550 µl culture media gives the 
highest transfection efficiency as confirmed in fluorescence signal quantification (Figure 
28E). This finding allowed us to select 5 µl of lipofectamine dosage for transfection work.  
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Figure 28: Transfection efficiency with different lipofectamine dosage, 0 µl (A), 1 µl (B), 3 
µl (C), 5 µl (D) and green florescence signal quantification (E). Green signal 
means cells transfected with pmaxGFP. a,bDifferent superscripts indicate 
significant difference among groups (p<0.05). 
 
Thereafter, AMPKA1-3’UTR plasmid co-transfected with miR-33b were performed at Day 2 
of cultured granulosa cells. As the result, the presence of miR-33b was found to decrease 
luciferase activity in AMPKA1-3’UTR WT, meanwhile AMPKA1-3’UTR MT was not 
affected significantly (Figure 29). This result shows that miR-33b was valid targeted to 
3’UTR of AMPKA1 mRNA in bovine granulosa cells.  
 
 
 
Figure 29: miR-33b targeted bovine AMPKA1 3'UTR as validated by luciferase activity 
assay. Asterisk (*) represent statistically significant differences (p<0.05). 
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4.3.5 The effect of miR-33b inhibitor on AMPKA1 gene expression in granulosa cells 
 
In this study, abundance of miR-33 inhibits AMPKA1 gene expression in bovine granulosa 
cells. Therefore, it is suggested that inhibition of miR-33 will be beneficial to increase 
AMPKA1 activity. To answer that question, granulosa cells were transfected with 50 nM 
miR-33 inhibitor at Day 2 of culture followed with 24 h incubation and AMPKA1 gene 
expression analysis. Moreover, to confirm the effect of miR-33b inhibitor on AMPKA1 
activity, granulosa cells culture with 0.5 mM AICAR treatment was also performed. In this 
study, presence of miR-33b inhibitor significantly increases AMPKA1 expression as pattern 
shows in AICAR (Figure 30A and 30B). This result was confirmed in Western blot analysis 
where miR-33b inhibitor has increased protein level of AMPKA1 compared to control, 
however when it is compared to AICAR treatment, its expression is lesser (Figure 30C).  
 
 
 
Figure 30: Effect of miR-33b inhibitor (A), AICAR treatment (B) on AMPKA1 gene 
expression and AMPKA1/2 protein level by Western blot analysis (C). Asterisk 
(*) represent statistically significant difference p<0.05. 
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4.3.6 The effect of miR-33b inhibitor on lipid metabolism and mitochondrial activity 
gene expression in granulosa cells  
 
As indicated in figure 31, inhibition of miR-33b significantly increases ACC expression 
compared to control (without transfection). In the mitochondrial activity genes expression, 
inhibition of miR-33b didn’t affect to CPT1 but significantly increase PGC1A compared to 
control.  
 
 
 
Figure 31: Effect of miR-33b inhibitor on genes related to AMPK pathway in bovine 
granulosa cells. Asterisk (*) represent statistically significant differences 
(p<0.05). 
 
4.3.7 miR-33b expression in blastocysts derived from in vitro cultured in the presence 
and absence of serum 
 
Taking into account that miR-33b has been validated to target AMPKA1 in bovine granulosa 
cells and considering the aim to know its role during embryo culture in the further study, the 
expression of miR-33b in blastocysts sample were analyzed. For that, miR-33b expression 
was profiled in blastocysts derived from in vitro in the presence or absence of serum. Instead 
of serum, BSAFAF was used as macromolecules source. As the result, miR-33b significantly 
higher abundant in blastocysts cultured with serum compared to without serum (Figure 32A) 
and AMPKA1 gene was showed in the contrary expression (Figure 32B).  
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Figure 32: miR-33b (A) and AMPKA1 (B) expression of blastocysts cultured in the presence 
and absence of serum. Asterisk (*) represent statistically significant differences 
(p<0.05). 
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5 Discussion 
 
5.1 AMPK activity and lipid metabolism related genes in in vitro bovine embryos 
under different of culture environment 
 
It is well known that the supplementation of serum to culture media results in lipid 
accumulation, enhances ROS production and alters mitochondrial condition subsequently lead 
to lower cryotolerance of blastocyst. The molecular background behind this phenomenon is 
far from known. Recently, the AMPK pathway was identified as differentially expressed in 
bovine blastocyst derived from alternate in vitro vs. in vivo culture environment (Gad et al. 
2012). In that study, blastocyst which spends longer time under in vitro environment showed 
more AMPKA1 down regulation compared to in vivo. Since AMPK pathway has been 
reported as master regulator of energy metabolism in a wide range of tissues and cells 
(Carling 2004, Carling et al. 2011), this study aimed to analyze its potential role in bovine 
embryos cultured in different culture environment in order to elucidate the molecular 
mechanism of AMPK pathway activity in regulation of embryo phenotype. 
 
5.1.1 In vitro culture environment affect AMPK expression 
 
In the first part of experiment, gene expression level of gene in AMPK pathway was 
compared. The result showed that AMPKA1 and AMPKA2 were found down regulated in 
blastocysts derived from in vitro. Meanwhile, the lipid metabolism gene, ACC (represent lipid 
synthesis), which is known as the direct target of AMPK shows an opposite expression. These 
results are in agreement with previous studies showing that down regulation of AMPK 
activates lipogenic genes (Li et al. 2011, You et al. 2004). It is reported that increased 
abundance of ACC enhances malonyl-CoA which in turn increases the conversion of free 
fatty acids into lipids (Dzamko et al. 2008, Hardie 1989, Ruderman and Prentki 2004). 
 
The down regulation of AMPKA1 and AMPKA2 was accompanied by lower expression of 
mitochondrial activity genes, CPT1 (lipid oxidation) and PGC1A (mitochondrial biogenesis), 
in vitro derived blastocysts. Earlier studies have been reported that reduction in AMPK 
activity causes lower activity of PGC1A (Dugan et al. 2013). Noteworthy, PGC1A has been 
reported to balance mitochondrial density and to protect cells from ROS by induction of ROS-
detoxifying enzymes (Finkel 2006, O'Donnell et al. 2013, St-Pierre et al. 2006). Moreover, 
PGC1A has been reported to control CPT1 which is already identified to be the rate-
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controlling enzyme in fatty acid oxidation (Louet et al. 2002). Low abundance of PGC1A 
went along with low expression of CPT1 of blastocysts derived in vitro when compared to 
fully in vivo derived blastocysts in our experiments. Thus, AMPK mediated down regulation 
of PGC1A and CPT1 is being in line with previous hypothesis that enhanced lipid 
accumulation of in vitro derived embryos is caused by the incapability of mitochondria, 
reduced mitochondrial activities, to metabolize lipid in culture media (Abe et al. 2002, 
Barcelo-Fimbres and Seidel 2007b, Ferguson and Leese 1999, McEvoy et al. 2000). 
 
The lipid content of in vitro vs. in vivo derived blastocysts confirmed the gene expression 
data. Results clearly showed a significantly higher lipid content in embryos derived from in 
vitro compared to in vivo, in agreement with several previous studies (Abe et al. 2002, Abe 
and Hoshi 2003, Barcelo-Fimbres and Seidel 2007b, Sudano et al. 2011). It has been well 
documented that culture environment affects embryo gene expression which is important for 
its physiological and metabolism (Badr et al. 2007, Lonergan et al. 2003a). For instance, 
Lonergan et al. (2003b) demonstrated that in vitro culture environment significantly increase 
the expression of genes that are responsible for apoptosis, oxidative stress and mitochondrial 
activity compared to in vivo condition.  
 
5.1.2 The presence of serum during bovine embryo negatively affect AMPK activity 
 
In addition to the other factors, the difference between in vivo vs. in vitro environment is 
especially the present of serum in culture media that suggested could have resulted to the 
observed differences with respect to AMPK gene expression and mitochondrial activity. 
Thus, we aimed to check whether addition of serum to culture medium could lead to similar 
effects with respect to the expression of AMPK and lipid related metabolism genes as well as 
lipid content.  
 
Result showed that the expression of genes in AMPK pathway, lipid metabolism and 
mitochondrial activity to vary in expression of stages before 16-cell. On the contrary, stages 
beyond 16-cell showed a stable expression. These results support the previous observations 
where embryo development is depend on early embryonic genome activation (EGA) 
involving protein synthesis (Ma et al. 2001, Memili and First 2000).  It is also reported by 
Khurana and Niemann (2000b) that the pattern of metabolic activity of in vitro embryo is 
relatively constant before 16-cell stage, as evidence by no difference with respect to the rate 
of oxidation before that stage. In addition to that, oxidative processes were associated to 
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mitochondrial development during embryogenesis. However, in early development of 
embryos, mitochondria are starting to elongate at 4-cell stage and fully functioning at the 
blastocyst stage (Cummins 2002). Consistent with the previous evidences, expression of 
genes related to AMPK pathway, lipid metabolism and mitochondrial activity in this study 
showed variation before 16-cell stage. It seems that, particularly before EGA, embryos 
development depends on its maternally derived transcript. 
 
Considering solely the blastocyst stage, results revealed that expression of genes in AMPK 
pathway of in vitro embryos cultured in presence or absence of serum resembled the trend in 
expression as observed for in vitro vs. in vivo derived embryos. The expression of AMPKA1 
and AMPKA2 in blastocysts cultured with serum are down regulated and confirmed with the 
expression of STK11 or namely LKB1 (upstream kinases) as the sign of AMPK activity as 
reported by Towler and Hardie (2007). This study also showed that lipid accumulation and 
mitochondrial activity went along with expression of ACC, CPT1, NQO1 and PGC1A are in 
perfect harmony. In addition to that, the expression of lipid metabolism transcription factor, 
(SREBP1, SREPB2) also support that result.  
 
Low expression of AMPK in bovine blastocysts derived from in vitro with serum, 
accompanied by up regulation of lipid synthesis as well as down regulation of mitochondrial 
activity. This result was in accordance with the hypothesis that enhanced lipid accumulation 
in IVP derived embryos is caused by the incapability of mitochondria to metabolize abundant 
free fatty acids in culture media (Abe et al. 2002, Barcelo-Fimbres and Seidel 2007b, 
Ferguson and Leese 1999, McEvoy et al. 2000). Comparing mitochondrial activity, with vs 
without serum, supports those previous studies. It is showed that blastocysts in the present of 
serum exhibit lower mitochondrial activity compared to without serum. In line with that, 
Cagnone and Sirard (2014) revealed a high lipid stress pathway is significantly associated 
with mitochondrial dysfunction especially in its ability to oxidase fatty acids which is 
abundant in serum. Moreover, previous studies (Abe et al. 2002, Abe and Hoshi 2003, Crosier 
et al. 2001) have been reported the defect of mitochondrial structure lead to lipid 
accumulation when embryos cultured under serum system. Due to many growing evidences in 
the recent year showed that AMPK is influencing the mitochondrial activities, AMPK became 
one of the most promising target in combating diseases caused by mitochondria dysfunction 
such as diabetes, obesity and cancer in human research area (Bokko et al. 2007, Faubert et al. 
2013, Hardie 2013, Hawley et al. 2003, Kim et al. 2014, Zhang et al. 2009).  
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5.1.3 Abundant fatty acid in culture environment induces lipid accumulation through 
reducing AMPK activity during bovine embryo culture  
 
Taking into account the result of first and second part of experiment 1, the result proved that 
serum supplementation to culture media causes change in AMPK gene expression. Significant 
down regulation of AMPK gene and mitochondrial activity in blastocysts cultured in vitro in 
the presence of serum implicating its role for lipid accumulation. To that regards, we suggest 
that down regulation of AMPK and its effects on the AMPK pathway programs early embryo 
to a rather anabolic mode as reflected by higher ACC expression as well as reduced 
mitochondrial biogenesis and/or activity due to down regulation of CPT1 and PGC1A. 
Although the mode by which addition of serum to culture medium causes down regulation of 
AMPK is not resolved, activity of AMPK was reported by Zhou et al. (2007) to be negatively 
correlated with fatty acid synthesis. That could implicate that excess presence of free fatty 
acids within serum could result in increased fatty acid synthesis within embryo and thus to be 
the cause leading to low AMPK activity.  
 
In order to investigate whether free fatty acids or whether factors other than free fatty acids 
are leading to change the expression of genes in AMPK pathway subsequently to lipid 
accumulation and mitochondrial dysfunction, bovine embryos were cultured in media 
supplemented with different macromolecules with or without fatty acids (BSA vs. BSAFAF) 
as well as in serum supplementation. Based on the supplementation of different 
macromolecules in culture media, no difference with respect to embryo development rate was 
observed (Table 4). However, embryos cultured in the presence of serum showed faster 
development kinetics compared to the other groups. It is in agreement with results where 
serum increase the production of blastocyst rate compared to those in the absence of serum 
(Gutierrez-Adan et al. 2001). The early develop blastocysts reported by Barrenetxea et al. 
(2005) and Muthukumar et al. (2013) induces higher pregnancy rates compared to the later 
one. However, the differences in development speed reported to be associated with alteration 
of gene expression via altering the abundance of specific transcript which is important to 
control embryo development competence (Dode et al. 2006, Ripamonte et al. 2012). 
 
The present study showed that embryos cultured in BSAFAF accumulate lower amounts of 
lipids than their counterparts cultured in BSA or serum being in agreement with previous 
studies (Abe et al. 2002, Gomez et al. 2008). Moreover, embryos cultured in presence of 
serum exhibited higher ROS level compared to culture in BSAFAF with culture using BSA as 
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supplement exhibiting intermediate values. Thus, ROS level were found to be much higher in 
embryos cultured in the presence of fatty acids (BSA) compared to those derived from fatty 
acid free culture (BSAFAF). Importantly, addition of fatty acids to culture medium decreased 
mitochondrial activity as observed for embryos cultured in presence of serum in our study. 
These results are in line with previous studies reporting an incapability of embryos to 
metabolize lipids due to low mitochondrial activity goes along with excessive levels of ROS 
(Abe et al. 2002, Abe and Hoshi 2003, Barcelo-Fimbres and Seidel 2007a, Barcelo-Fimbres 
and Seidel 2007b, Cagnone and Sirard 2014). Abundant generation of ROS during early 
development is generally suggested to be detrimental to the embryos due to negative effects 
on mtDNA structure (Harvey et al. 2002, Rizos et al. 2003) subsequently causing 
mitochondrial dysfunction (Abe et al. 2002, Crosier et al. 2001). That in turn leads to reduced 
ATP production levels and TCA cycle (Wang et al. 2009), subsequently induce lipid droplet 
formation and accumulation (Lee et al. 2013) by reducing the mitochondrial oxidation 
capacity (Schrauwen and Hesselink 2004). This is accompanied by inactivation of enzymes 
that are essential for energy production and detoxification of ROS that in turn caused 
disabling of the mitochondrial ROS scavenging machinery, result in modulated mitochondrial 
functions (Kumari et al. 2014).  
 
NQO1, which belongs to one of antioxidant enzyme, is found to be down regulated in 
blastocysts cultured with serum compared to without serum in experiment 1 part 2. This 
finding is in line with the previous studies where in in vitro derived bovine embryos need 
more antioxidant to face oxidative stress conditions (Rizos et al. 2003). Moreover, excess 
ROS production has been reported to cause fragmentation of mitochondria and results in 
functional defects with respect to oxidation capacity, size, number and density of 
mitochondria (Jheng et al. 2012) which could explain the low capability of the corresponding 
embryos to metabolize lipids. Thus, it is suggested that a harmful of encasing high ROS 
levels, mitochondrial dysfunction and enhanced lipid accumulation is a consequence of 
enhanced free fatty acids during in vitro culture. 
 
Moreover, the present result confirmed that expression of genes in the AMPK pathway 
resembled the trend of expression when culture medium was supplemented with fatty acids as 
observed for media supplemented with serum. Lipid accumulation, mitochondrial dysfunction 
and ROS level were in perfect agreement with expression of genes under study of the AMPK 
pathway. Again, AMPKA1 and AMPKA2, PGC1A and CPT1 were significantly down 
regulated meanwhile ACC showed up regulation in embryos cultured in presence of free fatty 
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acids (Figure 12). This result, however, was not only restricted on the RNA level but also 
accompanied with lower abundance of the AMPKA1/2 protein (Figure 13). In addition, lower 
activity of AMPK catalytic sub unit α indicated at phosphorylation site of Threonine-172 (p-
AMPK Thr172), was demonstrated in embryos cultured with free fatty acids (Figure 14).  
 
As mentioned before, activity of AMPKA has been reported to be dependent on the 
AMP:ATP ratio in cells with relative high ratio of AMP:ATP leading to higher activity of 
AMPK (Corton et al. 1994). When fatty acid supply is plentiful, there is an up regulation of 
mitochondrial activity and increase in oxidative capacity (Iossa et al. 2002, Mollica et al. 
1999), which is suggested to result in elevated ROS level as well as elevated ATP levels 
(Burton et al. 2003). Taking into account that the AMP:ATP ratio senses activity of AMPK 
(Corton et al. 1994), oversupply of ATP would lower the AMP:ATP ratio, chemical equation 
balance (Nelson and Cox 2005), and thereby lowering AMPK activity resembling a self-
controlling cycle. Conclusive to this study findings, it was reported by Tomas et al. (2002) in 
muscle cells that increased activity of AMPK causes inhibition of ACC which decreases 
malonyl-CoA concentration and increases fatty acid oxidation by β-oxidation suggested to 
result in lipolysis and therefore lower lipid accumulation. Lipolysis by β-oxidation, however, 
results in generation of ATP which is required to power the pre-implantation stages of 
development. Thus it is speculate that AMPK might be a key-enzyme precluding exorbitant 
lipolysis by depicting a negative feedback mechanism. Considering that embryo lipid droplets 
are an endogenous reserves for energy generation (Sturmey et al. 2009), such a mechanism 
would avoid overriding generation of ATP by utilization of these endogenous reserves 
guarantying that ATP production and ATP consumption are balanced. Conclusively, internal 
fatty acids have been considered as energy resource for the first days of development with 
embryos of species remaining unattached for a relative longer time in pig and cow embryos.  
Consequently, embryo will dependence on AMPK activity by sensing AMP:ATP ratio that 
warrants economic utilization of these internal energy stores which guaranty the embryo can 
develop largely based on its internal energy stores without the need of external fatty acids. 
That hypothesis is further supported by the finding that inhibition of triglyceride metabolism 
in bovine embryo prevented development to the blastocyst stage (Ferguson and Leese 2006) 
whereas culture in fatty acid free conditions did not prevent development to the blastocyst 
stage as shown by the present study as well as numerous others. Therefore, lipid droplets 
should be largely metabolized until later developmental stages as observed for in vivo derived 
blastocysts within this study.  
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On the other side, bovine embryos are capable of taking fatty acids from serum (Sata et al. 
1999) and that has been reported to mask changes in endogenous reserves (Ferguson and 
Leese 1999). In the condition of embryos cultured under serum, high uptake of fatty acid 
resulted abundance ATP through exceeding capacity of TCA cycle and ETC resulted more 
ROS production (Tarazona et al. 2006). When exogenous fatty acid supply is plentiful, there 
is up regulation of mitochondrial activity increasing oxidative stress (Iossa et al. 2002, 
Mollica et al. 1999) which is suggested to result in elevated ROS level (Burton et al. 2003) as 
well as elevated ATP levels that decreasing AMP:ATP ratio and therefore AMPK activity as 
consequence of energy balance system (Nelson and Cox 2005). As a consequence, profound 
inactivation of AMPK would subsequently stop further utilization of endogenous lipid stores 
but would favor lipogenic processes instead. Low activity of AMPK however might not 
prevent uptake and metabolize the exogenous fatty acids. Thus, high abundance and uptake of 
exogenous fatty acids might bypass the endogenous feedback system keeping AMPK activity 
on low levels due to high ATP levels as a consequence of imbalance between excessive ATP 
generation and moderate ATP consumption. Moreover, low AMPK activity would result in 
lower activity of PGC1A which in turn decrease mitochondrial biogenesis and/or activity. 
 
Moreover, a longer period culture in vitro under serum or free fatty acids during in vitro 
embryo culture over 7 days, higher oxidative stress due to higher ROS as the result of 
mitochondrial activity would cause mitochondrial dysfunction/damage by attacking mtDNA 
(Cui et al. 2012, Lenaz et al. 2002, Stuart and Brown 2006). Since mtDNA encode for 
enzymes essential for oxidative phosphorylation (Chandrasekaran et al. 1997, Marusich et al. 
1997, Shoubridge 2001), any defect of it could cause metabolic dysfunctions at the blastocyst 
stage and would impact subsequent embryo viability (Wilding et al. 2009). In addition, 
mitochondrial dysfunction also reduces capabilities to metabolize fatty acids thorough β-
oxidation. Therefore, fatty acids taken up from the culture environment or serum are diverted 
into lipid synthesis resulting in increased accumulation of triglycerides as observed previously 
(Boren and Brindle 2012, Henique et al. 2010, Hurd et al. 2007) implicating that lipid 
accumulation also reflects mitochondrial dysfunction as speculated earlier (Korge and Weiss 
2006). Based on that and considering this study result, a model as illustrated by figure 33 was 
summarized which demonstrating the relationship between AMPK activity, lipid 
accumulation, generation of ROS and mitochondrial activity during embryo culture in vitro in 
the presence of serum.  
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Figure 33:  Hypothetical model of AMPK mediated lipid metabolism in bovine embryo 
cultured in vitro. Under low fatty acid condition (upper panel), AMPK is more 
active and reducing ACC expression level by phosphorylation process. Thus the 
conversion of FA into lipid through Malony-CoA generation is less, dominantly 
Acetyl-CoA goes to TCA cycle which maintains ATP production. Thereafter, 
AMPKA promote PGC1A expression which is responsible to maintain 
mitochondrial condition and enhance oxidative stress response mechanism. In the 
contrary, culture environment with abundance fatty acid (lower panel) reduce 
AMPK activity which promote ACC expression subsequent to enhance 
conversion of Acetyl Co-A into Malonyl-CoA leading to lipid accumulation. 
Moreover, continuous and plenty supply of fatty acids increase β-oxidation 
followed by exceed TCA which resulting more ROS. As the consequence, high 
ROS level lowering mitochondrial activity and AMPK activity. Thereafter, low 
AMPK inhibits PGC1A expression which is involved in CPT1 regulation and 
responsible for mitochondrial biogenesis. 
 
Taken altogether, the present study has unraveled a special role of the AMPK pathway during 
early bovine embryo development. The environmental conditions known to cause lipid 
accumulation, mitochondrial dysfunction and high ROS level were reflected by down 
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regulation of AMPKA1, PGC1A and CPT1 resembling a reduced lipolytic trend and up 
regulation of ACC in parallel resembling an increased lipogenic trend in these embryos. Thus, 
expression of these genes reflected an anabolic direction of lipid metabolism. Of impact, 
present study results also indicate that active AMPK might be the key-enzyme precluding 
exorbitant lipolysis by depicting a negative feedback mechanism controlled by the AMP:ATP 
ratio. Moreover present study underlined the relevance of AMPK pathway in establishing an 
anabolic/lipogenic in bovine embryo phenotype and the key is the inability of mitochondria to 
metabolize available amount of fatty acids. However, further studies should be conducted to 
investigate distinct fatty acids relevant for this alteration of AMPK pathway or by restoring 
the mitochondrial activity or condition. Restoring mitochondrial activity or condition, 
therefore, using antioxidants or through AMPK activation has been beneficial for ATP 
production (Hawley et al. 2003, Imai et al. 2006, Merrill et al. 1997, Schafer et al. 2009). For 
that, keeping mitochondria normally function during pre-implantation embryo development is 
a prerequisite to high embryo quality and subsequent developmental outcomes.  
 
5.2 AMPK activity modulation of in vitro bovine embryos using AICAR 
supplementation 
 
According to the first experiment, the present study found that AMPK activity is associated 
with mitochondrial activities and lipid accumulation. Previous studies reported that 
modulation of AMPK activity becomes a strategy to improve mitochondrial function and to 
reduce lipid accumulation (Cui et al. 2012, Duchen and Szabadkai 2010, Taylor and Turnbull 
2005). Therefore, enhancing AMPK activity subsequent to rescuing mitochondrial condition 
would be one strategy to reduce lipid accumulation especially in embryo in vitro production 
under serum system. Ample evidences, shows that down regulation of AMPK can be 
artificially activated by using chemical compound such as AICAR (Imai et al. 2006, Merrill et 
al. 1997, Thomson et al. 2007) or metformin (Stephenne et al. 2011, Zang et al. 2004). In this 
study, AICAR was used because of its has promising therapeutic potential to increase AMPK 
activity in regards to manipulate lipid metabolism and reducing lipid accumulation as well in 
the field of diabetic research (Boon et al. 2008, Koistinen et al. 2003) and obesity research 
area (Drake et al. 2010, Yang et al. 2012). Moreover, previous study also reported that 
AICAR able to increase AMPK activity in matured bovine oocytes (Bilodeau-Goeseels et al. 
2007), mouse oocytes (Downs et al. 2010), mouse blastocyst (Eng et al. 2007), rat muscle 
(Kaushik et al. 2001) and hen granulosa cell (Tosca et al. 2006). However, the exact effect of 
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AICAR treatment on bovine embryo development in vitro especially in reducing lipid 
accumulation through modulation of AMPK activity is still need to be elucidated.   
 
5.2.1 Effect of AICAR on blastocyst development rate and cell number 
 
One of the aim in IVP technology is to produce blastocyst which having good quality to result 
in subsequent pregnancies. Top quality of in vitro embryo generally considered by high 
blastocyst cell number, good morphology and finally the implantation or pregnancy rate 
(Balaban et al. 2000, Gardner et al. 2000a). Despite many factors which influence 
implantation successful rate, speed of development to be one of indicator in which fast 
developing embryo induce more pregnancy compared to the slower one (Hasler 2000, Jacob 
et al. 2012, Muthukumar et al. 2013). For instance, Shapiro et al. (2000) demonstrated that 
pregnancy rates were higher when women transferred with expanded blastocysts compared to 
less developed one (43% vs. 17%; respectively). In addition to that, Archer et al. (2003) and 
Edgar et al. (2000) documented that reduction of implantation potential is influenced by the 
loss number of blastomere in human embryos. From these reports, blastocyst cell number is 
one of phenotype which can be a useful marker for pregnancy rate expectation. In this regard, 
serum application in embryo culture media is more effective than other macromolecules to 
improve development rate and cell number of resulted bovine blastocyst (Iwata et al. 2003, 
Lazzari et al. 2002).   
 
Initially, 100 µM AICAR concentrations showed the highest AMPK activity in blastocyst. 
Several studies reported different AICAR dosage to activate AMPK, for instance 2 mM in rat 
muscle (Kaushik et al. 2001), 750 µM in HeLa cell line (Jose et al. 2011), 1 mM in hen 
granulosa cell (Tosca et al. 2006), 1 µmol/l in mouse oocytes (Eng et al. 2007), 200 µM in 
mouse oocytes (Downs et al. 2010) and 1 mM in bovine oocytes (Bilodeau-Goeseels et al. 
2007). In agreement with that, this study showed that AICAR enhance AMPKA1 activity in 
blastocysts derived from in vitro culture. In this regard, AICAR is imidazole monophosphate 
(ZMP) which its structure similar to AMP, abundance of ZMP inside the cell change 
[AMP]:[ATP] subsequent promote AMPK activity. Moreover, sensitivity of cell in respond to 
AICAR looks like depend on the cell type, presumably the different ratio of [AMP]:[ATP] 
threshold in each type of cell which able to activate AMPK.  
 
The cell growth inhibition as the effect of activated AMPK by AICAR was demonstrated in 
this study. This was indicated by lower kinetic development speed and significantly less 
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blastocyst cell number at Day 7 compared to control (Table 5). Similarly, inhibitory effect of 
AICAR in nuclear maturation of bovine oocytes has been demonstrated in the previous study 
(Bilodeau-Goeseels et al. 2007). AMPK is the suppressor of cell proliferation by controlling 
variety of cellular events in normal cells as well as in tumor and cancer cells (Bode and Dong 
2004). AMPK activation overcomes the growth-stimulatory signaling via activation of p53-
p21 axis as well as inhibition of mTOR signaling, resulting in cell growth arrest or 
suppression of cell proliferation by disturbing cell cycle (Motoshima et al. 2006). The p21 or 
CDKN1A which is known as cyclin-dependent kinase inhibitor of CDK2 and CDK4 
complexes, regulates cell cycle progression and cell proliferation. The expression of 
CDKN1A is tightly controlled by p53 (TP53) and its induction leads to cell cycle arrest 
(Gartel and Radhakrishnan 2005, Harper et al. 1993). Cell with deficient of CDKN1A showed 
extensive cytochrome C release, mitochondrial membrane depolarization and caspase 
activation. On the contrary, increased level of CDKN1A causing cell cycle arrest and 
inhibiting DNA damage-induced apoptotic (Gartel and Radhakrishnan 2005, Harper et al. 
1993). By blocking deregulated cell cycle progression, CDKN1A can influence the sensitivity 
of mitochondria to pro-apoptotic signals in DNA damage which is one factor induced cancer 
cells as demonstrated by Le et al. (2005).  Based on the previous finding, the presence of 
AICAR in long period of bovine culture embryos might be inducing mitochondrial stress 
which increasing CDKN1A expression and associated with caspase 3 activity (Li et al. 2005). 
In addition, AICAR inhibit cell growth in term of cell proliferation primarily through 
inhibition of cholesterol and fatty acid synthesis mediated by increased level of AMPK 
activity.   
 
5.2.2 Effect of AICAR treatment on AMPK activity and lipid accumulation of bovine 
blastocysts 
 
As mentioned before, the attachment of AMP is allosteric modulator and the principal event 
to trigger AMPK activity. Under conditions of high [AMP], dephosphorylation of AMPK is 
inhibited by protein phosphatase. The upstream kinase (LKB1) then phosphorylates AMPK 
and makes it a better site for AMP attachment (Foretz et al. 2010). However, when protein 
phosphatase dephosphorylates AMPK, its make a worst site for AMP but good for ATP 
attachment, thus AMPK is deactivated. In this study, the expression pattern of PPP2CA, 
protein phosphatase, after AICAR treatment seems to be independent from AMPK activity. 
Its expression was in the same trend and not involved in the dephosphorylation of AMPK. For 
that we suspect other protein phosphatase, for example PP2A (Benziane et al. 2012, Wu et al. 
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2007) and SiT4 (Ruiz et al. 2011), might be involved in this process. These proteins 
phosphatase are need to be analyzed to see the potential of enhanced AMPK activity through 
its inhibition on bovine embryo.   
 
In the expression of lipid metabolism and mitochondrial activity gene, the present study 
demonstrated that AICAR reduces expression of ACC and simultaneously increases PGC1A 
and NQO1 expression. This result shows that enhancement of AMPK is capable to induce 
mitochondrial activity (Figure 20) and it is displayed in the reduction of lipid accumulation 
(Figure 22). As previously described, ACC is a critical enzyme that controls lipid synthesis 
and oxidation (Beckers et al. 2007). It is well known that AMPK directly phosphorylates and 
inactivates ACC subsequently suppress malonyl-CoA production. The suppression of 
malonyl-CoA then accelerates the entry of long-chain acyl-CoA into mitochondria which 
mean an increase of lipid oxidation, thus reduce lipid accumulation (Long and Zierath 2006). 
Moreover, PGC1A was reported to increase mitochondrial density and ROS detoxifying 
enzyme (Finkel 2006, O'Donnell et al. 2013, St-Pierre et al. 2006). In addition, Marmolino et 
al. (2010) demonstrated that AMPK kinase stimulation resulted in a faster up-regulation of 
PGC1A and SOD (antioxidant gene). In this regard AICAR treatment is able to rescue the 
mitochondrial biogenesis and its activity (Dugan et al. 2013).  
 
Blastocysts derived from in vitro culture with serum seem to have different structure 
including to dysfunction of mitochondria compared to either in vitro without serum or in vivo 
(Abe et al. 2002, Crosier et al. 2001). The AICAR treatment during embryo culture is one of 
intervention strategies by using small molecules to rescue the mitochondrial dysfunction. 
Small molecules therapies and metabolic manipulation generally aim to increase the capacity 
for ATP synthesis, bypass mitochondrial defect, stimulate mitochondrial biogenesis and 
reduce oxygen species level (Schiff et al. 2011). Another strategy that can be applied in effort 
to modulate mitochondrial function is to manipulate nutrient content in culture media (Schiff 
et al. 2011). For instance, Sudano et al. (2011) has combined low serum concentration and 
mitochondrial metabolic regulator to reduce lipid accumulation. Moreover, manipulation 
strategies in this regards can be expected as the magic bullet to improve mitochondrial 
condition during in vitro culture under serum. However, the way of applying that 
manipulation strategy with respect to embryonic development competence as well as gene 
expression and resulted offspring need to be elucidating accordingly in more experiment data. 
For instance, result in this study suggested that modulation of AMPK activity using AICAR 
treatment adversely impact on embryo development by decreasing blastocyst cell number. 
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Reduction of blastocyst cell number gives an information about of AICAR toxic effect that 
needs to be emphasized. However, the use of specific molecule to enhance or reduce embryo 
metabolism become a promising strategies in the effort to reduce lipid accumulation.   
 
Taking into account that lipid metabolism, particularly lipid oxidation, depends on 
mitochondrial activity, the manipulation processes which keep mitochondria normally 
function will be more effective in lowering lipid accumulation. Serving the embryo with 
either endogenous or exogenous antioxidant could be an indirect way to overcome lipid 
accumulation problem. Enhancing endogenous antioxidant level in blastocyst cultured in vitro 
has been proved to increase mitochondrial activity and lowering lipid accumulation (Amin et 
al. 2014). Meanwhile application of exogenous antioxidant, for instance melatonin in bovine 
embryo (Wang et al. 2014), enhances blastocyst quality in term of development rate and 
cryotolerance. Other growing evidence also demonstrated that supplementation of antioxidant 
in culture medium give positive effect on embryo development as compared to control 
without antioxidant (Ali et al. 2003, Hosseini et al. 2009, Lim et al. 1997, Livingston et al. 
2004, Luvoni et al. 1996, Orsi and Leese 2001, Ozawa et al. 2006). Understanding the factor 
and consequences of mitochondrial dysfunction and its complexity especially in bovine 
embryo develop in vitro, becomes a way to develop a rational treatment strategy. Indeed, the 
main consideration is the quality of resulted embryo and its ability to induce pregnancies. In 
this regards, appropriate regulation of energy is very critical for embryo development and 
viability. Thus the plasticity of embryo to adapt with the various culture environments still 
open many possibilities to develop better culture strategies which consider the accepted 
embryo physiology. 
  
5.3 Post transcriptional regulation of AMPKA1 by using miRNA in bovine granulosa 
cells as a model 
 
Growing evidences showed that miRNAs are involved in various mammalian physiological 
processes. Studies from our group reveal the present and dynamic expression of bovine 
miRNA in ovary (Hossain et al. 2009), COC’s and preimplantation embryo (Abd El Naby et 
al. 2013, Tesfaye et al. 2009), granulosa cells (Salilew-Wondim et al. 2014), follicular fluid 
(Sohel et al. 2013) and placenta (Hossain et al. 2014). In addition, ample evidences 
demonstrated the fundamental role of miRNA which play in early embryonic development. 
For example, Tripurani et al. (2011) reported that miR-196a regulates bovine newborn ovary 
homeobox gene (NOBOX) which is important for folliculogenesis and blastocysts 
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development. miR-212 demonstrated to regulates transcription factor in the germline alpha 
(FIGLA) which is essential for fertilization and early embryonic survival in bovine embryo 
(Tripurani et al. 2013). Moreover, miR-17 families are evidenced control stem cells 
differentiation in mouse embryo (Foshay and Gallicano 2009). These works, give a display 
about the exploration area of miRNA function, especially in the effort to explain the 
mechanism of specific gene that having possibilities to solve problems in animal 
reproduction. As demonstrated in experiment 1, lipid accumulation in embryo culture in vitro 
in the presence of serum is associated with the down regulation of AMPKA1. Therefore, this 
study was aimed to know the AMPKA1 post regulatory mechanism in bovine granulosa by 
using specific miRNA.   
 
5.3.1 Effect of serum on candidate miRNAs in granulosa cells 
 
The presence of serum gives better support in granulosa cells development as observed in 
cells confluency. The same result was reported by Langhout et al. (1991) that presence of 
serum increases granulosa cell number compared to those cultured without serum. Abundance 
of growth factor, insulin and antioxidant in serum, by far, to be beneficially for cell growth. 
Moreover, lipid droplet accumulation in Day 2 of granulosa culture with serum was also 
observed. As reported in the previous studies, the presence of serum during cell culture 
reported turn granulosa and theca cells into luteal cells (Kayani et al. 2009, Roberts and 
Skinner 1990) which indicated by formation of lipid droplet (Nelson et al. 1992). This 
luteinization process was histologically evidenced by Hansel et al. (1987), that granulosa cells 
will turn into large luteal cell while theca cells become the small one. Moreover, based on 
morphological examination small luteal cell characterized by large oval nucleus, flattened and 
some lipid droplet, meanwhile large luteal cell having small spherical nuclei, not flatted and 
loaded with numerous lipid droplets (Nelson et al. 1992). 
 
In the present study, low expression of AMPKA1 (Figure 24) followed by the abundance of 
miR-33b (Figure 25) in granulosa cells, indicated its post regulatory mechanism on AMPKA1 
mRNA. Similarly, activity of luciferase construct containing AMPKA1-3’UTR in our study 
was suppressed by the presence of miR-33b and the regulation was abolished by mutation in 
miR-33b binding site indicating the specific binding of miR-33b to AMPKA1 mRNA. It is 
documented that miR-33a/b is expressed in many types of cells across different species 
(Goedeke et al. 2013) and it has been reported to play important role in lipid homeostasis 
(Rayner et al. 2011a, Rayner et al. 2011b, Shao et al. 2014, Taniguchi et al. 2014). In this 
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regards, miR-33a/b reduces fatty acid oxidation through negative regulation on AMPK 
protein (Davalos et al. 2011). Therefore, inhibition of miR-33b expression is potential to 
increase AMPKA1 activity and reduce lipid accumulation as well.  
 
5.3.2 Regulation of AMPKA1 by miR-33b 
 
Inhibition of miR-33b resulted in increasing of AMPKA1 expression in this study. This result 
is in agreement with the previous studies that antagomir-33 increases the expression of gene 
related to cholesterol transport (ABCA1), mitochondrial activity (CROT, CPT1A) and energy 
balance (AMPKA1) (Rayner et al. 2011b, Rayner et al. 2011a). Lines of evidence reviewed 
by Fernandez-Hernando and Moore (2011) shows that miR-33 family regulate lipid 
homeostasis through metabolism of cholesterol, fatty acid, glucose and also insulin signaling 
that related to energy production in cell (Hardie and Pan 2002). Therefore, inhibition of miR-
33 expression in regards to regulate lipid metabolism became a promising way to treat 
metabolic disorder. 
 
Several evidences showed that increased level of ACC enhance malonyl-CoA subsequent to 
lipid accumulation (Dzamko et al. 2008, Hardie 1989, Ruderman and Prentki 2004). In the 
contrary, low expression of ACC lowering malonyl-CoA and increasing fatty acid oxidation 
respectively (Dzamko et al. 2008, Hardie 1989, Ruderman et al. 2003, Ruderman and Prentki 
2004). In this case, the presence of malonyl CoA is the limiting factor of fatty acid oxidation 
by inhibiting CPT1 activity which transporting fatty acid into mitochondria where β-oxidation 
takes place. Together with CPT2, CPT1 works in mitochondria internal membrane to 
facilitate fatty acid translocation (Bonnefont et al. 2004). However, this study showed that 
stimulation of AMPKA1 through miR-33b inhibition shows an enhanced ACC expression and 
has no effect on CPT1 expression. Indeed, high level of ACC keeps malonyl-CoA in high 
level explained no different on CPT1 expression. As mentioned before, ACC is AMPK direct 
target and both works by phosphorylation (Carling et al. 2008, Carling et al. 2011, Long and 
Zierath 2006). Due to in this experiment we use granulosa cells which undergo luteinization 
process, therefore lipid accumulation is a normal process. In this regards lipid synthesis is 
controlled by high expression of ACC due to lipid is the source of cholesterol for 
steroidogenesis (Drouineaud et al. 2007).  
 
The result of present study demonstrated that inhibition of miR-33b resulted in stimulation of 
AMPKA1 activity and increase PGC1A expression simultaneously. Reported by Marmolino 
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et al. (2010) stimulation of AMPK activity resulted in fast up-regulation of PGC1A and 
positively enhance mitochondrial activity by increasing its density and its capabilities to 
scavenging ROS (Finkel 2006, O'Donnell et al. 2013). Despite the different expectation of 
ACC and CPT1 expression, this study clearly demonstrated the tight connection between 
AMPKA1 and PGC1A as well as in experiment 1 and 2.  
 
According to the finding in this study, it is possible to speculate that down regulation of 
AMPKA1 which lead to lipid accumulation is due to the abundance of miR-33b in blastocyst 
cultured in the presence of serum (Figure 32). That result emphasized possibility to study the 
effect of miR-33b inhibition in effort to enhance AMPKA1 in bovine embryo. However, to 
elucidate miR-33b specific functions, a functional study in bovine embryo need to be 
performed. Due to the presence of zona pellucida, it is needed to consider carefully in regard 
to miRNA delivery strategies, technique, efficiency and toxic effect during embryo 
development (Joo et al. 2014). So far, the known technique to deliver miRNA into zygote is 
by microinjection (Tripurani et al. 2011, Tripurani et al. 2013) and free injection method also 
being reported (Joo et al. 2014). Recently, functional study of genes by miRNAs becomes a 
growing area in different research field. However, little research has been conducted to 
understand gene function post transcriptionally in embryo development to explain underlying 
molecular mechanism. Huge efforts are needed to explore this area, especially in mammalian 
embryos as general or in bovine as the focus model.  
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6 Summary 
 
The major problem associated with in vitro production of bovine embryos in the presence of 
serum is lipid accumulation resulting in low cryotolerance compared to those derived from in 
vivo or without serum. It is suggested that lipid accumulation occurs from culture 
environment which modifies internal embryo properties, however its molecular mechanism is 
largely unknown. A recent study in our group, found AMPKA1 down regulation, part of 
AMPK heterotrimetrix complex, in a transcriptome profile of blastocyst derived in vitro 
compared to in vivo. Taking into account that AMPK is a lipid metabolism regulator, it is 
suggested that down regulation of AMPK is one factor which is responsible for elevated lipid 
accumulation. 
 
In order to know the role of AMPK on lipid metabolism during IVC of bovine embryos, the 
first experiment was divided into 3 parts. In experiment 1 part 1, two groups of blastocysts 
were produced by in vivo and in vitro, followed by expression analysis of genes in AMPK 
pathway (AMPKA1, AMPKA2), lipid metabolism (ACC) and mitochondrial activities 
(CPT1, PGC1A). Three biological replicates, each containing 10 embryos per group, were 
used for total RNA isolation using Arcturus®PicoPure®RNA isolation kit. Furthermore, 
cDNA synthesis was performed in 20 µl reaction volume and mRNA transcripts were 
measured in qRT-PCR using relative standard curve method and normalized by GAPDH. 
Moreover, blastocyst lipid content was stained with oil red and spectrophotometer was used to 
quantify the lipid content. In the second part of experiment 1, embryos were produced with 
and without serum followed by gene expression analysis of genes in AMPK pathway 
(AMPKA1, AMPKA2, STK11), lipid metabolism (SREBP1, SREBP2, ACC), antioxidant 
(NQO1) and mitochondrial activities (CPT1, PGC1A). Moreover, AMPKA protein 
expression at blastocyst stage was analyzed using immunofluorescence method and 
mitochondrial activity was detected using MitoTracker under confocal laser scanning 
microscope. To investigate whether macromolecules supplementation affected AMPKA1 
down regulation, in experiment 1 part 3 blastocysts were produced using different 
macromolecules namely serum, BSA and BSAFAF. Blastocyst development rate and 
expression of genes in AMPK pathway (AMPKA1, AMPKA2), lipid synthesis (ACC), 
mitochondrial activities (CPT1, PGC1A) were compared between groups. In addition, protein 
expression analysis, phosphorylation site of AMPKA at Thr172, ROS level and mitochondrial 
activity were also performed. Result of first experiment showed that compared to blastocysts 
derived from in vivo or in the absence of serum, the expression level of AMPKA1 was 
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significantly (p<0.05) lower in blastocysts produced with serum. The present study found that 
down regulation of AMPKA1 mRNA level increased the lipid content compared to in vivo, 
BSA and BSAFAF. A similar trend was confirmed in which higher (p<0.05) mRNA level of 
ACC and low expression of CPT1, NQO1 and PGC1A in culture with serum was found. 
Moreover, low phosphorylation site of AMPK, high level of ROS and low mitochondrial 
activities were followed by lipid accumulation in blastocysts cultured in the presence of 
serum (abundant fatty acid), in contrast to blastocysts derived from culture with BSAFAF 
(less fatty acid) supplementation. Results of the first experiment demonstrated the relationship 
of AMPK activity, generation of ROS, mitochondrial activity and lipid accumulation during 
embryo culture in vitro. Collectively, this study underlined the relevance of the AMPK 
pathway in establishing an anabolic/lipogenic bovine embryo phenotype and notably the 
inability of the mitochondria to metabolize the abundant lipid in culture environment. 
Therefore, altering AMPK activity during in vitro embryo culture might be beneficial to 
reduce lipid accumulation. 
 
In the effort to reduce lipid accumulation of in vitro derived blastocyst through AMPK 
activity modulation, AICAR was applied in embryo culture media. In thi  part of experiment, 
bovine blastocysts were produced in culture media supplemented with 100 µM AICAR, 
followed by investigation of embryo development rate, blastocyst cell number, gene 
expression, AMPK protein analysis, mitochondrial activities and lipid accumulation. As the 
result, AICAR treatments showed no difference in embryo development rate but significantly 
(p<0.05) reduced blastocyst cell number compared to those not supplemented with AICAR. 
AICAR was found to increase (p<0.05) the expression of genes in AMPK pathway 
(AMPKA1, STK11), antioxidant (NQO1) and mitochondrial activities (CPT2, PGC1A), the 
lipid synthesis gene (ACC) was downregulated (p<0.05). In addition, AMPKA protein and 
mitochondrial activities were enhanced by AICAR treatment and reflected in the trend of 
blastocysts lipid content reduction.  
 
In order to elucidate the potential regulatory mechanism of AMPKA1 by miRNA, specific 
miRNA that potentially targeted to AMPKA1 were predicted, profiled and validated in 
experiment 3. For that, a series of in silico analysis was performed and 11 miRNAs were 
predicted to target AMPKA1. In the miRNA profiling analysis using three reference genes 
(U6, Snord48 and 5S) miR-33b was found to be the most abundant one compared to other 
miRNA candidates. Similar result was demonstrated in luciferase activity of plasmid 
containing AMPKA1-3’UTR where its activity was suppressed by the presence of miR-33b 
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and the regulation was abolished by mutation in miR-33b binding site which indicate the 
specific binding of miR-33b to AMPKA1 mRNA. In the effort to increase AMPK activity, 50 
nM of miR-33b were transfected to granulosa cells followed by gene expression analysis of 
AMPKA1, ACC, CPT1 and PGC1A. As a result, inhibition of miR-33b significantly (p<0.05) 
increases AMPKA1, ACC and PGC1A, however expression of CPT1 was not affected. High 
level of ACC expression suggested a granulosa luteinization process. 
 
Altogether, the present study showing culture dependent down regulation of AMPKA1 
resulted in enhanced lipid accumulation due to reduced mitochondrial activities. The result of 
present study also highlights that AMPKA1 activities can be modulated by using artificial 
activator and specific miRNA inhibitor. 
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7 Zusammenfassung 
 
Das Hauptproblem der in vitro Produktion von bovine Embryonen ist die durch Serum 
entstehende Lipidanreicherung sowie die daraus resultierende verringerte Kyrotoleranz im 
Vergleich zu den in vivo oder ohne Serum entstehenden Embryonen. Es wird angenommen, 
dass die Lipidanreicherung unter Kulturbediungungen die inneren embryonalen Eigenschaften 
modifiziert. Allerdings sind die dafür verantwortlichen molekularen Mechanismen immer 
noch unklar. Die neuesten Studien unsere Arbeitsgruppe ergaben, dass AMPKA1, ein Teil des 
AMPK heterotrimetrix Komplex, in in vitro Blastozyten im Vergleich zu in vivo entstandenen 
Blastozyten runter reguliert war. Vor dem Hintergrund, dass AMPK ein Regulator des 
Lipidmetabolismus ist, kann angenommen werden, dass die runter Regulierung des AMPK 
ein Faktor für die erhöhte Lipidanreicherung sein könnte.  
 
Um die Rolle des AMPK im Lipidmetabolsimus während der IVK von bovine Embryonen zu 
verstehen, wurden in der vorliegenden Studie drei Experimente durchgeführt. Im ersten 
Experiment wurden zwei Gruppen aus in vivo und in vitro produzierten Blastozyten für die 
Expressionsanalyse von Genen des AMPK Signalwegs (AMPKA1, AMPKA2), des 
Lipidmetabolismus (ACC) und der Mitochondrienaktivität (CPT1, PGC1A) eingesetzt. 
Insgesamt wurden drei biologische Wiederholungen verwendet und jede bestand aus 10 
Embryonen. Die RNA Isolierung erfolgte mittels dem Arcturus®PicoPure®RNA Kit und für 
die anschließende cDNA Synthese wurde ein Reaktionsvolumen von 20 µl eingesetzt. Mittels 
qRT-PCR und der relativen Standardkurvenmethode wurde die mRNA Expressionsanalyse 
durchgeführt. Die anschließende Normalisierung erfolgte mit dem Houskeeping Gen 
GAPDH. Zusätzlich wurde der Lipidgehalt der Blastozyten mit der Oil Red Anfärbung und 
mit Hilfe des Spektrophotometers untersucht. Im zweiten Teil des ersten Experiments wurden 
Embryonen mit und ohne Serum erzeugt und die Expression von Genen des AMPK 
Signalwegs (AMPKA1, AMPKA2, STK11), des Lipidmetabolismus (SREBP1, SREBP2, 
ACC), der Antioxidant- (NQO1) und Mitochondrienaktivitäten (CPT1, PGC1A) analysiert. 
Zusätzlich wurde die AMPKA Proteinexpression der Blastozysten mittels Immunfluoreszen 
bestimmt und die Mitochondrienaktivität durch MitoTracker unter dem Konfokalmikroskop 
untersucht. Um festzustellen, ob Makromolekülergänzungen die runter Regulierung des 
AMPKA1 beeinflussen, wurden im dritten Teil des ersten Experiments Blastozysten durch die 
Zugabe unterschiedlicher Makromoleküle, die Seren BSA und BSAFAF, produziert. Die 
Blastozysten Entwicklungsrate und die Expression der Gene des AMPK Signalwegs 
(AMPKA1, AMPKA2), der Lipidsynthese (ACC), der Mitochondrienaktivität (CPT1, 
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PGC1A) wurden zwischen den Gruppen verglichen. Zusätzlich wurden Analysen zur 
Proteinexpression, für die Bestimmung der Phosphorylierungsstelle im AMPKA am Thr172, 
des ROS Levels und der Mitochondrienaktivität durchgeführt. Die Ergebnisse des ersten 
Experiments zeigten, dass im Vergleich zu in vivo Blastozysten oder ohne Serum kultivierte 
Blastozysten das AMPKA1 Expressionsniveau in Serum kultivierter Blastozysten signifikant 
(p<0,05) geringer war. Die vorliegende Studie erbrachte, dass die AMPKA1 runter 
Regulierung den Lipidgehalt verstärkte im Vergleich zu in vivo, BSA und BSAFAF 
produzierten Blastozysten. Ein ähnlicher Trend bestätigte sich mit einem höheren (p<0,05) 
ACC mRNA Level und einer geringeren Genexpression von CPT1, NQO1 und PGC1A bei 
der Zugabe von Serum. Zusätzlich konnte eine geringe Phosphorylierung des AMPKA, ein 
hohes ROS Level und eine geringe Mitochondrienaktivität identifiziert werden, gefolgt von 
einer Lipidanreicherung in Blastozysten die mit Serum (reich an Fettsäuren) produziert 
wurden, im Vergleich zu Blastozysten die unter der BSAFAF (geringer Fettsäureanteil) 
Zugabe erzeugt wurden. Die Ergebnisse des ersten Experiments zeigten einen deutlichen 
Zusammenhang der AMPK Aktivität mit der ROS Entwicklung, der Mitochondrienaktivität 
und der Lipidanreicherung während der in vitro Embryokultur. Insgesamt hebt diese Studie 
die Relevanz des AMPK Signalwegs bei der Entstehung eines anabol/lipogenen bovinen 
Embryos hervor sowie die Unfähigkeit der Mitochondrien den Lipidüberfluss unter 
Kulturbedingungen zu metabolisieren. Deshalb könnte eine veränderte AMPK Aktivität 
während der in vitro Kultur nützlich für eine reduzierte Lipidanreicherung sein. 
 
Mit dem Ziel die Lipidanreicherung in in vitro produzierten Blastozysten, durch die 
Veränderung der AMPK Aktivität, zu reduzieren, wurde AICAR dem Embryokulturmedium 
zugefügt. In diesem Teil des Experiments wurden bovine Blastozysten in Kulturmedium das 
mit 100 µM AICAR angereichert war, produziert. Im Anschluss daran wurde die 
Embryoentwicklungsrate, die Blastozystenzellzahl, die Genexpression, die AMPK 
Proteinexpression, die Mitochondrienaktivität und die Lipidanreicherung untersucht. Dabei 
zeigte sich, das die Zugabe von AICAR keine Veränderungen in der 
Embryoentwicklungsrate, aber eine signifikant (p<0,05) reduzierte Blastozystenzellzahl im 
Vergleich zu den AICAR unbehandelten Blastozysten bewirkte. Weiterhin, erhöhte AICAR 
(p<0.05) die Expression von Genen des AMPK Signalwegs (AMPKA1, STK11), der 
Antioxidant- (NQO1) und Mitochondrienaktivität (CPT2, PGC1A) und reduzierte sie bei 
Genen der Lipidsynthese (ACC) (p<0.05). Durch die AICAR Zugabe waren zusätzlich die 
AMPKA Protein- und Mitochondrienaktivitäten verbessert, das spiegelt den reduzierten 
Trend des Lipidgehalts in Blastozysten wieder. 
Zusammenfassung 
 
105
Um den potentiellen regulatorischen Mechanismus des AMPKA1 durch miRNA zu 
verdeutlichen, wurde nach spezifischen miRNAs deren Zielgen möglicherweise AMPKA1 
sein könnte, gesucht. Dafür wurden eine Reihe von in silico Untersuchungen durchgeführt 
und 11 miRNAs ermittelt. In der miRNA Profilanalyse, unter Verwendung von drei 
Referenzgenen (U6, Snord48 und 5S), war die miR-33b im Vergleich zu den anderen 
Kandidaten miRNAs am meisten angereichert. Ein ähnliches Ergebnis erbrachte die 
Bestimmung der Luciferaseaktivität des AMPKA1-3’UTR Plasmids, wobei dessen Aktivität 
durch die miR-33b Präsenz unterdrückt und die Regulierung durch die Mutation in der miR-
33b Bindungsstelle abgeschwächt war. Dieses deutet auf die spezifische Bindung der miR-
33b mit der AMPKA1 mRNA hin. Mit dem Ziel, die AMPK Aktivität zu erhöhen, wurden 50 
nM miR-33b in Granulosazellen transfiziert und die Genexpression von AMPKA1, ACC, 
CPT1 und PGC1A überprüft. Das Ergebnis zeigte, dass die Unterdrückung von miR-33b 
(p<0.05) die Expression von AMPKA1, ACC und PGC1A signifikant erhöhte, während kein 
Einfluss auf die CPT1Genexpression festgestellt wurde. Die hohe ACC Genexpression deutet 
auf den natürlichen Granulosaluteinisierungsprozess hin. 
  
Zusammenfassend zeigte die vorliegende Studie, dass die kulturbedingte runter Regulierung 
des AMPKA1 in einer erhöhten Lipidanreicherung durch die reduzierte 
Mitochondrienaktivität resultiert. Ebenfalls heben die Ergebnisse dieser Studie hervor, dass 
die AMPKA1 Aktivität durch den Einsatz von künstlichen Aktivatoren und spezifischen 
miRNA Inhibitoren moduliert werden kann.  
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